Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Giuseppe Viale
Based on 155 articles published since 2007
||||
Expertise Level
The expertise of Giuseppe Viale ranks in the
  • Top 0.023%
  • ... of 251,815 published authors worldwide on Breast Neoplasms
  • ... from 2007 through 2018
  • ... based on contributions to 155 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
Expert badge
similar to this:
 
Work Locations
Details
Most likely:    European Institute of Oncology      
2017
  • European Institute of Oncology, Milano, Italy. Electronic address: · Champalimaud Clinical Center, Lisbon, Portugal. · European School of Oncology, Milano, Italy. · European Institute of Oncology, Milano, Italy; University of Milan, Milano, Italy. · European Institute of Oncology, Milano, Italy. · Pubmed 27876474
  • Molecular Biotechnology Center, Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin 10126, Italy. · Molecular Biotechnology Center, Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin 10126, Italy. Electronic address: · Department of Medical Sciences, University of Torino, Turin, Italy; Pathology Unit, Department of Laboratory Medicine, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Turin, Italy. · IFOM, The FIRC Institute for Molecular Oncology Foundation, Milan, Italy. · Program of Molecular Medicine, IEO, European Institute of Oncology, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy; Department of Oncology and Hemato-oncology (DIPO), University of Milan, Milan, Italy. · Department of Cell Physiology and Metabolism, University of Geneva, Geneva, Switzerland. · Molecular Biotechnology Center, Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin 10126, Italy; Department of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA. · Unit of Investigative Oncology, Candiolo Cancer Institute - FPO, IRCCS, Candiolo (TO), Italy. · Institute for Research in Biomedicine, Università della Svizzera Italiana, Bellinzona, Switzerland. · Department of Biological Science and Bioengineering, Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an, Shaanxi, P. R. China. · Program of Molecular Medicine, IEO, European Institute of Oncology, Milan, Italy; Department of Oncology and Hemato-oncology (DIPO), University of Milan, Milan, Italy. · Department of Medical Sciences, University of Torino, Turin, Italy; Unit of Pathology, Candiolo Cancer Institute - FPO, IRCCS, Candiolo (TO), Italy. · IFOM, The FIRC Institute for Molecular Oncology Foundation, Milan, Italy; Program of Molecular Medicine, IEO, European Institute of Oncology, Milan, Italy; Department of Oncology and Hemato-oncology (DIPO), University of Milan, Milan, Italy. · Molecular Biotechnology Center, Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin 10126, Italy. Electronic address: · Pubmed 29017056
  • Division of Radiation Oncology, European Institute of Oncology, Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy. · Unit of Medical Physics, European Institute of Oncology, Milan, Italy. · Division of Radiation Oncology, European Institute of Oncology, Milan, Italy; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy. · Division of Breast Surgery, European Institute of Oncology, Milan, Italy. · Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy; Division of Breast Surgery, European Institute of Oncology, Milan, Italy. · Division of Radiation Oncology, European Institute of Oncology, Milan, Italy; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy. Electronic address: · Division of Pathology, European Institute of Oncology, Milan, Italy; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy. · Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy; Department of Medical Imaging and Radiation Sciences, European Institute of Oncology, Milan, Italy. · Pubmed 28816144
  • Transformative Pathology, Ontario Institute for Cancer Research (OICR), MaRS Centre, 661 University Avenue, Suite 510, Toronto, ON M5G 0A3, Canada; University of Edinburgh Cancer Research Centre, Institute of Genetics and Molecular Medicine, The University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK. Electronic address: · Cancer Research UK Clinical Trials Unit, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK. Electronic address: · International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA. Electronic address: · Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University, Charterhouse Square, London EC1M 6BQ, UK. Electronic address: · Department of Pathology, Elizabeth University Hospital, 1345 Govan Road, Govan, Glasgow G51 4TF, UK. Electronic address: · Department of Pathology, European Institute of Oncology and University of Milan, Via Giuseppe Ripamonti, 435, 20141 Milan, Italy. Electronic address: · Breast Center, Kantonsspital, St. Gallen, and Swiss Group for Clinical Cancer Research SAKK, CH-9007 St. Gallen, Switzerland. Electronic address: · Department of Medical Oncology, Erasmus MC Cancer Institute, PO Box 5201, Rotterdam 3008 AE, The Netherlands. Electronic address: · Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands. Electronic address: · Division of Surgery, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands. Electronic address: · Leicester Clinical Trials Unit, University of Leicester, Leicester LE5 4PW, UK. Electronic address: · Surgical Oncology, University of Newcastle, Calvary Mater Newcastle Hospital, Locked Bag 7, HRMC, Newcastle, NSW 2310, Australia. Electronic address: · Department of Pathology, European Institute of Oncology and University of Milan, Via Giuseppe Ripamonti, 435, 20141 Milan, Italy. Electronic address: · Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University, Charterhouse Square, London EC1M 6BQ, UK. Electronic address: · Academic Department of Biochemistry, Royal Marsden Hospital, and Endocrinology, Breakthrough Breast Cancer Centre, Institute of Cancer Research, Fulham Road, London SW3 6JJ, UK. Electronic address: · Cancer Research UK Clinical Trials Unit, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK. Electronic address: · Pubmed 28494403
  • Institute of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland. · Private Group Practice for Pathology and PathoPlan GbR, Lübeck, Germany. · Department of Pathology and Laboratory of Pathology, West China Hospital, Sichuan University, Chengdu, China. · Institute of Pathology, University Erlangen-Nürnberg, Erlangen, Germany. · Centre Jean Perrin, Centre regional de Lutte contre le cancer d'Auvergne, Clermont-Ferrand, France. · European Institute of Oncology, University of Milan, Milan, Italy. · Institute of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Pathology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China. · Institute of Pathology, Klinikum Region Hannover, Hannover, Germany. · BioNTech Diagnostics GmbH, Mainz, Germany. · Department of Oncology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland. · ACOMED Statistik, Leipzig, Germany. · Department of Pathology, Heidelberg University Hospital, Heidelberg, Germany. · Transformative Pathology, Ontario Institute for Cancer Research (OICR), Toronto, ON, Canada. · Pubmed 28490348
  • Istituto Europeo di Oncologia, Milan, Italy. · IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy. · Dipartimento di Oncologia e Emato-oncologia, Università degli Studi di Milano, Milan, Italy. · Istituto Europeo di Oncologia, Milan, Italy · Pubmed 28298340
  • Department of Surgery and Cancer, Imperial College London, London, UK. · Department of Experimental Oncology, European Institute of Oncology Milan, Italy. · Hematology Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, IT. · Swammerdam Institute for Life Sciences, University of Amsterdam. · Genomics Division, Lawrence Berkeley National Laboratory, 1 Cyclotron Road, Berkeley, CA, USA. · Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Arcavacata di Rende (CS), Italy. · Division of Stem Cells and Cancer, Deutsches Krebsforschungszentrum (DKFZ), and Institute for Stem Cell Technology and Experimental Medicine GmbH, Heidelberg, Germany. · Division of Pathology, European Institute of Oncology and University of Milan, School of Medicine, Milan, Italy. · Department of Oncology and Hemato-oncology, University of Milano, Milan, IT. · Division of Medical Senology, European Institute of Oncology, IEO, Milan, Italy. · Department of Biosciences, University of Milano, Milan, IT. · Pubmed 28112739
  • Division of Breast Surgery, European Institute of Oncology, Milan, Italy. Electronic address: · Division of Breast Surgery, European Institute of Oncology, Milan, Italy. · Division of Plastic and Reconstructive Surgery, European Institute of Oncology, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Division of Cancer Prevention and Genetics, European Institute of Oncology, Milan, Italy. · Early Drug Development for Innovative Therapies Division, European Institute of Oncology, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy; University of Milan, School of Medicine, Milan, Italy. · Division of Breast Surgery, European Institute of Oncology, Milan, Italy; University of Milan, School of Medicine, Milan, Italy. · Pubmed 27810700
2016
  • IBCSG Central Pathology Laboratory, Department of Pathology and Laboratory Medicine, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · University of Milan, Milan, Italy. · International Breast Cancer Study Group (IBCSG) Statistical Center, Boston, MA, USA. · Harvard T. H. Chan School of Public Health, Boston, MA, USA. · IBCSG Central Pathology Laboratory, Department of Pathology and Laboratory Medicine, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · University of Milan, Milan, Italy. · Division of Experimental Therapeutics, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · National Institute of Oncology, Ráth György u. 7/9, Budapest, 1122, Hungary. · Breast Center St. Gallen, Kantonsspital, St. Gallen, Switzerland. · Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. · Divisione di Oncologia, Ospedale degli Infermi, Viale Settembrini 2, 47923, Rimini, Italy. · Program for Breast Health, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · International Breast Cancer Study Group, Translational Research Coordination and Central Pathology Office, IBCSG Coordinating Center, Effingerstrasse 40, 3008, Bern, Switzerland. · Frontier Science and Technology Research Foundation, Boston, MA, USA. · Division of Medical Senology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Harvard Medical School, Boston, MA, USA. · Pubmed 27372069
  • Department of Pathology, European Institute of Oncology and University of Milan, Via Ripamonti 435, 20141, Milan, Italy. · Department of Statistics, European Organization for Research and Treatment of Cancer, Brussels, Belgium. · Medical Affairs, Agendia, Amsterdam, The Netherlands. · Department of Pathology, European Institute of Oncology and University of Milan, Via Ripamonti 435, 20141, Milan, Italy. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA. · Department of Surgery, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal. · Pubmed 26820652
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium2Medical Oncology Clinic, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Breast and Gynecological Surgery, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark6Danish Breast Cancer Cooperative Group, Copenhagen, Denmark. · Department of Pathology, European Institute of Oncology, University of Milan, Milan, Italy. · Avera Cancer Institute, Sioux Falls, South Dakota. · International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · International Breast Cancer Study Group Coordinating Center and Central Pathology Office, Bern, Switzerland. · Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark6Danish Breast Cancer Cooperative Group, Copenhagen, Denmark11Department of Oncology, Odense University Hospital, Odense, Denmark12AgeCare, Odense University Hospital, Odense. · Medical Oncology Clinic, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Villejuif, France14INSERM U1018, CESP, Université Paris-Sud, Villejuif France. · Pubmed 26633571
  • Division of Cancer Prevention and Genetics, European Institute of Oncology, Via Ripamonti 435, Milan, 20141, Italy. · International Breast Cancer Study Group (IBCSG) Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard T. H. Chan School of Public Health, 450 Brookline Avenue, Boston, MA, 02215, USA. · Institute of Oncology of Southern Switzerland (IOSI), Bellinzona, Switzerland. · International Breast Cancer Study Group, Bern, Switzerland. · Swiss Group for Clinical Cancer Research SAKK, Lugano Viganello, Switzerland. · IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA, 02215, USA. · Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Via Ripamonti 435, Milan, 20141, Italy. · Division of Cancer Prevention and Genetics, European Institute of Oncology, Via Ripamonti 435, Milan, 20141, Italy. · International Breast Cancer Study Group (IBCSG) Coordinating Center, Effingerstrasse 40, Bern, CH-3008, Switzerland. · Division of Medical Senology, European Institute of Oncology, Via Ripamonti 435, Milan, 20141, Italy. · IBCSG Statistical Center, Frontier Science and Technology Research Foundation, Boston, MA, USA. · Dana-Farber Cancer Institute, Department of Biostatistics and Computatonal Biology, 450 Brookline Ave, Boston, MA, 02215, USA. · International Breast Cancer Study Group and University of Sydney School of Public Health, Sydney, Australia. · IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Harvard Medical School, Frontier Science and Technology Research Foundation, 450 Brookline Avenue, Boston, MA, 02215, USA. · Program for Breast Health, European Institute of Oncology, Via Ripamonti 435, Milan, 20141, Italy. · Translational Research Coordination and Central Pathology Office, IBCSG Coordinating Center, Effingerstrasse 40, Bern, CH-3008, Switzerland. · Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · National Cancer Institute of Canada, Kingston, ON, Canada. · Pubmed 27825388
  • Medical Oncology Division & Breast Unit, 72100 Brindisi, Italy. Electronic address: · Pathology Division, European Institute of Oncology, University of Milan, 20141 Milan, Italy. · Medical Oncology & Breast Unit, University of Verona, Azienda Ospedaliera Universitaria Integrata, 37134 Verona, Italy. · Medical Oncology Division & Breast Unit, 72100 Brindisi, Italy. · Biostatistics, Regina Elena National Cancer Institute, 00144 Rome, Italy. · Pubmed 27750105
  • University of Milan, Istituto Europeo di Oncologia, Milan, Italy. · UCL Advanced Diagnostics, London, UK. · Clarient Pathology Services, Aliso Viejo, CA, USA. · Dako, An Agilent Technologies Company, Glostrup, Denmark. · Dx-Rx Institute, Baunevaenget 76, DK-3480 Fredensborg, Denmark. Electronic address: · Pubmed 27461826
  • Institute of Pathology, Charité Universitätsmedizin Berlin, Berlin, Germany. · German Cancer Consortium (DKTK), Partner site Berlin, Berlin, Germany. · VMscope GmbH, Berlin, Germany. · Service de Biostatistique et d'Epidémiologie; Institute Gustave Roussy, Villejuif, France. · German Breast Group (GBG), Neu-Isenburg, Germany. · Clinic of Gynecology and Obstetrics, Sana Klinikum Offenbach, Offenbach, Germany. · Indiana University School of Medicine, Indianapolis, IN, USA. · Clinical Institute of Pathology, Medizinische Universität Wien, Wien, Austria. · Department of Pathology & Molecular Medicine, McMaster University, Hamilton, ON, Canada. · Weill Cornell Medical College, Doha, Qatar. · Harvard Medical School, Boston, MA, USA. · Tumor Pathology Department, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice, Poland. · Institut für Pathologie, Medizinische Hochschule Hannover, Hannover, Germany. · Pathology, GZA Ziekenhuizen, Sint-Augustinus, Wilrijk, Belgium. · Radiation Oncology and Pathology, Weill Cornell Medical College, New York, NY, USA. · Department of Pathology and Cytology GZA Hospitals, Wilrijk, Belgium. · Department of Pathology University Hospitals Leuven, Leuven, Belgium. · Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · Anatomical Pathology, Vancouver Hospital, Vancouver, BC, Canada. · Division of Pathology, NSABP, Pittsburgh, PA, USA. · Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, ON, Canada. · UQ School of Medicine and Pathology Queensland, The University of Queensland Centre for Clinical Research, Brisbane, QLD, Australia. · ERTICa Research Team, Department of Pathology, Jean Perrin Comprehensive Cancer Center, University of Auvergne EA4677, Clermont-Ferrand, France. · Division of Pathology and Laboratory Medicine, University of Milan, Milan, Italy. · Department of Pathology, Yale University School of Medicine, New Haven, CT, USA. · Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA, USA. · Department for Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Sektion Gynäkopathologie, Pathologisches Institut, University of Heidelberg, Heidelberg, Germany. · Anatomie Pathologique, Institut Jules Bordet, Brussels, Belgium. · Molecular Diagnostic Oncology, Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Department of Pathology, European Institute of Oncology, University of Milan, Milan, Italy. · Department of Pathology, Netherlands Cancer Institute, Amsterdam, Netherlands. · Jules Bordet Institute, Brussels, Belgium. · Department of Gynecology, Helios-Klinikum Berlin-Buch, Berlin, Germany. · Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen EMN, Friedrich-Alexander University Erlangen, Erlangen, Germany. · Department of Gynecology, Klinikum Südstadt Rostock, Rostock, Germany. · Molecular Immunology Unit, Institut Jules Bordet, Brussels, Belgium. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Univ. Paris Sud, Univ. Paris-Saclay, Villejuif, France. · Division of Research and Clinical Medicine, Peter MacCallum Cancer Center, Melbourne, VIC, Australia. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Brussels, Belgium. · Pubmed 27363491
  • IFOM, the FIRC Institute of Molecular Oncology, Milan, Italy. · IFOM, the FIRC Institute of Molecular Oncology, Milan, Italy Department of Pediatrics, Graduate School of Medicine The University of Tokyo, Tokyo, Japan. · Molecular Medicine Program, European Institute of Oncology, Milan, Italy. · Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy Department of Pathology, European Institute of Oncology, Milan, Italy. · IFOM, the FIRC Institute of Molecular Oncology, Milan, Italy Molecular Medicine Program, European Institute of Oncology, Milan, Italy Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy. · IFOM, the FIRC Institute of Molecular Oncology, Milan, Italy Molecular Medicine Program, European Institute of Oncology, Milan, Italy. · Institut Curie, PSL Research University, Paris Cedex 05, France Centre National de la Recherche Scientifique, Unité Mixte de Recherche 144 CNRS UMR 144, Paris Cedex 05, France. · IFOM, the FIRC Institute of Molecular Oncology, Milan, Italy Molecular Medicine Program, European Institute of Oncology, Milan, Italy · Pubmed 27255086
  • Division of Research and Clinical Medicine, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Frontier Science Foundation- Hellas, Athens, Greece3University of Athens, Athens, Greece. · Frontier Science Foundation- Hellas, Athens, Greece4Athens University of Economics and Business, Athens, Greece. · Frontier Science Foundation- Hellas, Athens, Greece. · Avera Cancer Institute, Department of Molecular and Experimental Medicine, Sioux Falls, South Dakota. · Department of Pathology, University of Chicago, Chicago, Illinois. · BREAST Datacentre, Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. · University of Milan, European Institute of Oncology, Milan, Italy. · Targos Molecular Pathology GmbH, Kassel, Germany. · Department of Medicine, Institute Jules Bordet, Universite Libre de Bruxelles and Breast International Group (BIG), Brussels, Belgium12Breast International Group (BIG), Brussels, Belgium. · Royal Marsden Hospital, London, England. · INSERM U1018 CESP, Service de Biostatistique et d'Epidémiologie, Villejuif, France. · Pubmed 27100299
2015
  • Department of Histopathology and NIH Cambridge Biomedical Research Centre, Addenbrooke's Hospital, Cambridge, UK. · Department of Pathology, Yale University, New Haven, CT, USA. · Department of Pathology, European Institute of Oncology and University of Milan, Milan, Italy. · Edinburgh Cancer Research UK Centre,University of Edinburgh, Edinburgh, UK. · Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA. · Institute of Pathology, Charité Hospital, Berlin, Germany. · Department of Biopathology, Institut Bergonié, Bordeaux, France. · Department of Pathology, Centre Jean Perrin and Université d'Auvergne, Clermont-Ferrand, France. · Division of Subspecialty General Surgery, Mayo Clinic, Rochester, MN, USA. · Early Drug Development for Innovative Therapies Division, European Institute of Oncology, Milan, Italy. · Edinburgh Breast Unit, Western General Hospital, Edinburgh, UK. · Carol Franc Buck Breast Care Center, University of California, San Francisco, CA, USA. · Department of Radiotherapy and Radiation Oncology, Landeskrankenhaus, Paracelsus Medical University, Salzburg, Austria. · Department of Gynecology and Obstetrics, Interdisciplinary Breast Center, Klinikum Esslingen, Esslingen, Germany. · Institute of Pathology, Medical University of Graz, Graz, Austria. · Department of Gynecology, General Hospital Leoben, Leoben, Austria. · German Breast Group, Neu-Isenburg, and Department of Gynecology and Obstetrics, University Women's Hospital, Frankfurt, Germany. · Department of Radiation Oncology, Ohio State University, Columbus, OH, USA. · Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 26205180
  • Avera Cancer Institute, 1000 E 23rd Street, Sioux Falls, SD, 57105, USA. · Department of Biostatistics and Computational Biology, International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard T. H. Chan School of Public Health, 450 Brookline Ave, Boston, MA, 02215, USA. · VM Institute of Research, 6100 Av Royalmount, Montréal, QC, H4P 2R2, Canada. · AKESOgen, Inc., 3155 Northwoods Pl NW, Norcross, GA, 30071, USA. · Avera Cancer Institute, 1000 E 23rd Street, Sioux Falls, SD, 57105, USA. · Genomic and Molecular Pathology, University of Chicago, 900 E 57th St. Room 1260D, Chicago, IL, 60637, USA. · International Breast Cancer Study Group Coordinating Center and Central Pathology Office, Effingerstrasse 40, 3008, Bern, Switzerland. · Division of Pathology and Laboratory Medicine, International Breast Cancer Study Group Central Pathology Office, European Institute of Oncology, Via Ripamonti 435, 20146, Milan, Italy. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, Via Ripamonti 435, 20146, Milan, Italy. · Breast Center, Kantonsspital St. Gallen, Rorschacher Strasse 95, 9007, St. Gallen, Switzerland. · Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. · International Breast Cancer Study Group, Bern, Switzerland. · International Breast Cancer Study Group, Bern, Switzerland. · Auckland City Hospital, PO Box 26498, Epsom, Auckland, 1344, New Zealand. · Australia and New Zealand Breast Cancer Trials Group, Newcastle, Australia. · Department of Oncology, Multidisciplinary Breast Center, KULeuven (University of Leuven), University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium. · Institute Georges François Leclerc, 1 Rue Professeur Marion, BP 77 980, 21079, Dijon Cedex, France. · International Breast Cancer Study Group Coordinating Center, Effingerstrasse 40, 3008, Bern, Switzerland. · International Breast Cancer Study Group Statistical Center, Frontier Science and Technology Research Foundation, 450 Brookline Ave, Boston, MA, 02215, USA. · International Breast Cancer Study Group, Bern, Switzerland. · University of Sydney, Sydney, Australia. · International Breast Cancer Study Group, Bern, Switzerland. · Program for Breast Health (Senology), European Institute of Oncology, Via Ripamonti 435, 20146, Milan, Italy. · International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, Harvard T.H. Chan School of Public Health, Frontier Science and Technology Research Foundation, 450 Brookline Ave, Boston, MA, 02215, USA. · International Breast Cancer Study Group, Bern, Switzerland. · Institute of Oncology of Southern Switzerland (IOSI), Ospedale Italiano, Via Capelli, 6962, Viganello, Switzerland. · International Breast Cancer Study Group Central Pathology Office, Division of Pathology and Laboratory Medicine, European Institute of Oncology, University of Milan, Via Ripamonti 435, 20146, Milan, Italy. · Division of Hematology/Oncology, University of Michigan Comprehensive Cancer Center, 1500 E Medical Cntr Drive/SPC 5946, Ann Arbor, MI, 48109, USA. · Department of Biostatistics and Computational Biology, International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave, Boston, MA, 02215, USA. · Pubmed 26590813
  • Division of Medical Oncology, E.O. Ospedali Galliera, Genoa, Italy. Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom. · Office of the Scientific Director, E.O. Ospedali Galliera, Genoa, Italy. · Divisions of Cancer Prevention and Genetics, European Institute of Oncology, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy. · Division of Breast Surgery, European Institute of Oncology, Milan, Italy. · Division of Medical Oncology, E.O. Ospedali Galliera, Genoa, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy. University of Milan, School of Medicine, Milan, Italy. · Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom. · Pubmed 26276754
  • Division of Medical Senology, European Institute of Oncology, Milan, Italy. Electronic address: · Division of Epidemiology and Biostatistics, European Institute of Oncology, and Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Department of Pathology, European Institute of Oncology, Milan, Italy; University of Milan School of Medicine, Milan, Italy. · Department of Pathology, European Institute of Oncology, Milan, Italy. · University of Milan School of Medicine, Milan, Italy; Division of Senology, European Institute of Oncology, Milan, Italy. · Division of Senology, European Institute of Oncology, Milan, Italy. · Program of Senology (Breast Health), European Institute of Oncology, Milan, Italy. · Pubmed 25933934
  • Division of Experimental Therapeutics, Breast Health Program, Istituto Europeo di Oncologia, Italy. Electronic address: · Division of Epidemiology and Biostatistics, Istituto Europeo di Oncologia, Italy; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milano, Italy. · Laboratory Division of Hematology-Oncology, Italy. · Department of Experimental Oncology, Italy; University of Milano, School of Medicine, Milano, Italy. · Division of Experimental Therapeutics, Breast Health Program, Istituto Europeo di Oncologia, Italy. · Department of Pathology, Istituto Europeo di Oncologia, Italy; University of Milano, School of Medicine, Milano, Italy. · Pubmed 25772326
  • Department of Biostatistics and Computational Biology, International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Mailstop CLS-11007, Boston, MA, 02215, USA. · Institute of Oncology of Southern Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Lugano Viganello, Switzerland. · Peter MacCallum Cancer Center, St Vincent's Hospital, University of Melbourne, Melbourne, VIC, Australia. · Australia & New Zealand Breast Cancer Trials Group (ANZBCTG), University of Newcastle, Callaghan, NSW, Australia. · The University of Chicago Medical Center and Alliance for Clinical Trials in Oncology, Chicago, IL, USA. · Tom Baker Cancer Centre and NCIC Clinical Trials Group, Calgary, AB, Canada. · International Breast Cancer Study Group Coordinating Center and Central Pathology Office, Bern, Switzerland. · International Breast Cancer Study Group Central Pathology Office, Department of Pathology, European Institute of Oncology, Milan, Italy. · International Breast Cancer Study Group Central Pathology Office, Department of Pathology, European Institute of Oncology, Milan, Italy. · Pathological Department, National Institute of Oncology, Budapest, Hungary. · Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru. · Division of Pathology, Salvatore Maugeri Foundation, Pavia, Italy. · Struttura Operativa Complessa di Anatomia Patologica, Azienda Ospedaliero-Universitaria di Udine, Udine, Italy. · Kantonsspital St. Gallen, Swiss Group for Clinical Cancer Research (SAKK), St. Gallen, Switzerland. · University of Insubria-Ospedale di Circolo and Fondazione Macchi, Varese, Italy. · Department of Pathology, Vall d'Hebron University Hospital, SOLTI Group, Barcelona, Spain. · Pathology Department, Hospital Universitario «12 de Octubre», i+12, Universidad Complutense Madrid, SOLTI Group, Madrid, Spain. · Laboratoire Anatomopathologie, Institut Bergonié, Bordeaux, France. · EORTC, Brussels, Belgium. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Program for Breast Health, European Institute of Oncology, Milan, Italy. · International Breast Cancer Study Group Statistical Center, Frontier Science and Technology Research Foundation, Boston, MA, USA. · University of Sydney, Sydney, Australia. · International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Harvard T.H. Chan School of Public Health, Boston, MA, USA. · Frontier Science and Technology Research Foundation, Boston, MA, USA. · International Breast Cancer Study Group Central Pathology Office, European Institute of Oncology, University of Milan, Milan, Italy. · Pubmed 26493064
  • Targos Molecular Pathology GmbH, Kassel, Germany. · Institute of Pathology, University of Cologne, Cologne, Germany. · Institute of Pathology Nordhessen, Kassel, Germany. · Institute of Pathology, University of Göttingen, Göttingen, Germany. · Department of Pathology, University of Milan and European Institute of Oncology, Milan, Italy. · Nazarbayev University School of Medicine, Astana, Kazakhstan. · Clinic for Gynecology and Obstetrics, Helios Klinikum Berlin-Buch, Berlin, Germany. · Pubmed 26403781
  • Division of Medical Senology, European Institute of Oncology, Milan, Italy. Electronic address: · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy. · Division of Laboratory Medicine, European Institute of Oncology, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Department of Medicine, European Institute of Oncology, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy; School of Medicine, University of Milan, Milan, Italy. · Division of Senology, European Institute of Oncology, Milan, Italy. · Pubmed 26362840
  • Division of Medical Senology, European Institute of Oncology, Milan, Italy. Electronic address: · Department of Quantitative Methods and Statistics, University of Milan-Bicocca, Milan, Italy; Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Department of Pathology, European Institute of Oncology, Milan, Italy; School of Medicine, University of Milan, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Division of Senology, European Institute of Oncology, Milan, Italy. · Department of Pathology, European Institute of Oncology, Milan, Italy. · Program of Senology (Breast Health), European Institute of Oncology, Milan, Italy. · Pubmed 26255932
  • University of Milan, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy. Electronic address: · Pubmed 26255744
  • 1 Department of Biotechnology and Biosciences, University of Milano-Bicocca , Milan, Italy . · 2 SYSBIO Centre of Systems Biology , Milan, Italy . · 3 Department of Experimental Oncology, European Institute of Oncology , Milan, Italy . · 4 Department of Pathology, European Institute of Oncology , Milan, Italy . · 5 Department of Surgery, European Institute of Oncology , Milan, Italy . · 6 Oncology Research Unit, Pfizer Global Research and Development , La Jolla, California. · 7 Sanofi Oncology , Cambridge, Massachusetts. · 8 Institute for Applied Cancer, The University of Texas MD Anderson Cancer Center Science , Houston, Texas. · 9 Department of Biosciences, University of Milan , Milan, Italy . · Pubmed 25897982
  • Johns Hopkins Kimmel Comprehensive Cancer Center, Baltimore, MD. · University of Utah School of Medicine and Intermountain Healthcare, Salt Lake City, UT. · University of Rochester Medical Center, Rochester, NY. · Stanford University Medical Center, Stanford, CA. · Ontario Institute for Cancer Research, Toronto, Ontario, Canada. · University of Western Sydney and Healthscope Pathology, Sydney, New South Wales, Australia. · St Jude Medical Center, Fullerton, CA. · Sunnybrook Health Sciences Center, Toronto, Ontario, Canada. · Mayo Clinic, Rochester, MN. · American Society of Clinical Oncology, Alexandria, VA. · National Adjuvant Surgical Breast and Bowel Project, Pittsburgh, PA. · Mayo Clinic, Jacksonville, FL. · University of Southern California, Los Angeles, CA. · North Carolina State University, Raleigh, NC. · Indiana University Medical Center, Indianapolis, IN. · University of Milan, European Institute of Oncology, Milan, Italy. · Royal Marsden Hospital, London, United Kingdom. · National Cancer Institute, Bethesda, MD. · University of Michigan Comprehensive Cancer Care Center, Ann Arbor, MI. · Pubmed 25753441
  • BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Division of Pathology, European Institute of Oncology, Milan, Italy. · Fertility and Procreation Unit, Department of Gynecology Oncology, European Institute of Oncology, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy; University of Milan, School of Medicine, Milan, Italy. · Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Pubmed 25702955
  • Biometric Research Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland, USA. · Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy. · Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK. · Transformative Pathology, Ontario Institute for Cancer Research, Toronto, Ontario, Canada. · The Emmes Corporation, Rockville, Maryland, USA. · Indiana University Simon Cancer Center, Indianapolis, Indiana, USA. · Department of Pathology and Molecular Medicine, Juravinski Hospital and Cancer Centre, McMaster University, Hamilton, Ontario, Canada. · Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Lund, Sweden. · Montefiore Medical Center and the Albert Einstein College of Medicine, Bronx, New York, USA. · Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. · PhenoPath Laboratories, Seattle, Washington, USA. · Lester and Sue Smith Breast Center and Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas, USA. · Department of Laboratory Medicine and Pathology, University of Alberta, Alberta, Canada. · Department of Pathology, Kawasaki Medical School, Kurashiki City, Japan. · Department of Pathology, Hakuaikai Sagara Hospital, Matsubaracho, Kagoshima, Japan. · Department of Pathology, Centre Jean Perrin and Université d'Auvergne, Clermont-Ferrand, France. · Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK. · Department of Pathology, Jichi Medical University, Shimotsuke, Tochigi, Japan. · Institut Jules Bordet, Brussels, Belgium. · Birmingham Heart of England, National Health Service, Birmingham, UK. · Slagelse Hospital, Slagelse, Region Sjælland, Denmark. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, and University of Milan, Milan, Italy. · Academic Department of Biochemistry, Royal Marsden Hospital, London, UK. · Breast Oncology Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, USA. · Pubmed 25698062
  • Molecular Medicine Program, Department of Experimental Oncology, European Institute of Oncology, Milan, Italy. · Molecular Medicine Program, Department of Experimental Oncology, European Institute of Oncology, Milan, Italy; Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Molecular Medicine Program, Department of Experimental Oncology, European Institute of Oncology, Milan, Italy; IFOM, The FIRC Institute for Molecular Oncology Foundation, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy; School of Medicine, University of Milan, Milan, Italy. · Molecular Medicine Program, Department of Experimental Oncology, European Institute of Oncology, Milan, Italy; IFOM, The FIRC Institute for Molecular Oncology Foundation, Milan, Italy; Center for Genomic Science of IIT@SEMM, Istituto Italiano di Tecnologia (IIT), Milan, Italy. · Molecular Medicine Program, Department of Experimental Oncology, European Institute of Oncology, Milan, Italy; IFOM, The FIRC Institute for Molecular Oncology Foundation, Milan, Italy; Department of Scienze della Salute, University of Milan, Milan, Italy. Electronic address: · Molecular Medicine Program, Department of Experimental Oncology, European Institute of Oncology, Milan, Italy. Electronic address: · Pubmed 25459350
2014
  • Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada. · Institute of Pathology Nordhessen, Kassel, Germany. · Healthscope Pathology, Norwest Private Hospital, Bella Vista, NSW, Australia. · State of São Paulo Cancer Institute (ICESP), São Paulo, Brazil. · Royal Marsden Hospital, London, UK. · International University of Health and Welfare (IUHW), Center for Diagnostic Pathology, IUHW Mita Hospital, Tokyo, Japan. · Centre Jean Perrin and University of Auvergne, EA 4233, Clermont-Ferrand, France. · The Academic Medical Center (AMC), The University of Amsterdam, Amsterdam, The Netherlands. · University of Milan and European Institute of Oncology, Milan, Italy. · Pubmed 23807776
  • Division of Breast Surgery, European Institute of Oncology, Milan, Italy. Electronic address: · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy; Department of Occupational Health, University of Milan, Milan, Italy. · Division of Cancer Prevention and Genetics, European Institute of Oncology, Milan, Italy. · Division of Breast Surgery, European Institute of Oncology, Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy. · Scientific Directorate, European Institute of Oncology, Milan, Italy. · Pubmed 25261930
  • Fondazione Istituto FIRC di Oncologia Molecolare (IFOM), 20139 Milan, Italy. · Fondazione Istituto FIRC di Oncologia Molecolare (IFOM), 20139 Milan, Italy Dipartimento di Oncologia Sperimentale, Istituto Europeo di Oncologia, 20141 Milan, Italy. · Dipartimento di Oncologia Sperimentale, Istituto Europeo di Oncologia, 20141 Milan, Italy. · Fondazione Istituto FIRC di Oncologia Molecolare (IFOM), 20139 Milan, Italy Dipartimento di Oncologia Sperimentale, Istituto Europeo di Oncologia, 20141 Milan, Italy Dipartimento di Scienze della Salute, Università degli Studi di Milano, 20122 Milan, Italy · Fondazione Istituto FIRC di Oncologia Molecolare (IFOM), 20139 Milan, Italy Dipartimento di Scienze della Salute, Università degli Studi di Milano, 20122 Milan, Italy · Pubmed 25049275
  • Division of Medical Senology, European Institute of Oncology, Milan, Italy. Electronic address: · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Division of Prevention and Genetics, European Institute of Oncology, Milan, Italy. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy; University of Milan School of Medicine, Milan, Italy. · Division of Senology, European Institute of Oncology, Milan, Italy; University of Milan School of Medicine, Milan, Italy. · Division of Senology, European Institute of Oncology, Milan, Italy. · Scientific Direction, European Institute of Oncology, Milan, Italy. · Pubmed 24742826
  • Division of Pathology, European Institute of Oncology, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy; University of Milan School of Medicine; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy; University of Milan School of Medicine; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy. Electronic address: · Pubmed 24709436
  • Division of Medical Senology, European Institute of Oncology, Milan, Italy. Electronic address: · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy; Department of Statistics and Quantitative Methods, Unit of Biostatistics, Epidemiology and Public Health, University of Milan-Bicocca, Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy; School of Medicine, University of Milan, Italy. · School of Medicine, University of Milan, Italy; Molecular Senology Unit, European Institute of Oncology, Milan, Italy. · Division of Senology, European Institute of Oncology, Milan, Italy. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy. · Vice-Scientific Director, European Institute of Oncology, Milan, Italy. · Pubmed 24325948
  • Early Drug Development for Innovative Therapies Division, Department of Medicine, European Institute of Oncology, Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Department of Breast Oncology, National Cancer Institute "Fondazione Pascale", Naples, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy. · Department of Endocrinology and Molecular and Clinical Oncology, University of Naples Federico II, Napoli, Italy. · Department of Advanced Medical Sciences, Operative Unit of General Surgery and Transplants, University of Naples Federico II, Napoli, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy; University of Milan School of Medicine, Milan, Italy. · Early Drug Development for Innovative Therapies Division, Department of Medicine, European Institute of Oncology, Milan, Italy. Electronic address: · Pubmed 24314620
  • European Institute of Oncology, Medical Oncology, via Ripamonti 435, Milan, Italy. Electronic address: · European Institute of Oncology, Division of Epidemiology and Biostatistics, via Ripamonti 435, Milan, Italy. · European Institute of Oncology, Division of Pathology, via Ripamonti 435, Milan, Italy; University of Milan, School of Medicine, Milan, Italy. · European Institute of Oncology, Division of Epidemiology and Biostatistics, via Ripamonti 435, Milan, Italy; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, via Bicocca degli Arcimboldi 8, 20126 Milan, Italy. · European Institute of Oncology, Medical Oncology, via Ripamonti 435, Milan, Italy. · Second University of Naples, Medical Oncology, via Pansini 5, Naples, Italy. · Pubmed 24269135
  • Unit of Investigative Clinical Oncology (INCO), Fondazione del Piemonte per l'Oncologia, Institute for Cancer Research and Treatment (IRCCs), Candiolo, Italy. · Division of Medical Oncology, European Institute of Oncology, Milan, Italy. · Division of Medical Oncology, Fondazione del Piemonte per l'Oncologia, Institute for Cancer Research and Treatment (IRCCs), Candiolo, Italy. · University of Turin, Department of Biomedical Sciences and Human Oncology, Turin, Italy. · Department of Pathology and Laboratory Medicine, European Institute of Oncology, University of Milan, Milan, Italy. · Unit of Investigative Clinical Oncology (INCO), Fondazione del Piemonte per l'Oncologia, Institute for Cancer Research and Treatment (IRCCs), Candiolo, Italy; Division of Medical Oncology, Fondazione del Piemonte per l'Oncologia, Institute for Cancer Research and Treatment (IRCCs), Candiolo, Italy. Electronic address: · Pubmed 24210572
  • Division of Medical Senology, European Institute of Oncology, Milan, Italy. Electronic address: · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Division of Pathology and Laboratory Medicine, European Institute of Oncology and University of Milan, Italy. · Integrated Breast Surgery Unit, European Institute of Oncology and University of Milan, Italy. · Division of Senology, European Institute of Oncology, Milan, Italy. · Division of Radiation Oncology, European Institute of Oncology, Milan, Italy. · Department of Medicine, European Institute of Oncology, Milan, Italy. · Pubmed 24183613
  • Department of Medical Oncology, European Institute of Oncology, Milan, Italy. Electronic address: · Department of Medical Oncology, European Institute of Oncology, Milan, Italy. · Department of Pathology, European Institute of Oncology, Milan, Italy; University of Milan, School of Medicine, Italy. · Pubmed 24508454
2013
  • University of Milan School of Medicine, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy. Electronic address: · Pubmed 24074800
2011
  • Department of Pathology and Laboratory Medicine, European Institute of Oncology, University of Milan, Milan, Italy. · Pubmed 22015299
2009
  • Department of Pathology and Laboratory Medicine, European Institute of Oncology, University of Milan School of Medicine, Via Ripamonti 435, Milan, Italy. · Pubmed 19914539
  • Department of Pathology, European Institute of Oncology, University of Milan School of Medicine, Milan, Italy. · Pubmed 19775600
  • Division of Pathology, European Institute of Oncology, Università degli Studi di Milano, Milan, Italy. · Pubmed 19670216
2008
  • Division of Pathology and Laboratory Medicine, European Institute of Oncology, University of Milan, Milan, Italy. · Pubmed 18981464
2017
  • From the German Breast Group, Neu-Isenburg, Germany (G.M.); Frontier Science (Scotland), Kincraig, United Kingdom (M. Procter); the Breast European Adjuvant Study Team (BrEAST) Data Center (E.A., N.R.), the Breast International Group (D.Z., A.A.), and Institut Jules Bordet, Université Libre de Bruxelles (M. Piccart) - all in Brussels; Roche Pharma (M.B., E.C., A.K.) and the Department of Cardiology, Cardio-Oncology, Bern University Hospital (T.S.) - both in Bern, Switzerland; the Department of Pathology, European Institute of Oncology, University of Milan, Milan (G.V.); the National Institute of Oncology, Budapest, Hungary (I.L.); Centre François Baclesse, Caen, France (C.L.); the Sarah Cannon Research Institute and Tennessee Oncology, Nashville (D.A.Y.); Instituto Nacional de Câncer, Rio de Janeiro (J. Bines); Dana-Farber Cancer Institute, Harvard Medical School, Harvard T. H. Chan School of Public Health, and Frontier Science and Technology Research Foundation - all in Boston (R.D.G.); and the Department of Medicine, Memorial Sloan Kettering Cancer Center, New York (J. Baselga). · Pubmed 28581356
  • *School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, NY †Istituto Europeo di Oncologia, University of Milan, Milan, Italy ‡UCL Advanced Diagnostics, London, UK §Dako A/S, Glostrup, Denmark. · Pubmed 26657878
2016
  • From Champalimaud Clinical Center-Champalimaud Foundation, Lisbon, Portugal (F.C.); Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (L.J.V.); European Organization for Research and Treatment of Cancer Headquarters (J.B., L. Slaets, V.G., B.M., K.T.), Breast International Group Headquarters (T.G., C. Straehle), and Institut Jules Bordet, Université Libre de Bruxelles (C. Sotiriou, M.P.), Brussels, and Centre Hospitalier Universitaire Université Catholique de Louvain, Namur (P.V.) - both in Belgium; University of Milan and Istituto Europeo di Oncologia (G.V.) and Europa Donna-European Breast Cancer Coalition (S.K.), Milan, and Azienda Istituti Ospitalieri di Cremona, Cremona (R.P.) - both in Italy; Gustave Roussy, Villejuif (S.D., M.S.), Institut Curie Paris Sciences et Lettres, Université Paris Descartes, Sorbonne Paris Cité, Paris (J.-Y.P.). Institut Curie-Hôpital Rene Huguenin, Saint-Cloud (E.B.), and Centre Georges-Francois-Leclerc, Dijon (S.C.) - all in France; Swiss Institute of Bioinformatics and University of Lausanne, Lausanne, Switzerland (M.D.); Agendia (A.M.G., L. Stork) and the Netherlands Cancer Institute (R.B., E.R.), Amsterdam, Alrijne Ziekenhuis, Rijnland Leiderdorp (P.A.N.), Jeroen Bosch Hospital, 's-Hertogenbosch (T.J.S.), and Medisch Centrum Alkmaar, Alkmaar (J.M.H.) - all in the Netherlands; Institute of Oncology, Ljubljana, Slovenia (E.M.); Evangelisches Krankenhaus Bethesda, Duisburg, Germany (U.N.); University of Texas Health Sciences Center, San Antonio (P.R.); Hospital Universitario Vall d'Hebron, Barcelona (I.T.R.); Imperial College London, London (G.T.); and University of Texas M.D. Anderson Cancer Center, Houston (A.M.T.). · Pubmed 27557300
  • Marco Colleoni, Giuseppe Viale, and Aron Goldhirsch, European Institute of Oncology; Giuseppe Viale, University of Milan, Milan; Lorenzo Gianni, Ospedale degli Infermi, Rimini; Fabio Puglisi, University Hospital of Udine, University of Udine, Udine; Carlo Tondini, Osp. Papa Giovanni XXIII, Bergamo; Katia Cagossi, Ospedale di Carpi, Carpi, Italy; Kathryn P. Gray, Shari Gelber, Richard D. Gelber, Meredith M. Regan, and Karen N. Price, International Breast Cancer Study Group Statistical Center; Kathryn P. Gray, Shari Gelber, Richard D. Gelber, and Meredith M. Regan, Dana-Farber Cancer Institute; Kathryn P. Gray and Richard D. Gelber, Harvard T.H. Chan School of Public Health; Richard D. Gelber and Meredith M. Regan, Harvard Medical School; Richard D. Gelber and Karen N. Price, Frontier Science and Technology Foundation, Boston, MA; István Láng, National Institute of Oncology, Budapest, Hungary; Beat Thürlimann, Kantonsspital, St Gallen; Beat Thürlimann, Elena Kralidis, and Daniel Rauch, Swiss Group for Clinical Cancer Research, Bern; Elena Kralidis, Kantonsspital Aarau, Aarau; Daniel Rauch, Spital Thun, Thun, Switzerland; Ehtesham A. Abdi, The Tweed Head Hospital, Tweed Heads, New South Wales and Griffith University, Southport, Queensland; Ehtesham A. Abdi and Jacquie Chirgwin, Australia and New Zealand Breast Cancer Trials Group; Jacquie Chirgwin, Box Hill and Maroondah Hospitals and Monash University, Melbourne, Victoria; Alan S. Coates, International Breast Cancer Study Group and University of Sydney School of Public Health, Sydney, New South Wales, Australia; Henry L. Gomez, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru; Barbro K. Linderholm, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, and Sahlgrenska University Hospital, Gothenburg, Sweden; and Alexandru Eniu, Cancer Institute Ion Chiricuta, Cluj, Romania. · Marco Colleoni, Giuseppe Viale, and Aron Goldhirsch, European Institute of Oncology; Giuseppe Viale, University of Milan, Milan; Lorenzo Gianni, Ospedale degli Infermi, Rimini; Fabio Puglisi, University Hospital of Udine, University of Udine, Udine; Carlo Tondini, Osp. Papa Giovanni XXIII, Bergamo; Katia Cagossi, Ospedale di Carpi, Carpi, Italy; Kathryn P. Gray, Shari Gelber, Richard D. Gelber, Meredith M. Regan, and Karen N. Price, International Breast Cancer Study Group Statistical Center; Kathryn P. Gray, Shari Gelber, Richard D. Gelber, and Meredith M. Regan, Dana-Farber Cancer Institute; Kathryn P. Gray and Richard D. Gelber, Harvard T.H. Chan School of Public Health; Richard D. Gelber and Meredith M. Regan, Harvard Medical School; Richard D. Gelber and Karen N. Price, Frontier Science and Technology Foundation, Boston, MA; István Láng, National Institute of Oncology, Budapest, Hungary; Beat Thürlimann, Kantonsspital, St Gallen; Beat Thürlimann, Elena Kralidis, and Daniel Rauch, Swiss Group for Clinical Cancer Research, Bern; Elena Kralidis, Kantonsspital Aarau, Aarau; Daniel Rauch, Spital Thun, Thun, Switzerland; Ehtesham A. Abdi, The Tweed Head Hospital, Tweed Heads, New South Wales and Griffith University, Southport, Queensland; Ehtesham A. Abdi and Jacquie Chirgwin, Australia and New Zealand Breast Cancer Trials Group; Jacquie Chirgwin, Box Hill and Maroondah Hospitals and Monash University, Melbourne, Victoria; Alan S. Coates, International Breast Cancer Study Group and University of Sydney School of Public Health, Sydney, New South Wales, Australia; Henry L. Gomez, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru; Barbro K. Linderholm, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, and Sahlgrenska University Hospital, Gothenburg, Sweden; and Alexandru Eniu, Cancer Institute Ion Chiricuta, Cluj, Romania. · Pubmed 27325862
  • Martine Piccart-Gebhart, Université Libre de Bruxelles, Brussels, Belgium; Eileen Holmes, Eleanor McFadden, and Andrew P. Holmes, Frontier Science (Scotland), Kincraig, Kingussie, United Kingdom; José Baselga, Memorial Sloan Kettering Cancer Center, New York, NY; Evandro de Azambuja, Institut Jules Bordet, Brussels, Belgium; Evandro de Azambuja and Stella Dolci, Breast European Adjuvant Study Team, Brussels, Belgium; Amylou C. Dueck and Anne E. McCullough, Mayo Clinic, Scottsdale, AZ; Giuseppe Viale, University of Milan, Milan, Italy; Giuseppe Viale and Aron Goldhirsch, Istituto Europeo di Oncologia, Milan, Italy; Jo Anne Zujewski, National Cancer Institute, Bethesda, MD; Aron Goldhirsch, Ospedale Regionale di Lugano, Viganello-Lugano, Switzerland; Alison Armour, GlaxoSmithKline, Collegeville, PA; Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada; Kathleen I. Pritchard, University of Toronto, Toronto, Ontario, Canada; Liu Tonghua, Peking Union Medical College Hospital, Beijing, People's Republic of China; Liu Tonghua and Binghe Xu, China Academy of Chinese Medical Sciences, Beijing, People's Republic of China; Holger Eidtmann, University Hospital Kiel, Kiel, Germany; Phuong Dinh, Breast International Group, Brussels, Belgium; Serena Di Cosimo, Istituto Nazionale del Tumori, Milan, Italy; Serena Di Cosimo, SOLTI Breast Cancer Research Group, Barcelona, Spain; Nadia Harbeck, Frauenklinik der Universität München, Munich, Germany; Sergei Tjulandin, Blokhin Russian Cancer Research Center of RAMS, Moscow, Russia; Young-Hyuck Im, Korean Cancer Study Group, Seoul, South Korea; Young-Hyuck Im, Samsung Medical Center, Seoul, South Korea; Chiun-Shen Huang, National Taiwan University Hospital, Taipei, Republic of China; Véronique Diéras, Institut Curie, Paris, France; David W. Hillman, Mayo Clinic, Rochester, MN; Antonio C. Wolff, The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Christian Jackisch, Klinikum Offenba · Pubmed 26598744
  • Meredith M. Regan and Richard D. Gelber, Dana-Farber Cancer Institute, Harvard Medical School; Karen N. Price and Richard D. Gelber, Frontier Science and Technology Research Foundation; Richard D. Gelber, Harvard T.H. Chan School of Public Health, Boston, MA; Prudence A. Francis, MacCallum Cancer Center, St Vincent's Hospital, University of Melbourne, Melbourne; University of Newcastle, Newcastle; Alan S. Coates, University of Sydney, Sydney, Australia; Olivia Pagani, Institute of Oncology of Southern Switzerland, Lugano Viganello, Switzerland; Gini F. Fleming, University of Chicago Medical Center, Chicago, IL; Barbara A. Walley, National Cancer Institute of Canada Clinical Trials Group, Calgary, Alberta, Canada; Giuseppe Viale, University of Milan; Giuseppe Viale, Marco Colleoni, and Aron Goldhirsch, European Institute of Oncology, Milan; Carlo Tondini, Ospedale Papa Giovanni XXIII, Bergamo; Graziella Pinotti, Ospedale di Circolo and Fondazione Macchi, Varese, Italy; István Láng, National Institute of Oncology, Budapest, Hungary; Henry L. Gómez, Instituto Nacional de Enfermedades Neoplásticas, Lima, Peru. · Meredith M. Regan and Richard D. Gelber, Dana-Farber Cancer Institute, Harvard Medical School; Karen N. Price and Richard D. Gelber, Frontier Science and Technology Research Foundation; Richard D. Gelber, Harvard T.H. Chan School of Public Health, Boston, MA; Prudence A. Francis, MacCallum Cancer Center, St Vincent's Hospital, University of Melbourne, Melbourne; University of Newcastle, Newcastle; Alan S. Coates, University of Sydney, Sydney, Australia; Olivia Pagani, Institute of Oncology of Southern Switzerland, Lugano Viganello, Switzerland; Gini F. Fleming, University of Chicago Medical Center, Chicago, IL; Barbara A. Walley, National Cancer Institute of Canada Clinical Trials Group, Calgary, Alberta, Canada; Giuseppe Viale, University of Milan; Giuseppe Viale, Marco Colleoni, and Aron Goldhirsch, European Institute of Oncology, Milan; Carlo Tondini, Ospedale Papa Giovanni XXIII, Bergamo; Graziella Pinotti, Ospedale di Circolo and Fondazione Macchi, Varese, Italy; István Láng, National Institute of Oncology, Budapest, Hungary; Henry L. Gómez, Instituto Nacional de Enfermedades Neoplásticas, Lima, Peru. · Pubmed 27044936
  • Christine Desmedt, Gabriele Zoppoli, Denis Larsimont, Debora Fumagalli, David Brown, Françoise Rothé, Delphine Vincent, Naima Kheddoumi, Ghizlane Rouas, Samira Majjaj, Sylvain Brohée, Roberto Salgado, Martine Piccart-Gebhart, and Christos Sotiriou, Institut Jules Bordet; Christine Galant, Cliniques Universitaires Saint Luc, Brussels; Peter Van Loo, University of Leuven; Thomas Van Brussel and Diether Lambrechts, VIB Vesalius Research Center, Leuven, Belgium; Gabriele Zoppoli, University of Genoa and Istituto di Ricerca a Carattere Clinico-Scientifico San Martino-National Cancer Institute, Genoa; Giancarlo Pruneri, Patrick Maisonneuve, and Giuseppe Viale, European Institute of Oncology; Marco Fornili and Elia Biganzoli, University of Milan, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale Tumori, Milan, Italy; Gunes Gundem and Peter J. Campbell, Wellcome Trust Sanger Institute, Cambridgeshire; Peter Van Loo, The Francis Crick Institute, London, United Kingdom; Ron Bose, Washington University School of Medicine, St Louis, MO; Otto Metzger, Dana-Farber Cancer Institute, Boston, MA; and François Bertucci, Institut Paoli-Calmettes, Marseille, France. · Christine Desmedt, Gabriele Zoppoli, Denis Larsimont, Debora Fumagalli, David Brown, Françoise Rothé, Delphine Vincent, Naima Kheddoumi, Ghizlane Rouas, Samira Majjaj, Sylvain Brohée, Roberto Salgado, Martine Piccart-Gebhart, and Christos Sotiriou, Institut Jules Bordet; Christine Galant, Cliniques Universitaires Saint Luc, Brussels; Peter Van Loo, University of Leuven; Thomas Van Brussel and Diether Lambrechts, VIB Vesalius Research Center, Leuven, Belgium; Gabriele Zoppoli, University of Genoa and Istituto di Ricerca a Carattere Clinico-Scientifico San Martino-National Cancer Institute, Genoa; Giancarlo Pruneri, Patrick Maisonneuve, and Giuseppe Viale, European Institute of Oncology; Marco Fornili and Elia Biganzoli, University of Milan, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale Tumori, Milan, Italy; Gunes Gundem and Peter J. Campbell, Wellcome Trust Sanger Institute, Cambridgeshire; Peter Van Loo, The Francis Crick Institute, London, United Kingdom; Ron Bose, Washington University School of Medicine, St Louis, MO; Otto Metzger, Dana-Farber Cancer Institute, Boston, MA; and François Bertucci, Institut Paoli-Calmettes, Marseille, France. · Pubmed 26926684
2015
  • Otto Metzger Filho, Anita Giobbie-Hurder, and Eric P. Winer, Dana-Farber Cancer Institute; Richard D. Gelber and Meredith M. Regan, Harvard Medical School; Karen N. Price, Frontier Science and Technology Research, Boston, MA; Elizabeth Mallon, Southern General Hospital; Barry Gusterson, Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom; Giuseppe Viale, European Institute of Oncology and University of Milan; Marco Colleoni and Aron Goldhirsch, European Institute of Oncology, Milan, Italy; Beat Thürlimann, Kantonsspital, St. Gallen, and Swiss Group for Clinical Cancer Research, Bern, Switzerland; Bent Ejlertsen, Rigshospitalet, Copenhagen, Denmark; Marc Debled, Institut Bergoniié, Bordeaux, France; and Alan S. Coates, International Breast Cancer Study Group, Bern, Switzerland, and University of Sydney, Sydney, Australia. · Otto Metzger Filho, Anita Giobbie-Hurder, and Eric P. Winer, Dana-Farber Cancer Institute; Richard D. Gelber and Meredith M. Regan, Harvard Medical School; Karen N. Price, Frontier Science and Technology Research, Boston, MA; Elizabeth Mallon, Southern General Hospital; Barry Gusterson, Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom; Giuseppe Viale, European Institute of Oncology and University of Milan; Marco Colleoni and Aron Goldhirsch, European Institute of Oncology, Milan, Italy; Beat Thürlimann, Kantonsspital, St. Gallen, and Swiss Group for Clinical Cancer Research, Bern, Switzerland; Bent Ejlertsen, Rigshospitalet, Copenhagen, Denmark; Marc Debled, Institut Bergoniié, Bordeaux, France; and Alan S. Coates, International Breast Cancer Study Group, Bern, Switzerland, and University of Sydney, Sydney, Australia. · Pubmed 26215945
2014
  • Antonio C. Wolff, Johns Hopkins Kimmel Comprehensive Cancer Center, Baltimore; Lisa M. McShane, National Cancer Institute, Bethesda, MD; M. Elizabeth H. Hammond, University of Utah School of Medicine and Intermountain Healthcare, Salt Lake City, UT; David G. Hicks, University of Rochester Medical Center, Rochester, NY; Mitch Dowsett, Royal Marsden Hospital, London, United Kingdom; Kimberly H. Allison, Stanford University Medical Center, Stanford; Patrick Fitzgibbons, St Jude Medical Center, Fullerton; Michael F. Press, University of Southern California, Los Angeles, CA; Donald C. Allred, Washington University School of Medicine, St Louis, MO; John M.S. Bartlett, Ontario Institute for Cancer Research; Wedad Hanna, Sunnybrook Health Sciences Center, Toronto, Ontario, Canada; Michael Bilous, University of Western Sydney and Healthscope Pathology, Sydney, New South Wales, Australia; Robert B. Jenkins, Mayo Clinic, Rochester, MN; Pamela B. Mangu, American Society of Clinical Oncology, Alexandria, VA; Soonmyung Paik, National Surgical Adjuvant Breast and Bowel Project, Pitsburgh, PA; Edith A. Perez, Mayo Clinic, Jacksonville, FL; Patricia A. Spears, North Carolina State University, Raleigh, NC; Gail H. Vance, Indiana University Medical Center, Indianapolis, IN; Giuseppe Viale, University of Milan, European Institute of Oncology, Milan, Italy; and Daniel F. Hayes, University of Michigan Comprehensive Cancer Care Center, Ann Arbor, MI. · Pubmed 24099077
  • Felipe Ades, Lina Pugliano, Debora Fumagalli, Evandro de Azambuja, Christos Sotiriou, and Martine Piccart, Institut Jules Bordet, Université Libre de Bruxelles; Dimitrios Zardavas, Breast International Group, Brussels, Belgium; Ivana Bozovic-Spasojevic, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia; and Giuseppe Viale, European Institute of Oncology, University of Milan, Milan, Italy. · Felipe Ades, Lina Pugliano, Debora Fumagalli, Evandro de Azambuja, Christos Sotiriou, and Martine Piccart, Institut Jules Bordet, Université Libre de Bruxelles; Dimitrios Zardavas, Breast International Group, Brussels, Belgium; Ivana Bozovic-Spasojevic, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia; and Giuseppe Viale, European Institute of Oncology, University of Milan, Milan, Italy. · Pubmed 25049332
  • Department of Medical Sciences, University of Turin, Turin, Italy; Pathology Unit, Department of Laboratory Medicine, Azienda Ospedaliera Città della Salute e della Scienza di Torino, Turin, Italy; Pathology Division, Santa Croce Hospital, Moncalieri, Italy; Pathology Division, Azienda USL Valle d'Aosta, Aosta, Italy; Pathology Division, Valdese Hospital, Turin, Italy; Pathology Division, Martini Hospital, Turin, Italy; Pathology Division, ASL 9, Civile Hospital, Ivrea, Italy; Department of Pathology, Regina Elena National Cancer Institute, Rome, Italy; Division of Pathology, European Institute of Oncology, Milan, Italy; University of Milan School of Medicine, Milan, Italy · Department of Medical Sciences, University of Turin, Turin, Italy; Pathology Unit, Department of Laboratory Medicine, Azienda Ospedaliera Città della Salute e della Scienza di Torino, Turin, Italy; Pathology Division, Santa Croce Hospital, Moncalieri, Italy; Pathology Division, Azienda USL Valle d'Aosta, Aosta, Italy; Pathology Division, Valdese Hospital, Turin, Italy; Pathology Division, Martini Hospital, Turin, Italy; Pathology Division, ASL 9, Civile Hospital, Ivrea, Italy; Department of Pathology, Regina Elena National Cancer Institute, Rome, Italy; Division of Pathology, European Institute of Oncology, Milan, Italy; University of Milan School of Medicine, Milan, Italy. · Pubmed 25323485
  • Division of Medical Senology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy, · Pubmed 25007961
  • Department of MedicineInstitut Jules Bordet, BrEAST Data Centre, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 121, 1000 Brussels, BelgiumBreast Cancer Translational Research Laboratory (BCTL) J. C. HeusonInstitut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumFertility and Procreation UnitDepartment of Gynecologic Oncology, European Institute of Oncology, Milan, ItalyTranslational Breast Cancer Genomic LabCancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, AustraliaSir Peter MacCallum Department of OncologyUniversity of Melbourne, Parkville, Victoria, AustraliaVesalius Research CentreVIB, Leuven, BelgiumLaboratory of Translational GeneticsDepartment of Oncology, University of Leuven, Leuven, BelgiumDepartment of PathologyDivision of Epidemiology and BiostatisticsEuropean Institute of Oncology, Milan, ItalyDepartment of MedicineMedical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumDepartment of MedicineInstitut Jules Bordet, BrEAST Data Centre, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 121, 1000 Brussels, BelgiumBreast Cancer Translational Research Laboratory (BCTL) J. C. HeusonInstitut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumFertility and Procreation UnitDepartment of Gynecologic Oncology, European Institute of Oncology, Milan, ItalyTranslational Breast Cancer Genomic LabCancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, AustraliaSir Peter MacCallum Department of OncologyUniversity of Melbourne, Parkville, Victoria, AustraliaVesalius Research CentreVIB, Leuven, BelgiumLaboratory of Translational GeneticsDepartment of Oncology, University of Leuven, Leuven, BelgiumDepartment of PathologyDivision of Epidemiology and BiostatisticsEuropean Institute of Oncology, Milan, ItalyDepartment of MedicineMedical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxel · Department of MedicineInstitut Jules Bordet, BrEAST Data Centre, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 121, 1000 Brussels, BelgiumBreast Cancer Translational Research Laboratory (BCTL) J. C. HeusonInstitut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumFertility and Procreation UnitDepartment of Gynecologic Oncology, European Institute of Oncology, Milan, ItalyTranslational Breast Cancer Genomic LabCancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, AustraliaSir Peter MacCallum Department of OncologyUniversity of Melbourne, Parkville, Victoria, AustraliaVesalius Research CentreVIB, Leuven, BelgiumLaboratory of Translational GeneticsDepartment of Oncology, University of Leuven, Leuven, BelgiumDepartment of PathologyDivision of Epidemiology and BiostatisticsEuropean Institute of Oncology, Milan, ItalyDepartment of MedicineMedical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Pubmed 24825746
2013
  • Antonio C. Wolff, Johns Hopkins Kimmel Comprehensive Cancer Center, Baltimore; Lisa M. McShane, National Cancer Institute, Bethesda, MD; M. Elizabeth H. Hammond, University of Utah School of Medicine and Intermountain Healthcare, Salt Lake City, UT; David G. Hicks, University of Rochester Medical Center, Rochester, NY; Mitch Dowsett, Royal Marsden Hospital, London, United Kingdom; Kimberly H. Allison, Stanford University Medical Center, Stanford; Patrick Fitzgibbons, St Jude Medical Center, Fullerton; Michael F. Press, University of Southern California, Los Angeles, CA; Donald C. Allred, Washington University School of Medicine, St Louis, MO; John M.S. Bartlett, Ontario Institute for Cancer Research; Wedad Hanna, Sunnybrook Health Sciences Center, Toronto, Ontario, Canada; Michael Bilous, University of Western Sydney and Healthscope Pathology, Sydney, New South Wales, Australia; Robert B. Jenkins, Mayo Clinic, Rochester, MN; Pamela B. Mangu, American Society of Clinical Oncology, Alexandria, VA; Soonmyung Paik, National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA; Edith A. Perez, Mayo Clinic, Jacksonville, FL; Patricia A. Spears, North Carolina State University, Raleigh, NC; Gail H. Vance, Indiana University Medical Center, Indianapolis, IN; Giuseppe Viale, University of Milan, European Institute of Oncology, Milan, Italy; and Daniel F. Hayes, University of Michigan Comprehensive Cancer Care Center, Ann Arbor, MI. · Pubmed 24101045
  • Department of Medicine, European Institute of Oncology, Milan, Italy. Electronic address: · Pubmed 23871531
  • Molecular Senology Unit, Senology Division, European Institute of Oncology, Milan, Italy. · Pubmed 23491275
  • Scientific Directorate, European Institute of Oncology, Milan, Italy. Electronic address: · Pubmed 24225155
  • Affiliations of authors: Biometric Research Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD (MCP, LMM); Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada (SCYL, DG, EM, TON); Department of Laboratory Medicine and Pathology, University of Alberta, Alberta, Canada (JCH); Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy (MGM); Division of Pathology and Laboratory Medicine, European Institute of Oncology, and University of Milan, Milan, Italy (GV); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom (LAZ); Department of Pathology, Centre Jean Perrin, Clermont-Ferrand, and Université d'Auvergne, France (FP-L); Transformative Pathology, Ontario Institute for Cancer Research, Toronto, Ontario, Canada (JMSB); PhenoPath Laboratories, Seattle, WA (AMG); Department of Pathology, MD Anderson Cancer Center, Houston, TX (WFS); Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, United Kingdom (TP); The EMMES Corporation, Rockville, MD (RAE); Breast Oncology Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI (DFH); Academic Department of Biochemistry, Royal Marsden Hospital, London, United Kingdom (MD); on behalf of the International Ki67 in Breast Cancer Working Group of the Breast International Group and North American Breast Cancer Group. · Pubmed 24203987
  • Division of Medical Senology, Department of Medicine, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy. Electronic address: · Pubmed 24091127
  • Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Pubmed 23912960
  • Division of Pathology, European Institute of Oncology, Milan, Italy. · Pubmed 23763700
  • Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Pubmed 23412771
  • Research Unit in Medical Senology, Department of Medicine, European Institute of Oncology, Milan, Italy. · Pubmed 23245877
  • Research Unit in Medical Senology, Department of Medicine, European Institute of Oncology, Milan, Italy. · Pubmed 23098574
2012
  • Department of Medicine, European Institute of Oncology, Milan, Italy. · Pubmed 22520733
  • Division of Pathology and Laboratory Medicine Radiological Senology Unit, European Institute of Oncology, Milan, Italy. · Pubmed 22882656
  • Medical Senology Research Unit & Division of Medical Oncology, Department of Medicine, European Institute of Oncology, Milan, Italy. · Pubmed 22749924
  • Research Unit in Medical Senology, Department of Medicine, European Institute of Oncology, Milan, Italy. · Pubmed 22399188
  • Division of Pathology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · Pubmed 22228432
  • Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Pubmed 22212746
  • Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy. · Pubmed 22212008
  • Department of Medicine, European Institute of Oncology, Via Ripamonti 435, Milan, Italy. · Pubmed 22171586
  • Division of Senology, Unit of Molecular Senology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · Pubmed 21468637
2011
  • Division of Cancer Prevention and Genetics, European Institute of Oncology, Milan, Italy. · Pubmed 21685235
  • Division of Senology, European Institute of Oncology, Milano, Italy. · Pubmed 21479691
  • Division of Breast Surgery, European Institute of Oncology, Milan, Italy. · Pubmed 22015303
  • Division of Medical Oncology, Department of Medicine, Unit Research of Medical Senology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy. · Pubmed 21822638
  • Medical Senology Research Unit, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy. · Pubmed 21397505
  • Division of Senology, European Institute of Oncology, University of Milan, Milan, Italy. · Pubmed 21248632
  • Research Unit of Medical Senology at the Department of Medicine, European Institute of Oncology, Milano, Italy. · Pubmed 21221766
  • Research Unit of Medical Senology, European Institute of Oncology, via Ripamonti 435, Milan, Italy. · Pubmed 20638282
2010
  • Research Unit of Medical Senology, European Institute of Oncology, Milan, Italy. · Pubmed 21147693
  • IEO European Institute of Oncology, Milan, Italy. · Pubmed 21147866
  • Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Pubmed 20705566
  • Division of Medical Oncology, Department of Medicine, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · Pubmed 20625816
  • Department of Medicine, Research Unit in Medical Senology, European Institute of Oncology, Milan, Italy. · Pubmed 20471822
  • Research Unit in Medical Senology, Department of Medicine, European Institute of Oncology, Università degli Studi di Milano, Milan, Italy. · Pubmed 20458051
  • European Institute of Oncology, Milan, Italy. · Pubmed 20195151
  • Unit of Research in Medical Senology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · Pubmed 20117001
  • Division of Senology, European Institute of Oncology, Milan, Italy. · Pubmed 19662412
2009
  • Research Unit in Medical Senology, Department of Medicine, European Institute of Oncology, Via Ripamonti 435, Milan, Italy. · Pubmed 19914533
  • Department of Medicine, Research Unit in Medical Senology, European Institute of Oncology, Milan, Italy. · Pubmed 18941889
  • Research Unit in Medical Senology, Division of Medical Oncology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · Pubmed 20044624
  • Department of Medicine, Division of Medical Oncology, Istituto Europeo di Oncologia, Milano, Italy. · Pubmed 19884553
  • Scientific Director European Institute of Oncology, Milan, Italy. · Pubmed 19645785
  • Department of Radiology, Breast Imaging Unit, European Institute of Oncology, Milan, Italy. · Pubmed 19342236
  • Division of Cancer Prevention and Genetics, European Institute of Oncology, Milan, Italy. · Pubmed 19264824
  • Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy. · Pubmed 19222698
  • Research Unit of Medical Senology, European Institute of Oncology, Milan, Italy. · Pubmed 19182679
  • Scientific Director European Institute of Oncology, Via G. Ripamonti 435, I-20141 Milan, Italy. · Pubmed 19128957
Probable:    University of Milan Statale      
2017
  • European Institute of Oncology, Milano, Italy. Electronic address: · Champalimaud Clinical Center, Lisbon, Portugal. · European School of Oncology, Milano, Italy. · European Institute of Oncology, Milano, Italy; University of Milan, Milano, Italy. · European Institute of Oncology, Milano, Italy. · Pubmed 27876474
  • Molecular Biotechnology Center, Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin 10126, Italy. · Molecular Biotechnology Center, Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin 10126, Italy. Electronic address: · Department of Medical Sciences, University of Torino, Turin, Italy; Pathology Unit, Department of Laboratory Medicine, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Turin, Italy. · IFOM, The FIRC Institute for Molecular Oncology Foundation, Milan, Italy. · Program of Molecular Medicine, IEO, European Institute of Oncology, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy; Department of Oncology and Hemato-oncology (DIPO), University of Milan, Milan, Italy. · Department of Cell Physiology and Metabolism, University of Geneva, Geneva, Switzerland. · Molecular Biotechnology Center, Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin 10126, Italy; Department of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA. · Unit of Investigative Oncology, Candiolo Cancer Institute - FPO, IRCCS, Candiolo (TO), Italy. · Institute for Research in Biomedicine, Università della Svizzera Italiana, Bellinzona, Switzerland. · Department of Biological Science and Bioengineering, Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an, Shaanxi, P. R. China. · Program of Molecular Medicine, IEO, European Institute of Oncology, Milan, Italy; Department of Oncology and Hemato-oncology (DIPO), University of Milan, Milan, Italy. · Department of Medical Sciences, University of Torino, Turin, Italy; Unit of Pathology, Candiolo Cancer Institute - FPO, IRCCS, Candiolo (TO), Italy. · IFOM, The FIRC Institute for Molecular Oncology Foundation, Milan, Italy; Program of Molecular Medicine, IEO, European Institute of Oncology, Milan, Italy; Department of Oncology and Hemato-oncology (DIPO), University of Milan, Milan, Italy. · Molecular Biotechnology Center, Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin 10126, Italy. Electronic address: · Pubmed 29017056
  • Division of Radiation Oncology, European Institute of Oncology, Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy. · Unit of Medical Physics, European Institute of Oncology, Milan, Italy. · Division of Radiation Oncology, European Institute of Oncology, Milan, Italy; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy. · Division of Breast Surgery, European Institute of Oncology, Milan, Italy. · Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy; Division of Breast Surgery, European Institute of Oncology, Milan, Italy. · Division of Radiation Oncology, European Institute of Oncology, Milan, Italy; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy. Electronic address: · Division of Pathology, European Institute of Oncology, Milan, Italy; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy. · Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy; Department of Medical Imaging and Radiation Sciences, European Institute of Oncology, Milan, Italy. · Pubmed 28816144
  • Transformative Pathology, Ontario Institute for Cancer Research (OICR), MaRS Centre, 661 University Avenue, Suite 510, Toronto, ON M5G 0A3, Canada; University of Edinburgh Cancer Research Centre, Institute of Genetics and Molecular Medicine, The University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK. Electronic address: · Cancer Research UK Clinical Trials Unit, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK. Electronic address: · International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA. Electronic address: · Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University, Charterhouse Square, London EC1M 6BQ, UK. Electronic address: · Department of Pathology, Elizabeth University Hospital, 1345 Govan Road, Govan, Glasgow G51 4TF, UK. Electronic address: · Department of Pathology, European Institute of Oncology and University of Milan, Via Giuseppe Ripamonti, 435, 20141 Milan, Italy. Electronic address: · Breast Center, Kantonsspital, St. Gallen, and Swiss Group for Clinical Cancer Research SAKK, CH-9007 St. Gallen, Switzerland. Electronic address: · Department of Medical Oncology, Erasmus MC Cancer Institute, PO Box 5201, Rotterdam 3008 AE, The Netherlands. Electronic address: · Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands. Electronic address: · Division of Surgery, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands. Electronic address: · Leicester Clinical Trials Unit, University of Leicester, Leicester LE5 4PW, UK. Electronic address: · Surgical Oncology, University of Newcastle, Calvary Mater Newcastle Hospital, Locked Bag 7, HRMC, Newcastle, NSW 2310, Australia. Electronic address: · Department of Pathology, European Institute of Oncology and University of Milan, Via Giuseppe Ripamonti, 435, 20141 Milan, Italy. Electronic address: · Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University, Charterhouse Square, London EC1M 6BQ, UK. Electronic address: · Academic Department of Biochemistry, Royal Marsden Hospital, and Endocrinology, Breakthrough Breast Cancer Centre, Institute of Cancer Research, Fulham Road, London SW3 6JJ, UK. Electronic address: · Cancer Research UK Clinical Trials Unit, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK. Electronic address: · Pubmed 28494403
  • Institute of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland. · Private Group Practice for Pathology and PathoPlan GbR, Lübeck, Germany. · Department of Pathology and Laboratory of Pathology, West China Hospital, Sichuan University, Chengdu, China. · Institute of Pathology, University Erlangen-Nürnberg, Erlangen, Germany. · Centre Jean Perrin, Centre regional de Lutte contre le cancer d'Auvergne, Clermont-Ferrand, France. · European Institute of Oncology, University of Milan, Milan, Italy. · Institute of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Pathology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China. · Institute of Pathology, Klinikum Region Hannover, Hannover, Germany. · BioNTech Diagnostics GmbH, Mainz, Germany. · Department of Oncology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland. · ACOMED Statistik, Leipzig, Germany. · Department of Pathology, Heidelberg University Hospital, Heidelberg, Germany. · Transformative Pathology, Ontario Institute for Cancer Research (OICR), Toronto, ON, Canada. · Pubmed 28490348
  • Istituto Europeo di Oncologia, Milan, Italy. · IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy. · Dipartimento di Oncologia e Emato-oncologia, Università degli Studi di Milano, Milan, Italy. · Istituto Europeo di Oncologia, Milan, Italy · Pubmed 28298340
  • Department of Surgery and Cancer, Imperial College London, London, UK. · Department of Experimental Oncology, European Institute of Oncology Milan, Italy. · Hematology Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, IT. · Swammerdam Institute for Life Sciences, University of Amsterdam. · Genomics Division, Lawrence Berkeley National Laboratory, 1 Cyclotron Road, Berkeley, CA, USA. · Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Arcavacata di Rende (CS), Italy. · Division of Stem Cells and Cancer, Deutsches Krebsforschungszentrum (DKFZ), and Institute for Stem Cell Technology and Experimental Medicine GmbH, Heidelberg, Germany. · Division of Pathology, European Institute of Oncology and University of Milan, School of Medicine, Milan, Italy. · Department of Oncology and Hemato-oncology, University of Milano, Milan, IT. · Division of Medical Senology, European Institute of Oncology, IEO, Milan, Italy. · Department of Biosciences, University of Milano, Milan, IT. · Pubmed 28112739
  • Division of Breast Surgery, European Institute of Oncology, Milan, Italy. Electronic address: · Division of Breast Surgery, European Institute of Oncology, Milan, Italy. · Division of Plastic and Reconstructive Surgery, European Institute of Oncology, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Division of Cancer Prevention and Genetics, European Institute of Oncology, Milan, Italy. · Early Drug Development for Innovative Therapies Division, European Institute of Oncology, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy; University of Milan, School of Medicine, Milan, Italy. · Division of Breast Surgery, European Institute of Oncology, Milan, Italy; University of Milan, School of Medicine, Milan, Italy. · Pubmed 27810700
2016
  • IBCSG Central Pathology Laboratory, Department of Pathology and Laboratory Medicine, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · University of Milan, Milan, Italy. · International Breast Cancer Study Group (IBCSG) Statistical Center, Boston, MA, USA. · Harvard T. H. Chan School of Public Health, Boston, MA, USA. · IBCSG Central Pathology Laboratory, Department of Pathology and Laboratory Medicine, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · University of Milan, Milan, Italy. · Division of Experimental Therapeutics, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · National Institute of Oncology, Ráth György u. 7/9, Budapest, 1122, Hungary. · Breast Center St. Gallen, Kantonsspital, St. Gallen, Switzerland. · Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. · Divisione di Oncologia, Ospedale degli Infermi, Viale Settembrini 2, 47923, Rimini, Italy. · Program for Breast Health, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · International Breast Cancer Study Group, Translational Research Coordination and Central Pathology Office, IBCSG Coordinating Center, Effingerstrasse 40, 3008, Bern, Switzerland. · Frontier Science and Technology Research Foundation, Boston, MA, USA. · Division of Medical Senology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Harvard Medical School, Boston, MA, USA. · Pubmed 27372069
  • Department of Pathology, European Institute of Oncology and University of Milan, Via Ripamonti 435, 20141, Milan, Italy. · Department of Statistics, European Organization for Research and Treatment of Cancer, Brussels, Belgium. · Medical Affairs, Agendia, Amsterdam, The Netherlands. · Department of Pathology, European Institute of Oncology and University of Milan, Via Ripamonti 435, 20141, Milan, Italy. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA. · Department of Surgery, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal. · Pubmed 26820652
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium2Medical Oncology Clinic, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Breast and Gynecological Surgery, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark6Danish Breast Cancer Cooperative Group, Copenhagen, Denmark. · Department of Pathology, European Institute of Oncology, University of Milan, Milan, Italy. · Avera Cancer Institute, Sioux Falls, South Dakota. · International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · International Breast Cancer Study Group Coordinating Center and Central Pathology Office, Bern, Switzerland. · Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark6Danish Breast Cancer Cooperative Group, Copenhagen, Denmark11Department of Oncology, Odense University Hospital, Odense, Denmark12AgeCare, Odense University Hospital, Odense. · Medical Oncology Clinic, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Villejuif, France14INSERM U1018, CESP, Université Paris-Sud, Villejuif France. · Pubmed 26633571
  • Division of Cancer Prevention and Genetics, European Institute of Oncology, Via Ripamonti 435, Milan, 20141, Italy. · International Breast Cancer Study Group (IBCSG) Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard T. H. Chan School of Public Health, 450 Brookline Avenue, Boston, MA, 02215, USA. · Institute of Oncology of Southern Switzerland (IOSI), Bellinzona, Switzerland. · International Breast Cancer Study Group, Bern, Switzerland. · Swiss Group for Clinical Cancer Research SAKK, Lugano Viganello, Switzerland. · IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA, 02215, USA. · Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Via Ripamonti 435, Milan, 20141, Italy. · Division of Cancer Prevention and Genetics, European Institute of Oncology, Via Ripamonti 435, Milan, 20141, Italy. · International Breast Cancer Study Group (IBCSG) Coordinating Center, Effingerstrasse 40, Bern, CH-3008, Switzerland. · Division of Medical Senology, European Institute of Oncology, Via Ripamonti 435, Milan, 20141, Italy. · IBCSG Statistical Center, Frontier Science and Technology Research Foundation, Boston, MA, USA. · Dana-Farber Cancer Institute, Department of Biostatistics and Computatonal Biology, 450 Brookline Ave, Boston, MA, 02215, USA. · International Breast Cancer Study Group and University of Sydney School of Public Health, Sydney, Australia. · IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Harvard Medical School, Frontier Science and Technology Research Foundation, 450 Brookline Avenue, Boston, MA, 02215, USA. · Program for Breast Health, European Institute of Oncology, Via Ripamonti 435, Milan, 20141, Italy. · Translational Research Coordination and Central Pathology Office, IBCSG Coordinating Center, Effingerstrasse 40, Bern, CH-3008, Switzerland. · Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · National Cancer Institute of Canada, Kingston, ON, Canada. · Pubmed 27825388
  • Medical Oncology Division & Breast Unit, 72100 Brindisi, Italy. Electronic address: · Pathology Division, European Institute of Oncology, University of Milan, 20141 Milan, Italy. · Medical Oncology & Breast Unit, University of Verona, Azienda Ospedaliera Universitaria Integrata, 37134 Verona, Italy. · Medical Oncology Division & Breast Unit, 72100 Brindisi, Italy. · Biostatistics, Regina Elena National Cancer Institute, 00144 Rome, Italy. · Pubmed 27750105
  • University of Milan, Istituto Europeo di Oncologia, Milan, Italy. · UCL Advanced Diagnostics, London, UK. · Clarient Pathology Services, Aliso Viejo, CA, USA. · Dako, An Agilent Technologies Company, Glostrup, Denmark. · Dx-Rx Institute, Baunevaenget 76, DK-3480 Fredensborg, Denmark. Electronic address: · Pubmed 27461826
  • Institute of Pathology, Charité Universitätsmedizin Berlin, Berlin, Germany. · German Cancer Consortium (DKTK), Partner site Berlin, Berlin, Germany. · VMscope GmbH, Berlin, Germany. · Service de Biostatistique et d'Epidémiologie; Institute Gustave Roussy, Villejuif, France. · German Breast Group (GBG), Neu-Isenburg, Germany. · Clinic of Gynecology and Obstetrics, Sana Klinikum Offenbach, Offenbach, Germany. · Indiana University School of Medicine, Indianapolis, IN, USA. · Clinical Institute of Pathology, Medizinische Universität Wien, Wien, Austria. · Department of Pathology & Molecular Medicine, McMaster University, Hamilton, ON, Canada. · Weill Cornell Medical College, Doha, Qatar. · Harvard Medical School, Boston, MA, USA. · Tumor Pathology Department, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice, Poland. · Institut für Pathologie, Medizinische Hochschule Hannover, Hannover, Germany. · Pathology, GZA Ziekenhuizen, Sint-Augustinus, Wilrijk, Belgium. · Radiation Oncology and Pathology, Weill Cornell Medical College, New York, NY, USA. · Department of Pathology and Cytology GZA Hospitals, Wilrijk, Belgium. · Department of Pathology University Hospitals Leuven, Leuven, Belgium. · Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · Anatomical Pathology, Vancouver Hospital, Vancouver, BC, Canada. · Division of Pathology, NSABP, Pittsburgh, PA, USA. · Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, ON, Canada. · UQ School of Medicine and Pathology Queensland, The University of Queensland Centre for Clinical Research, Brisbane, QLD, Australia. · ERTICa Research Team, Department of Pathology, Jean Perrin Comprehensive Cancer Center, University of Auvergne EA4677, Clermont-Ferrand, France. · Division of Pathology and Laboratory Medicine, University of Milan, Milan, Italy. · Department of Pathology, Yale University School of Medicine, New Haven, CT, USA. · Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA, USA. · Department for Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Sektion Gynäkopathologie, Pathologisches Institut, University of Heidelberg, Heidelberg, Germany. · Anatomie Pathologique, Institut Jules Bordet, Brussels, Belgium. · Molecular Diagnostic Oncology, Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Department of Pathology, European Institute of Oncology, University of Milan, Milan, Italy. · Department of Pathology, Netherlands Cancer Institute, Amsterdam, Netherlands. · Jules Bordet Institute, Brussels, Belgium. · Department of Gynecology, Helios-Klinikum Berlin-Buch, Berlin, Germany. · Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen EMN, Friedrich-Alexander University Erlangen, Erlangen, Germany. · Department of Gynecology, Klinikum Südstadt Rostock, Rostock, Germany. · Molecular Immunology Unit, Institut Jules Bordet, Brussels, Belgium. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Univ. Paris Sud, Univ. Paris-Saclay, Villejuif, France. · Division of Research and Clinical Medicine, Peter MacCallum Cancer Center, Melbourne, VIC, Australia. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Brussels, Belgium. · Pubmed 27363491
  • Division of Experimental Therapeutics, University of Milan-Bicocca, Milan, Italy. · Division of Epidemiology and Biostatistics, University of Milan-Bicocca, Milan, Italy Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy. · Department of Pathology, School of Medicine, University of Milan, Milan, Italy. · Division of Epidemiology and Biostatistics, University of Milan-Bicocca, Milan, Italy. · Breast Health Program, European Institute of Oncology, Milan, Italy. · Division of Experimental Therapeutics, University of Milan-Bicocca, Milan, Italy · Pubmed 27354620
  • IFOM, the FIRC Institute of Molecular Oncology, Milan, Italy. · IFOM, the FIRC Institute of Molecular Oncology, Milan, Italy Department of Pediatrics, Graduate School of Medicine The University of Tokyo, Tokyo, Japan. · Molecular Medicine Program, European Institute of Oncology, Milan, Italy. · Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy Department of Pathology, European Institute of Oncology, Milan, Italy. · IFOM, the FIRC Institute of Molecular Oncology, Milan, Italy Molecular Medicine Program, European Institute of Oncology, Milan, Italy Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy. · IFOM, the FIRC Institute of Molecular Oncology, Milan, Italy Molecular Medicine Program, European Institute of Oncology, Milan, Italy. · Institut Curie, PSL Research University, Paris Cedex 05, France Centre National de la Recherche Scientifique, Unité Mixte de Recherche 144 CNRS UMR 144, Paris Cedex 05, France. · IFOM, the FIRC Institute of Molecular Oncology, Milan, Italy Molecular Medicine Program, European Institute of Oncology, Milan, Italy · Pubmed 27255086
  • Division of Research and Clinical Medicine, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Frontier Science Foundation- Hellas, Athens, Greece3University of Athens, Athens, Greece. · Frontier Science Foundation- Hellas, Athens, Greece4Athens University of Economics and Business, Athens, Greece. · Frontier Science Foundation- Hellas, Athens, Greece. · Avera Cancer Institute, Department of Molecular and Experimental Medicine, Sioux Falls, South Dakota. · Department of Pathology, University of Chicago, Chicago, Illinois. · BREAST Datacentre, Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. · University of Milan, European Institute of Oncology, Milan, Italy. · Targos Molecular Pathology GmbH, Kassel, Germany. · Department of Medicine, Institute Jules Bordet, Universite Libre de Bruxelles and Breast International Group (BIG), Brussels, Belgium12Breast International Group (BIG), Brussels, Belgium. · Royal Marsden Hospital, London, England. · INSERM U1018 CESP, Service de Biostatistique et d'Epidémiologie, Villejuif, France. · Pubmed 27100299
2015
  • Department of Histopathology and NIH Cambridge Biomedical Research Centre, Addenbrooke's Hospital, Cambridge, UK. · Department of Pathology, Yale University, New Haven, CT, USA. · Department of Pathology, European Institute of Oncology and University of Milan, Milan, Italy. · Edinburgh Cancer Research UK Centre,University of Edinburgh, Edinburgh, UK. · Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA. · Institute of Pathology, Charité Hospital, Berlin, Germany. · Department of Biopathology, Institut Bergonié, Bordeaux, France. · Department of Pathology, Centre Jean Perrin and Université d'Auvergne, Clermont-Ferrand, France. · Division of Subspecialty General Surgery, Mayo Clinic, Rochester, MN, USA. · Early Drug Development for Innovative Therapies Division, European Institute of Oncology, Milan, Italy. · Edinburgh Breast Unit, Western General Hospital, Edinburgh, UK. · Carol Franc Buck Breast Care Center, University of California, San Francisco, CA, USA. · Department of Radiotherapy and Radiation Oncology, Landeskrankenhaus, Paracelsus Medical University, Salzburg, Austria. · Department of Gynecology and Obstetrics, Interdisciplinary Breast Center, Klinikum Esslingen, Esslingen, Germany. · Institute of Pathology, Medical University of Graz, Graz, Austria. · Department of Gynecology, General Hospital Leoben, Leoben, Austria. · German Breast Group, Neu-Isenburg, and Department of Gynecology and Obstetrics, University Women's Hospital, Frankfurt, Germany. · Department of Radiation Oncology, Ohio State University, Columbus, OH, USA. · Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 26205180
  • Avera Cancer Institute, 1000 E 23rd Street, Sioux Falls, SD, 57105, USA. · Department of Biostatistics and Computational Biology, International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard T. H. Chan School of Public Health, 450 Brookline Ave, Boston, MA, 02215, USA. · VM Institute of Research, 6100 Av Royalmount, Montréal, QC, H4P 2R2, Canada. · AKESOgen, Inc., 3155 Northwoods Pl NW, Norcross, GA, 30071, USA. · Avera Cancer Institute, 1000 E 23rd Street, Sioux Falls, SD, 57105, USA. · Genomic and Molecular Pathology, University of Chicago, 900 E 57th St. Room 1260D, Chicago, IL, 60637, USA. · International Breast Cancer Study Group Coordinating Center and Central Pathology Office, Effingerstrasse 40, 3008, Bern, Switzerland. · Division of Pathology and Laboratory Medicine, International Breast Cancer Study Group Central Pathology Office, European Institute of Oncology, Via Ripamonti 435, 20146, Milan, Italy. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, Via Ripamonti 435, 20146, Milan, Italy. · Breast Center, Kantonsspital St. Gallen, Rorschacher Strasse 95, 9007, St. Gallen, Switzerland. · Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. · International Breast Cancer Study Group, Bern, Switzerland. · International Breast Cancer Study Group, Bern, Switzerland. · Auckland City Hospital, PO Box 26498, Epsom, Auckland, 1344, New Zealand. · Australia and New Zealand Breast Cancer Trials Group, Newcastle, Australia. · Department of Oncology, Multidisciplinary Breast Center, KULeuven (University of Leuven), University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium. · Institute Georges François Leclerc, 1 Rue Professeur Marion, BP 77 980, 21079, Dijon Cedex, France. · International Breast Cancer Study Group Coordinating Center, Effingerstrasse 40, 3008, Bern, Switzerland. · International Breast Cancer Study Group Statistical Center, Frontier Science and Technology Research Foundation, 450 Brookline Ave, Boston, MA, 02215, USA. · International Breast Cancer Study Group, Bern, Switzerland. · University of Sydney, Sydney, Australia. · International Breast Cancer Study Group, Bern, Switzerland. · Program for Breast Health (Senology), European Institute of Oncology, Via Ripamonti 435, 20146, Milan, Italy. · International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, Harvard T.H. Chan School of Public Health, Frontier Science and Technology Research Foundation, 450 Brookline Ave, Boston, MA, 02215, USA. · International Breast Cancer Study Group, Bern, Switzerland. · Institute of Oncology of Southern Switzerland (IOSI), Ospedale Italiano, Via Capelli, 6962, Viganello, Switzerland. · International Breast Cancer Study Group Central Pathology Office, Division of Pathology and Laboratory Medicine, European Institute of Oncology, University of Milan, Via Ripamonti 435, 20146, Milan, Italy. · Division of Hematology/Oncology, University of Michigan Comprehensive Cancer Center, 1500 E Medical Cntr Drive/SPC 5946, Ann Arbor, MI, 48109, USA. · Department of Biostatistics and Computational Biology, International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave, Boston, MA, 02215, USA. · Pubmed 26590813
  • Division of Medical Oncology, E.O. Ospedali Galliera, Genoa, Italy. Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom. · Office of the Scientific Director, E.O. Ospedali Galliera, Genoa, Italy. · Divisions of Cancer Prevention and Genetics, European Institute of Oncology, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy. · Division of Breast Surgery, European Institute of Oncology, Milan, Italy. · Division of Medical Oncology, E.O. Ospedali Galliera, Genoa, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy. University of Milan, School of Medicine, Milan, Italy. · Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom. · Pubmed 26276754
  • Division of Medical Senology, European Institute of Oncology, Milan, Italy. Electronic address: · Division of Epidemiology and Biostatistics, European Institute of Oncology, and Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Department of Pathology, European Institute of Oncology, Milan, Italy; University of Milan School of Medicine, Milan, Italy. · Department of Pathology, European Institute of Oncology, Milan, Italy. · University of Milan School of Medicine, Milan, Italy; Division of Senology, European Institute of Oncology, Milan, Italy. · Division of Senology, European Institute of Oncology, Milan, Italy. · Program of Senology (Breast Health), European Institute of Oncology, Milan, Italy. · Pubmed 25933934
  • Division of Experimental Therapeutics, Breast Health Program, Istituto Europeo di Oncologia, Italy. Electronic address: · Division of Epidemiology and Biostatistics, Istituto Europeo di Oncologia, Italy; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milano, Italy. · Laboratory Division of Hematology-Oncology, Italy. · Department of Experimental Oncology, Italy; University of Milano, School of Medicine, Milano, Italy. · Division of Experimental Therapeutics, Breast Health Program, Istituto Europeo di Oncologia, Italy. · Department of Pathology, Istituto Europeo di Oncologia, Italy; University of Milano, School of Medicine, Milano, Italy. · Pubmed 25772326
  • Department of Biostatistics and Computational Biology, International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Mailstop CLS-11007, Boston, MA, 02215, USA. · Institute of Oncology of Southern Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Lugano Viganello, Switzerland. · Peter MacCallum Cancer Center, St Vincent's Hospital, University of Melbourne, Melbourne, VIC, Australia. · Australia & New Zealand Breast Cancer Trials Group (ANZBCTG), University of Newcastle, Callaghan, NSW, Australia. · The University of Chicago Medical Center and Alliance for Clinical Trials in Oncology, Chicago, IL, USA. · Tom Baker Cancer Centre and NCIC Clinical Trials Group, Calgary, AB, Canada. · International Breast Cancer Study Group Coordinating Center and Central Pathology Office, Bern, Switzerland. · International Breast Cancer Study Group Central Pathology Office, Department of Pathology, European Institute of Oncology, Milan, Italy. · International Breast Cancer Study Group Central Pathology Office, Department of Pathology, European Institute of Oncology, Milan, Italy. · Pathological Department, National Institute of Oncology, Budapest, Hungary. · Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru. · Division of Pathology, Salvatore Maugeri Foundation, Pavia, Italy. · Struttura Operativa Complessa di Anatomia Patologica, Azienda Ospedaliero-Universitaria di Udine, Udine, Italy. · Kantonsspital St. Gallen, Swiss Group for Clinical Cancer Research (SAKK), St. Gallen, Switzerland. · University of Insubria-Ospedale di Circolo and Fondazione Macchi, Varese, Italy. · Department of Pathology, Vall d'Hebron University Hospital, SOLTI Group, Barcelona, Spain. · Pathology Department, Hospital Universitario «12 de Octubre», i+12, Universidad Complutense Madrid, SOLTI Group, Madrid, Spain. · Laboratoire Anatomopathologie, Institut Bergonié, Bordeaux, France. · EORTC, Brussels, Belgium. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Program for Breast Health, European Institute of Oncology, Milan, Italy. · International Breast Cancer Study Group Statistical Center, Frontier Science and Technology Research Foundation, Boston, MA, USA. · University of Sydney, Sydney, Australia. · International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Harvard T.H. Chan School of Public Health, Boston, MA, USA. · Frontier Science and Technology Research Foundation, Boston, MA, USA. · International Breast Cancer Study Group Central Pathology Office, European Institute of Oncology, University of Milan, Milan, Italy. · Pubmed 26493064
  • Targos Molecular Pathology GmbH, Kassel, Germany. · Institute of Pathology, University of Cologne, Cologne, Germany. · Institute of Pathology Nordhessen, Kassel, Germany. · Institute of Pathology, University of Göttingen, Göttingen, Germany. · Department of Pathology, University of Milan and European Institute of Oncology, Milan, Italy. · Nazarbayev University School of Medicine, Astana, Kazakhstan. · Clinic for Gynecology and Obstetrics, Helios Klinikum Berlin-Buch, Berlin, Germany. · Pubmed 26403781
  • Division of Medical Senology, European Institute of Oncology, Milan, Italy. Electronic address: · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy. · Division of Laboratory Medicine, European Institute of Oncology, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Department of Medicine, European Institute of Oncology, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy; School of Medicine, University of Milan, Milan, Italy. · Division of Senology, European Institute of Oncology, Milan, Italy. · Pubmed 26362840
  • Division of Medical Senology, European Institute of Oncology, Milan, Italy. Electronic address: · Department of Quantitative Methods and Statistics, University of Milan-Bicocca, Milan, Italy; Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Department of Pathology, European Institute of Oncology, Milan, Italy; School of Medicine, University of Milan, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Division of Senology, European Institute of Oncology, Milan, Italy. · Department of Pathology, European Institute of Oncology, Milan, Italy. · Program of Senology (Breast Health), European Institute of Oncology, Milan, Italy. · Pubmed 26255932
  • University of Milan, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy. Electronic address: · Pubmed 26255744
  • Johns Hopkins Kimmel Comprehensive Cancer Center, Baltimore, MD. · University of Utah School of Medicine and Intermountain Healthcare, Salt Lake City, UT. · University of Rochester Medical Center, Rochester, NY. · Stanford University Medical Center, Stanford, CA. · Ontario Institute for Cancer Research, Toronto, Ontario, Canada. · University of Western Sydney and Healthscope Pathology, Sydney, New South Wales, Australia. · St Jude Medical Center, Fullerton, CA. · Sunnybrook Health Sciences Center, Toronto, Ontario, Canada. · Mayo Clinic, Rochester, MN. · American Society of Clinical Oncology, Alexandria, VA. · National Adjuvant Surgical Breast and Bowel Project, Pittsburgh, PA. · Mayo Clinic, Jacksonville, FL. · University of Southern California, Los Angeles, CA. · North Carolina State University, Raleigh, NC. · Indiana University Medical Center, Indianapolis, IN. · University of Milan, European Institute of Oncology, Milan, Italy. · Royal Marsden Hospital, London, United Kingdom. · National Cancer Institute, Bethesda, MD. · University of Michigan Comprehensive Cancer Care Center, Ann Arbor, MI. · Pubmed 25753441
  • BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Division of Pathology, European Institute of Oncology, Milan, Italy. · Fertility and Procreation Unit, Department of Gynecology Oncology, European Institute of Oncology, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy; University of Milan, School of Medicine, Milan, Italy. · Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Pubmed 25702955
  • Biometric Research Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland, USA. · Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy. · Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK. · Transformative Pathology, Ontario Institute for Cancer Research, Toronto, Ontario, Canada. · The Emmes Corporation, Rockville, Maryland, USA. · Indiana University Simon Cancer Center, Indianapolis, Indiana, USA. · Department of Pathology and Molecular Medicine, Juravinski Hospital and Cancer Centre, McMaster University, Hamilton, Ontario, Canada. · Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Lund, Sweden. · Montefiore Medical Center and the Albert Einstein College of Medicine, Bronx, New York, USA. · Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. · PhenoPath Laboratories, Seattle, Washington, USA. · Lester and Sue Smith Breast Center and Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas, USA. · Department of Laboratory Medicine and Pathology, University of Alberta, Alberta, Canada. · Department of Pathology, Kawasaki Medical School, Kurashiki City, Japan. · Department of Pathology, Hakuaikai Sagara Hospital, Matsubaracho, Kagoshima, Japan. · Department of Pathology, Centre Jean Perrin and Université d'Auvergne, Clermont-Ferrand, France. · Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK. · Department of Pathology, Jichi Medical University, Shimotsuke, Tochigi, Japan. · Institut Jules Bordet, Brussels, Belgium. · Birmingham Heart of England, National Health Service, Birmingham, UK. · Slagelse Hospital, Slagelse, Region Sjælland, Denmark. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, and University of Milan, Milan, Italy. · Academic Department of Biochemistry, Royal Marsden Hospital, London, UK. · Breast Oncology Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, USA. · Pubmed 25698062
  • Molecular Medicine Program, Department of Experimental Oncology, European Institute of Oncology, Milan, Italy. · Molecular Medicine Program, Department of Experimental Oncology, European Institute of Oncology, Milan, Italy; Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Molecular Medicine Program, Department of Experimental Oncology, European Institute of Oncology, Milan, Italy; IFOM, The FIRC Institute for Molecular Oncology Foundation, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy; School of Medicine, University of Milan, Milan, Italy. · Molecular Medicine Program, Department of Experimental Oncology, European Institute of Oncology, Milan, Italy; IFOM, The FIRC Institute for Molecular Oncology Foundation, Milan, Italy; Center for Genomic Science of IIT@SEMM, Istituto Italiano di Tecnologia (IIT), Milan, Italy. · Molecular Medicine Program, Department of Experimental Oncology, European Institute of Oncology, Milan, Italy; IFOM, The FIRC Institute for Molecular Oncology Foundation, Milan, Italy; Department of Scienze della Salute, University of Milan, Milan, Italy. Electronic address: · Molecular Medicine Program, Department of Experimental Oncology, European Institute of Oncology, Milan, Italy. Electronic address: · Pubmed 25459350
2014
  • Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada. · Institute of Pathology Nordhessen, Kassel, Germany. · Healthscope Pathology, Norwest Private Hospital, Bella Vista, NSW, Australia. · State of São Paulo Cancer Institute (ICESP), São Paulo, Brazil. · Royal Marsden Hospital, London, UK. · International University of Health and Welfare (IUHW), Center for Diagnostic Pathology, IUHW Mita Hospital, Tokyo, Japan. · Centre Jean Perrin and University of Auvergne, EA 4233, Clermont-Ferrand, France. · The Academic Medical Center (AMC), The University of Amsterdam, Amsterdam, The Netherlands. · University of Milan and European Institute of Oncology, Milan, Italy. · Pubmed 23807776
  • Division of Medical Senology, European Institute of Oncology, Milan, Italy. Electronic address: · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Division of Prevention and Genetics, European Institute of Oncology, Milan, Italy. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy; University of Milan School of Medicine, Milan, Italy. · Division of Senology, European Institute of Oncology, Milan, Italy; University of Milan School of Medicine, Milan, Italy. · Division of Senology, European Institute of Oncology, Milan, Italy. · Scientific Direction, European Institute of Oncology, Milan, Italy. · Pubmed 24742826
  • Division of Medical Senology, European Institute of Oncology, Milan, Italy. Electronic address: · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy; Department of Statistics and Quantitative Methods, Unit of Biostatistics, Epidemiology and Public Health, University of Milan-Bicocca, Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy; School of Medicine, University of Milan, Italy. · School of Medicine, University of Milan, Italy; Molecular Senology Unit, European Institute of Oncology, Milan, Italy. · Division of Senology, European Institute of Oncology, Milan, Italy. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy. · Vice-Scientific Director, European Institute of Oncology, Milan, Italy. · Pubmed 24325948
  • Early Drug Development for Innovative Therapies Division, Department of Medicine, European Institute of Oncology, Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Department of Breast Oncology, National Cancer Institute "Fondazione Pascale", Naples, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy. · Department of Endocrinology and Molecular and Clinical Oncology, University of Naples Federico II, Napoli, Italy. · Department of Advanced Medical Sciences, Operative Unit of General Surgery and Transplants, University of Naples Federico II, Napoli, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy; University of Milan School of Medicine, Milan, Italy. · Early Drug Development for Innovative Therapies Division, Department of Medicine, European Institute of Oncology, Milan, Italy. Electronic address: · Pubmed 24314620
  • European Institute of Oncology, Medical Oncology, via Ripamonti 435, Milan, Italy. Electronic address: · European Institute of Oncology, Division of Epidemiology and Biostatistics, via Ripamonti 435, Milan, Italy. · European Institute of Oncology, Division of Pathology, via Ripamonti 435, Milan, Italy; University of Milan, School of Medicine, Milan, Italy. · European Institute of Oncology, Division of Epidemiology and Biostatistics, via Ripamonti 435, Milan, Italy; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, via Bicocca degli Arcimboldi 8, 20126 Milan, Italy. · European Institute of Oncology, Medical Oncology, via Ripamonti 435, Milan, Italy. · Second University of Naples, Medical Oncology, via Pansini 5, Naples, Italy. · Pubmed 24269135
  • Unit of Investigative Clinical Oncology (INCO), Fondazione del Piemonte per l'Oncologia, Institute for Cancer Research and Treatment (IRCCs), Candiolo, Italy. · Division of Medical Oncology, European Institute of Oncology, Milan, Italy. · Division of Medical Oncology, Fondazione del Piemonte per l'Oncologia, Institute for Cancer Research and Treatment (IRCCs), Candiolo, Italy. · University of Turin, Department of Biomedical Sciences and Human Oncology, Turin, Italy. · Department of Pathology and Laboratory Medicine, European Institute of Oncology, University of Milan, Milan, Italy. · Unit of Investigative Clinical Oncology (INCO), Fondazione del Piemonte per l'Oncologia, Institute for Cancer Research and Treatment (IRCCs), Candiolo, Italy; Division of Medical Oncology, Fondazione del Piemonte per l'Oncologia, Institute for Cancer Research and Treatment (IRCCs), Candiolo, Italy. Electronic address: · Pubmed 24210572
  • Division of Medical Senology, European Institute of Oncology, Milan, Italy. Electronic address: · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Division of Pathology and Laboratory Medicine, European Institute of Oncology and University of Milan, Italy. · Integrated Breast Surgery Unit, European Institute of Oncology and University of Milan, Italy. · Division of Senology, European Institute of Oncology, Milan, Italy. · Division of Radiation Oncology, European Institute of Oncology, Milan, Italy. · Department of Medicine, European Institute of Oncology, Milan, Italy. · Pubmed 24183613
  • Department of Medical Oncology, European Institute of Oncology, Milan, Italy. Electronic address: · Department of Medical Oncology, European Institute of Oncology, Milan, Italy. · Department of Pathology, European Institute of Oncology, Milan, Italy; University of Milan, School of Medicine, Italy. · Pubmed 24508454
2013
  • University of Milan School of Medicine, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy. Electronic address: · Pubmed 24074800
2011
  • Department of Pathology and Laboratory Medicine, European Institute of Oncology, University of Milan, Milan, Italy. · Pubmed 22015299
2009
  • Department of Pathology and Laboratory Medicine, European Institute of Oncology, University of Milan School of Medicine, Via Ripamonti 435, Milan, Italy. · Pubmed 19914539
  • Department of Pathology, European Institute of Oncology, University of Milan School of Medicine, Milan, Italy. · Pubmed 19775600
  • Division of Pathology, European Institute of Oncology, Università degli Studi di Milano, Milan, Italy. · Pubmed 19670216
2008
  • Division of Pathology and Laboratory Medicine, European Institute of Oncology, University of Milan, Milan, Italy. · Pubmed 18981464
2017
  • From the German Breast Group, Neu-Isenburg, Germany (G.M.); Frontier Science (Scotland), Kincraig, United Kingdom (M. Procter); the Breast European Adjuvant Study Team (BrEAST) Data Center (E.A., N.R.), the Breast International Group (D.Z., A.A.), and Institut Jules Bordet, Université Libre de Bruxelles (M. Piccart) - all in Brussels; Roche Pharma (M.B., E.C., A.K.) and the Department of Cardiology, Cardio-Oncology, Bern University Hospital (T.S.) - both in Bern, Switzerland; the Department of Pathology, European Institute of Oncology, University of Milan, Milan (G.V.); the National Institute of Oncology, Budapest, Hungary (I.L.); Centre François Baclesse, Caen, France (C.L.); the Sarah Cannon Research Institute and Tennessee Oncology, Nashville (D.A.Y.); Instituto Nacional de Câncer, Rio de Janeiro (J. Bines); Dana-Farber Cancer Institute, Harvard Medical School, Harvard T. H. Chan School of Public Health, and Frontier Science and Technology Research Foundation - all in Boston (R.D.G.); and the Department of Medicine, Memorial Sloan Kettering Cancer Center, New York (J. Baselga). · Pubmed 28581356
  • *School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, NY †Istituto Europeo di Oncologia, University of Milan, Milan, Italy ‡UCL Advanced Diagnostics, London, UK §Dako A/S, Glostrup, Denmark. · Pubmed 26657878
2016
  • From Champalimaud Clinical Center-Champalimaud Foundation, Lisbon, Portugal (F.C.); Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (L.J.V.); European Organization for Research and Treatment of Cancer Headquarters (J.B., L. Slaets, V.G., B.M., K.T.), Breast International Group Headquarters (T.G., C. Straehle), and Institut Jules Bordet, Université Libre de Bruxelles (C. Sotiriou, M.P.), Brussels, and Centre Hospitalier Universitaire Université Catholique de Louvain, Namur (P.V.) - both in Belgium; University of Milan and Istituto Europeo di Oncologia (G.V.) and Europa Donna-European Breast Cancer Coalition (S.K.), Milan, and Azienda Istituti Ospitalieri di Cremona, Cremona (R.P.) - both in Italy; Gustave Roussy, Villejuif (S.D., M.S.), Institut Curie Paris Sciences et Lettres, Université Paris Descartes, Sorbonne Paris Cité, Paris (J.-Y.P.). Institut Curie-Hôpital Rene Huguenin, Saint-Cloud (E.B.), and Centre Georges-Francois-Leclerc, Dijon (S.C.) - all in France; Swiss Institute of Bioinformatics and University of Lausanne, Lausanne, Switzerland (M.D.); Agendia (A.M.G., L. Stork) and the Netherlands Cancer Institute (R.B., E.R.), Amsterdam, Alrijne Ziekenhuis, Rijnland Leiderdorp (P.A.N.), Jeroen Bosch Hospital, 's-Hertogenbosch (T.J.S.), and Medisch Centrum Alkmaar, Alkmaar (J.M.H.) - all in the Netherlands; Institute of Oncology, Ljubljana, Slovenia (E.M.); Evangelisches Krankenhaus Bethesda, Duisburg, Germany (U.N.); University of Texas Health Sciences Center, San Antonio (P.R.); Hospital Universitario Vall d'Hebron, Barcelona (I.T.R.); Imperial College London, London (G.T.); and University of Texas M.D. Anderson Cancer Center, Houston (A.M.T.). · Pubmed 27557300
  • Marco Colleoni, Giuseppe Viale, and Aron Goldhirsch, European Institute of Oncology; Giuseppe Viale, University of Milan, Milan; Lorenzo Gianni, Ospedale degli Infermi, Rimini; Fabio Puglisi, University Hospital of Udine, University of Udine, Udine; Carlo Tondini, Osp. Papa Giovanni XXIII, Bergamo; Katia Cagossi, Ospedale di Carpi, Carpi, Italy; Kathryn P. Gray, Shari Gelber, Richard D. Gelber, Meredith M. Regan, and Karen N. Price, International Breast Cancer Study Group Statistical Center; Kathryn P. Gray, Shari Gelber, Richard D. Gelber, and Meredith M. Regan, Dana-Farber Cancer Institute; Kathryn P. Gray and Richard D. Gelber, Harvard T.H. Chan School of Public Health; Richard D. Gelber and Meredith M. Regan, Harvard Medical School; Richard D. Gelber and Karen N. Price, Frontier Science and Technology Foundation, Boston, MA; István Láng, National Institute of Oncology, Budapest, Hungary; Beat Thürlimann, Kantonsspital, St Gallen; Beat Thürlimann, Elena Kralidis, and Daniel Rauch, Swiss Group for Clinical Cancer Research, Bern; Elena Kralidis, Kantonsspital Aarau, Aarau; Daniel Rauch, Spital Thun, Thun, Switzerland; Ehtesham A. Abdi, The Tweed Head Hospital, Tweed Heads, New South Wales and Griffith University, Southport, Queensland; Ehtesham A. Abdi and Jacquie Chirgwin, Australia and New Zealand Breast Cancer Trials Group; Jacquie Chirgwin, Box Hill and Maroondah Hospitals and Monash University, Melbourne, Victoria; Alan S. Coates, International Breast Cancer Study Group and University of Sydney School of Public Health, Sydney, New South Wales, Australia; Henry L. Gomez, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru; Barbro K. Linderholm, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, and Sahlgrenska University Hospital, Gothenburg, Sweden; and Alexandru Eniu, Cancer Institute Ion Chiricuta, Cluj, Romania. · Marco Colleoni, Giuseppe Viale, and Aron Goldhirsch, European Institute of Oncology; Giuseppe Viale, University of Milan, Milan; Lorenzo Gianni, Ospedale degli Infermi, Rimini; Fabio Puglisi, University Hospital of Udine, University of Udine, Udine; Carlo Tondini, Osp. Papa Giovanni XXIII, Bergamo; Katia Cagossi, Ospedale di Carpi, Carpi, Italy; Kathryn P. Gray, Shari Gelber, Richard D. Gelber, Meredith M. Regan, and Karen N. Price, International Breast Cancer Study Group Statistical Center; Kathryn P. Gray, Shari Gelber, Richard D. Gelber, and Meredith M. Regan, Dana-Farber Cancer Institute; Kathryn P. Gray and Richard D. Gelber, Harvard T.H. Chan School of Public Health; Richard D. Gelber and Meredith M. Regan, Harvard Medical School; Richard D. Gelber and Karen N. Price, Frontier Science and Technology Foundation, Boston, MA; István Láng, National Institute of Oncology, Budapest, Hungary; Beat Thürlimann, Kantonsspital, St Gallen; Beat Thürlimann, Elena Kralidis, and Daniel Rauch, Swiss Group for Clinical Cancer Research, Bern; Elena Kralidis, Kantonsspital Aarau, Aarau; Daniel Rauch, Spital Thun, Thun, Switzerland; Ehtesham A. Abdi, The Tweed Head Hospital, Tweed Heads, New South Wales and Griffith University, Southport, Queensland; Ehtesham A. Abdi and Jacquie Chirgwin, Australia and New Zealand Breast Cancer Trials Group; Jacquie Chirgwin, Box Hill and Maroondah Hospitals and Monash University, Melbourne, Victoria; Alan S. Coates, International Breast Cancer Study Group and University of Sydney School of Public Health, Sydney, New South Wales, Australia; Henry L. Gomez, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru; Barbro K. Linderholm, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, and Sahlgrenska University Hospital, Gothenburg, Sweden; and Alexandru Eniu, Cancer Institute Ion Chiricuta, Cluj, Romania. · Pubmed 27325862
  • Martine Piccart-Gebhart, Université Libre de Bruxelles, Brussels, Belgium; Eileen Holmes, Eleanor McFadden, and Andrew P. Holmes, Frontier Science (Scotland), Kincraig, Kingussie, United Kingdom; José Baselga, Memorial Sloan Kettering Cancer Center, New York, NY; Evandro de Azambuja, Institut Jules Bordet, Brussels, Belgium; Evandro de Azambuja and Stella Dolci, Breast European Adjuvant Study Team, Brussels, Belgium; Amylou C. Dueck and Anne E. McCullough, Mayo Clinic, Scottsdale, AZ; Giuseppe Viale, University of Milan, Milan, Italy; Giuseppe Viale and Aron Goldhirsch, Istituto Europeo di Oncologia, Milan, Italy; Jo Anne Zujewski, National Cancer Institute, Bethesda, MD; Aron Goldhirsch, Ospedale Regionale di Lugano, Viganello-Lugano, Switzerland; Alison Armour, GlaxoSmithKline, Collegeville, PA; Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada; Kathleen I. Pritchard, University of Toronto, Toronto, Ontario, Canada; Liu Tonghua, Peking Union Medical College Hospital, Beijing, People's Republic of China; Liu Tonghua and Binghe Xu, China Academy of Chinese Medical Sciences, Beijing, People's Republic of China; Holger Eidtmann, University Hospital Kiel, Kiel, Germany; Phuong Dinh, Breast International Group, Brussels, Belgium; Serena Di Cosimo, Istituto Nazionale del Tumori, Milan, Italy; Serena Di Cosimo, SOLTI Breast Cancer Research Group, Barcelona, Spain; Nadia Harbeck, Frauenklinik der Universität München, Munich, Germany; Sergei Tjulandin, Blokhin Russian Cancer Research Center of RAMS, Moscow, Russia; Young-Hyuck Im, Korean Cancer Study Group, Seoul, South Korea; Young-Hyuck Im, Samsung Medical Center, Seoul, South Korea; Chiun-Shen Huang, National Taiwan University Hospital, Taipei, Republic of China; Véronique Diéras, Institut Curie, Paris, France; David W. Hillman, Mayo Clinic, Rochester, MN; Antonio C. Wolff, The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Christian Jackisch, Klinikum Offenba · Pubmed 26598744
  • Meredith M. Regan and Richard D. Gelber, Dana-Farber Cancer Institute, Harvard Medical School; Karen N. Price and Richard D. Gelber, Frontier Science and Technology Research Foundation; Richard D. Gelber, Harvard T.H. Chan School of Public Health, Boston, MA; Prudence A. Francis, MacCallum Cancer Center, St Vincent's Hospital, University of Melbourne, Melbourne; University of Newcastle, Newcastle; Alan S. Coates, University of Sydney, Sydney, Australia; Olivia Pagani, Institute of Oncology of Southern Switzerland, Lugano Viganello, Switzerland; Gini F. Fleming, University of Chicago Medical Center, Chicago, IL; Barbara A. Walley, National Cancer Institute of Canada Clinical Trials Group, Calgary, Alberta, Canada; Giuseppe Viale, University of Milan; Giuseppe Viale, Marco Colleoni, and Aron Goldhirsch, European Institute of Oncology, Milan; Carlo Tondini, Ospedale Papa Giovanni XXIII, Bergamo; Graziella Pinotti, Ospedale di Circolo and Fondazione Macchi, Varese, Italy; István Láng, National Institute of Oncology, Budapest, Hungary; Henry L. Gómez, Instituto Nacional de Enfermedades Neoplásticas, Lima, Peru. · Meredith M. Regan and Richard D. Gelber, Dana-Farber Cancer Institute, Harvard Medical School; Karen N. Price and Richard D. Gelber, Frontier Science and Technology Research Foundation; Richard D. Gelber, Harvard T.H. Chan School of Public Health, Boston, MA; Prudence A. Francis, MacCallum Cancer Center, St Vincent's Hospital, University of Melbourne, Melbourne; University of Newcastle, Newcastle; Alan S. Coates, University of Sydney, Sydney, Australia; Olivia Pagani, Institute of Oncology of Southern Switzerland, Lugano Viganello, Switzerland; Gini F. Fleming, University of Chicago Medical Center, Chicago, IL; Barbara A. Walley, National Cancer Institute of Canada Clinical Trials Group, Calgary, Alberta, Canada; Giuseppe Viale, University of Milan; Giuseppe Viale, Marco Colleoni, and Aron Goldhirsch, European Institute of Oncology, Milan; Carlo Tondini, Ospedale Papa Giovanni XXIII, Bergamo; Graziella Pinotti, Ospedale di Circolo and Fondazione Macchi, Varese, Italy; István Láng, National Institute of Oncology, Budapest, Hungary; Henry L. Gómez, Instituto Nacional de Enfermedades Neoplásticas, Lima, Peru. · Pubmed 27044936
  • Christine Desmedt, Gabriele Zoppoli, Denis Larsimont, Debora Fumagalli, David Brown, Françoise Rothé, Delphine Vincent, Naima Kheddoumi, Ghizlane Rouas, Samira Majjaj, Sylvain Brohée, Roberto Salgado, Martine Piccart-Gebhart, and Christos Sotiriou, Institut Jules Bordet; Christine Galant, Cliniques Universitaires Saint Luc, Brussels; Peter Van Loo, University of Leuven; Thomas Van Brussel and Diether Lambrechts, VIB Vesalius Research Center, Leuven, Belgium; Gabriele Zoppoli, University of Genoa and Istituto di Ricerca a Carattere Clinico-Scientifico San Martino-National Cancer Institute, Genoa; Giancarlo Pruneri, Patrick Maisonneuve, and Giuseppe Viale, European Institute of Oncology; Marco Fornili and Elia Biganzoli, University of Milan, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale Tumori, Milan, Italy; Gunes Gundem and Peter J. Campbell, Wellcome Trust Sanger Institute, Cambridgeshire; Peter Van Loo, The Francis Crick Institute, London, United Kingdom; Ron Bose, Washington University School of Medicine, St Louis, MO; Otto Metzger, Dana-Farber Cancer Institute, Boston, MA; and François Bertucci, Institut Paoli-Calmettes, Marseille, France. · Christine Desmedt, Gabriele Zoppoli, Denis Larsimont, Debora Fumagalli, David Brown, Françoise Rothé, Delphine Vincent, Naima Kheddoumi, Ghizlane Rouas, Samira Majjaj, Sylvain Brohée, Roberto Salgado, Martine Piccart-Gebhart, and Christos Sotiriou, Institut Jules Bordet; Christine Galant, Cliniques Universitaires Saint Luc, Brussels; Peter Van Loo, University of Leuven; Thomas Van Brussel and Diether Lambrechts, VIB Vesalius Research Center, Leuven, Belgium; Gabriele Zoppoli, University of Genoa and Istituto di Ricerca a Carattere Clinico-Scientifico San Martino-National Cancer Institute, Genoa; Giancarlo Pruneri, Patrick Maisonneuve, and Giuseppe Viale, European Institute of Oncology; Marco Fornili and Elia Biganzoli, University of Milan, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale Tumori, Milan, Italy; Gunes Gundem and Peter J. Campbell, Wellcome Trust Sanger Institute, Cambridgeshire; Peter Van Loo, The Francis Crick Institute, London, United Kingdom; Ron Bose, Washington University School of Medicine, St Louis, MO; Otto Metzger, Dana-Farber Cancer Institute, Boston, MA; and François Bertucci, Institut Paoli-Calmettes, Marseille, France. · Pubmed 26926684
2015
  • Otto Metzger Filho, Anita Giobbie-Hurder, and Eric P. Winer, Dana-Farber Cancer Institute; Richard D. Gelber and Meredith M. Regan, Harvard Medical School; Karen N. Price, Frontier Science and Technology Research, Boston, MA; Elizabeth Mallon, Southern General Hospital; Barry Gusterson, Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom; Giuseppe Viale, European Institute of Oncology and University of Milan; Marco Colleoni and Aron Goldhirsch, European Institute of Oncology, Milan, Italy; Beat Thürlimann, Kantonsspital, St. Gallen, and Swiss Group for Clinical Cancer Research, Bern, Switzerland; Bent Ejlertsen, Rigshospitalet, Copenhagen, Denmark; Marc Debled, Institut Bergoniié, Bordeaux, France; and Alan S. Coates, International Breast Cancer Study Group, Bern, Switzerland, and University of Sydney, Sydney, Australia. · Otto Metzger Filho, Anita Giobbie-Hurder, and Eric P. Winer, Dana-Farber Cancer Institute; Richard D. Gelber and Meredith M. Regan, Harvard Medical School; Karen N. Price, Frontier Science and Technology Research, Boston, MA; Elizabeth Mallon, Southern General Hospital; Barry Gusterson, Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom; Giuseppe Viale, European Institute of Oncology and University of Milan; Marco Colleoni and Aron Goldhirsch, European Institute of Oncology, Milan, Italy; Beat Thürlimann, Kantonsspital, St. Gallen, and Swiss Group for Clinical Cancer Research, Bern, Switzerland; Bent Ejlertsen, Rigshospitalet, Copenhagen, Denmark; Marc Debled, Institut Bergoniié, Bordeaux, France; and Alan S. Coates, International Breast Cancer Study Group, Bern, Switzerland, and University of Sydney, Sydney, Australia. · Pubmed 26215945
2014
  • Antonio C. Wolff, Johns Hopkins Kimmel Comprehensive Cancer Center, Baltimore; Lisa M. McShane, National Cancer Institute, Bethesda, MD; M. Elizabeth H. Hammond, University of Utah School of Medicine and Intermountain Healthcare, Salt Lake City, UT; David G. Hicks, University of Rochester Medical Center, Rochester, NY; Mitch Dowsett, Royal Marsden Hospital, London, United Kingdom; Kimberly H. Allison, Stanford University Medical Center, Stanford; Patrick Fitzgibbons, St Jude Medical Center, Fullerton; Michael F. Press, University of Southern California, Los Angeles, CA; Donald C. Allred, Washington University School of Medicine, St Louis, MO; John M.S. Bartlett, Ontario Institute for Cancer Research; Wedad Hanna, Sunnybrook Health Sciences Center, Toronto, Ontario, Canada; Michael Bilous, University of Western Sydney and Healthscope Pathology, Sydney, New South Wales, Australia; Robert B. Jenkins, Mayo Clinic, Rochester, MN; Pamela B. Mangu, American Society of Clinical Oncology, Alexandria, VA; Soonmyung Paik, National Surgical Adjuvant Breast and Bowel Project, Pitsburgh, PA; Edith A. Perez, Mayo Clinic, Jacksonville, FL; Patricia A. Spears, North Carolina State University, Raleigh, NC; Gail H. Vance, Indiana University Medical Center, Indianapolis, IN; Giuseppe Viale, University of Milan, European Institute of Oncology, Milan, Italy; and Daniel F. Hayes, University of Michigan Comprehensive Cancer Care Center, Ann Arbor, MI. · Pubmed 24099077
  • Felipe Ades, Lina Pugliano, Debora Fumagalli, Evandro de Azambuja, Christos Sotiriou, and Martine Piccart, Institut Jules Bordet, Université Libre de Bruxelles; Dimitrios Zardavas, Breast International Group, Brussels, Belgium; Ivana Bozovic-Spasojevic, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia; and Giuseppe Viale, European Institute of Oncology, University of Milan, Milan, Italy. · Felipe Ades, Lina Pugliano, Debora Fumagalli, Evandro de Azambuja, Christos Sotiriou, and Martine Piccart, Institut Jules Bordet, Université Libre de Bruxelles; Dimitrios Zardavas, Breast International Group, Brussels, Belgium; Ivana Bozovic-Spasojevic, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia; and Giuseppe Viale, European Institute of Oncology, University of Milan, Milan, Italy. · Pubmed 25049332
  • Department of Medical Sciences, University of Turin, Turin, Italy; Pathology Unit, Department of Laboratory Medicine, Azienda Ospedaliera Città della Salute e della Scienza di Torino, Turin, Italy; Pathology Division, Santa Croce Hospital, Moncalieri, Italy; Pathology Division, Azienda USL Valle d'Aosta, Aosta, Italy; Pathology Division, Valdese Hospital, Turin, Italy; Pathology Division, Martini Hospital, Turin, Italy; Pathology Division, ASL 9, Civile Hospital, Ivrea, Italy; Department of Pathology, Regina Elena National Cancer Institute, Rome, Italy; Division of Pathology, European Institute of Oncology, Milan, Italy; University of Milan School of Medicine, Milan, Italy · Department of Medical Sciences, University of Turin, Turin, Italy; Pathology Unit, Department of Laboratory Medicine, Azienda Ospedaliera Città della Salute e della Scienza di Torino, Turin, Italy; Pathology Division, Santa Croce Hospital, Moncalieri, Italy; Pathology Division, Azienda USL Valle d'Aosta, Aosta, Italy; Pathology Division, Valdese Hospital, Turin, Italy; Pathology Division, Martini Hospital, Turin, Italy; Pathology Division, ASL 9, Civile Hospital, Ivrea, Italy; Department of Pathology, Regina Elena National Cancer Institute, Rome, Italy; Division of Pathology, European Institute of Oncology, Milan, Italy; University of Milan School of Medicine, Milan, Italy. · Pubmed 25323485
2013
  • Antonio C. Wolff, Johns Hopkins Kimmel Comprehensive Cancer Center, Baltimore; Lisa M. McShane, National Cancer Institute, Bethesda, MD; M. Elizabeth H. Hammond, University of Utah School of Medicine and Intermountain Healthcare, Salt Lake City, UT; David G. Hicks, University of Rochester Medical Center, Rochester, NY; Mitch Dowsett, Royal Marsden Hospital, London, United Kingdom; Kimberly H. Allison, Stanford University Medical Center, Stanford; Patrick Fitzgibbons, St Jude Medical Center, Fullerton; Michael F. Press, University of Southern California, Los Angeles, CA; Donald C. Allred, Washington University School of Medicine, St Louis, MO; John M.S. Bartlett, Ontario Institute for Cancer Research; Wedad Hanna, Sunnybrook Health Sciences Center, Toronto, Ontario, Canada; Michael Bilous, University of Western Sydney and Healthscope Pathology, Sydney, New South Wales, Australia; Robert B. Jenkins, Mayo Clinic, Rochester, MN; Pamela B. Mangu, American Society of Clinical Oncology, Alexandria, VA; Soonmyung Paik, National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA; Edith A. Perez, Mayo Clinic, Jacksonville, FL; Patricia A. Spears, North Carolina State University, Raleigh, NC; Gail H. Vance, Indiana University Medical Center, Indianapolis, IN; Giuseppe Viale, University of Milan, European Institute of Oncology, Milan, Italy; and Daniel F. Hayes, University of Michigan Comprehensive Cancer Care Center, Ann Arbor, MI. · Pubmed 24101045
  • Affiliations of authors: Biometric Research Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD (MCP, LMM); Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada (SCYL, DG, EM, TON); Department of Laboratory Medicine and Pathology, University of Alberta, Alberta, Canada (JCH); Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy (MGM); Division of Pathology and Laboratory Medicine, European Institute of Oncology, and University of Milan, Milan, Italy (GV); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom (LAZ); Department of Pathology, Centre Jean Perrin, Clermont-Ferrand, and Université d'Auvergne, France (FP-L); Transformative Pathology, Ontario Institute for Cancer Research, Toronto, Ontario, Canada (JMSB); PhenoPath Laboratories, Seattle, WA (AMG); Department of Pathology, MD Anderson Cancer Center, Houston, TX (WFS); Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, United Kingdom (TP); The EMMES Corporation, Rockville, MD (RAE); Breast Oncology Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI (DFH); Academic Department of Biochemistry, Royal Marsden Hospital, London, United Kingdom (MD); on behalf of the International Ki67 in Breast Cancer Working Group of the Breast International Group and North American Breast Cancer Group. · Pubmed 24203987
  • Division of Pathology, European Institute of Oncology, Milan, Italy. · Pubmed 23763700
2011
  • Division of Senology, European Institute of Oncology, University of Milan, Milan, Italy. · Pubmed 21248632
2010
  • Research Unit in Medical Senology, Department of Medicine, European Institute of Oncology, Università degli Studi di Milano, Milan, Italy. · Pubmed 20458051
Probable:    University of Milan Bicocca      
2014
  • Division of Pathology, European Institute of Oncology, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy; University of Milan School of Medicine; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy; University of Milan School of Medicine; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy. Electronic address: · Pubmed 24709436
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 155 total) written by Giuseppe Viale about Breast Neoplasms:

  • From the maximum tolerable to the minimum effective treatment: The Umberto Veronesi's life commitment to breast cancer care. 2017
  • Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer. 2017
  • Mitotic Spindle Assembly and Genomic Stability in Breast Cancer Require PI3K-C2α Scaffolding Function. 2017
  • Comparison of Treatment Outcome Between Invasive Lobular and Ductal Carcinomas in Patients Receiving Partial Breast Irradiation With Intraoperative Electrons. 2017
  • HER2 status predicts for upfront AI benefit: A TRANS-AIOG meta-analysis of 12,129 patients from ATAC, BIG 1-98 and TEAM with centrally determined HER2. 2017
  • An international reproducibility study validating quantitative determination of ERBB2, ESR1, PGR, and MKI67 mRNA in breast cancer using MammaTyper®. 2017
  • Pre-clinical validation of a selective anti-cancer stem cell therapy for Numb-deficient human breast cancers. 2017
  • Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancer. 2017
  • Robotic nipple-sparing mastectomy for the treatment of breast cancer: Feasibility and safety study. 2017
  • Immunohistochemical Performance of Estrogen and Progesterone Receptor Antibodies on the Dako Omnis Staining Platform: Evaluation in Multicenter Studies. 2017
Show List of Full Article Records
Google Searches

Learn more about Giuseppe Viale using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
European Institute of Oncology
University of Milan Statale
University of Milan Bicocca
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
European Institute of Oncology
2017
  • European Institute of Oncology, Milano, Italy. Electronic address: · Champalimaud Clinical Center, Lisbon, Portugal. · European School of Oncology, Milano, Italy. · European Institute of Oncology, Milano, Italy; University of Milan, Milano, Italy. · European Institute of Oncology, Milano, Italy. · Pubmed 27876474
  • Molecular Biotechnology Center, Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin 10126, Italy. · Molecular Biotechnology Center, Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin 10126, Italy. Electronic address: · Department of Medical Sciences, University of Torino, Turin, Italy; Pathology Unit, Department of Laboratory Medicine, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Turin, Italy. · IFOM, The FIRC Institute for Molecular Oncology Foundation, Milan, Italy. · Program of Molecular Medicine, IEO, European Institute of Oncology, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy; Department of Oncology and Hemato-oncology (DIPO), University of Milan, Milan, Italy. · Department of Cell Physiology and Metabolism, University of Geneva, Geneva, Switzerland. · Molecular Biotechnology Center, Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin 10126, Italy; Department of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA. · Unit of Investigative Oncology, Candiolo Cancer Institute - FPO, IRCCS, Candiolo (TO), Italy. · Institute for Research in Biomedicine, Università della Svizzera Italiana, Bellinzona, Switzerland. · Department of Biological Science and Bioengineering, Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an, Shaanxi, P. R. China. · Program of Molecular Medicine, IEO, European Institute of Oncology, Milan, Italy; Department of Oncology and Hemato-oncology (DIPO), University of Milan, Milan, Italy. · Department of Medical Sciences, University of Torino, Turin, Italy; Unit of Pathology, Candiolo Cancer Institute - FPO, IRCCS, Candiolo (TO), Italy. · IFOM, The FIRC Institute for Molecular Oncology Foundation, Milan, Italy; Program of Molecular Medicine, IEO, European Institute of Oncology, Milan, Italy; Department of Oncology and Hemato-oncology (DIPO), University of Milan, Milan, Italy. · Molecular Biotechnology Center, Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin 10126, Italy. Electronic address: · Pubmed 29017056
  • Division of Radiation Oncology, European Institute of Oncology, Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy. · Unit of Medical Physics, European Institute of Oncology, Milan, Italy. · Division of Radiation Oncology, European Institute of Oncology, Milan, Italy; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy. · Division of Breast Surgery, European Institute of Oncology, Milan, Italy. · Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy; Division of Breast Surgery, European Institute of Oncology, Milan, Italy. · Division of Radiation Oncology, European Institute of Oncology, Milan, Italy; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy. Electronic address: · Division of Pathology, European Institute of Oncology, Milan, Italy; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy. · Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy; Department of Medical Imaging and Radiation Sciences, European Institute of Oncology, Milan, Italy. · Pubmed 28816144
  • Transformative Pathology, Ontario Institute for Cancer Research (OICR), MaRS Centre, 661 University Avenue, Suite 510, Toronto, ON M5G 0A3, Canada; University of Edinburgh Cancer Research Centre, Institute of Genetics and Molecular Medicine, The University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK. Electronic address: · Cancer Research UK Clinical Trials Unit, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK. Electronic address: · International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA. Electronic address: · Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University, Charterhouse Square, London EC1M 6BQ, UK. Electronic address: · Department of Pathology, Elizabeth University Hospital, 1345 Govan Road, Govan, Glasgow G51 4TF, UK. Electronic address: · Department of Pathology, European Institute of Oncology and University of Milan, Via Giuseppe Ripamonti, 435, 20141 Milan, Italy. Electronic address: · Breast Center, Kantonsspital, St. Gallen, and Swiss Group for Clinical Cancer Research SAKK, CH-9007 St. Gallen, Switzerland. Electronic address: · Department of Medical Oncology, Erasmus MC Cancer Institute, PO Box 5201, Rotterdam 3008 AE, The Netherlands. Electronic address: · Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands. Electronic address: · Division of Surgery, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands. Electronic address: · Leicester Clinical Trials Unit, University of Leicester, Leicester LE5 4PW, UK. Electronic address: · Surgical Oncology, University of Newcastle, Calvary Mater Newcastle Hospital, Locked Bag 7, HRMC, Newcastle, NSW 2310, Australia. Electronic address: · Department of Pathology, European Institute of Oncology and University of Milan, Via Giuseppe Ripamonti, 435, 20141 Milan, Italy. Electronic address: · Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University, Charterhouse Square, London EC1M 6BQ, UK. Electronic address: · Academic Department of Biochemistry, Royal Marsden Hospital, and Endocrinology, Breakthrough Breast Cancer Centre, Institute of Cancer Research, Fulham Road, London SW3 6JJ, UK. Electronic address: · Cancer Research UK Clinical Trials Unit, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK. Electronic address: · Pubmed 28494403
  • Institute of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland. · Private Group Practice for Pathology and PathoPlan GbR, Lübeck, Germany. · Department of Pathology and Laboratory of Pathology, West China Hospital, Sichuan University, Chengdu, China. · Institute of Pathology, University Erlangen-Nürnberg, Erlangen, Germany. · Centre Jean Perrin, Centre regional de Lutte contre le cancer d'Auvergne, Clermont-Ferrand, France. · European Institute of Oncology, University of Milan, Milan, Italy. · Institute of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Pathology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China. · Institute of Pathology, Klinikum Region Hannover, Hannover, Germany. · BioNTech Diagnostics GmbH, Mainz, Germany. · Department of Oncology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland. · ACOMED Statistik, Leipzig, Germany. · Department of Pathology, Heidelberg University Hospital, Heidelberg, Germany. · Transformative Pathology, Ontario Institute for Cancer Research (OICR), Toronto, ON, Canada. · Pubmed 28490348
  • Istituto Europeo di Oncologia, Milan, Italy. · IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy. · Dipartimento di Oncologia e Emato-oncologia, Università degli Studi di Milano, Milan, Italy. · Istituto Europeo di Oncologia, Milan, Italy · Pubmed 28298340
  • Department of Surgery and Cancer, Imperial College London, London, UK. · Department of Experimental Oncology, European Institute of Oncology Milan, Italy. · Hematology Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, IT. · Swammerdam Institute for Life Sciences, University of Amsterdam. · Genomics Division, Lawrence Berkeley National Laboratory, 1 Cyclotron Road, Berkeley, CA, USA. · Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Arcavacata di Rende (CS), Italy. · Division of Stem Cells and Cancer, Deutsches Krebsforschungszentrum (DKFZ), and Institute for Stem Cell Technology and Experimental Medicine GmbH, Heidelberg, Germany. · Division of Pathology, European Institute of Oncology and University of Milan, School of Medicine, Milan, Italy. · Department of Oncology and Hemato-oncology, University of Milano, Milan, IT. · Division of Medical Senology, European Institute of Oncology, IEO, Milan, Italy. · Department of Biosciences, University of Milano, Milan, IT. · Pubmed 28112739
  • Division of Breast Surgery, European Institute of Oncology, Milan, Italy. Electronic address: · Division of Breast Surgery, European Institute of Oncology, Milan, Italy. · Division of Plastic and Reconstructive Surgery, European Institute of Oncology, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Division of Cancer Prevention and Genetics, European Institute of Oncology, Milan, Italy. · Early Drug Development for Innovative Therapies Division, European Institute of Oncology, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy; University of Milan, School of Medicine, Milan, Italy. · Division of Breast Surgery, European Institute of Oncology, Milan, Italy; University of Milan, School of Medicine, Milan, Italy. · Pubmed 27810700
2016
  • IBCSG Central Pathology Laboratory, Department of Pathology and Laboratory Medicine, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · University of Milan, Milan, Italy. · International Breast Cancer Study Group (IBCSG) Statistical Center, Boston, MA, USA. · Harvard T. H. Chan School of Public Health, Boston, MA, USA. · IBCSG Central Pathology Laboratory, Department of Pathology and Laboratory Medicine, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · University of Milan, Milan, Italy. · Division of Experimental Therapeutics, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · National Institute of Oncology, Ráth György u. 7/9, Budapest, 1122, Hungary. · Breast Center St. Gallen, Kantonsspital, St. Gallen, Switzerland. · Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. · Divisione di Oncologia, Ospedale degli Infermi, Viale Settembrini 2, 47923, Rimini, Italy. · Program for Breast Health, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · International Breast Cancer Study Group, Translational Research Coordination and Central Pathology Office, IBCSG Coordinating Center, Effingerstrasse 40, 3008, Bern, Switzerland. · Frontier Science and Technology Research Foundation, Boston, MA, USA. · Division of Medical Senology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Harvard Medical School, Boston, MA, USA. · Pubmed 27372069
  • Department of Pathology, European Institute of Oncology and University of Milan, Via Ripamonti 435, 20141, Milan, Italy. · Department of Statistics, European Organization for Research and Treatment of Cancer, Brussels, Belgium. · Medical Affairs, Agendia, Amsterdam, The Netherlands. · Department of Pathology, European Institute of Oncology and University of Milan, Via Ripamonti 435, 20141, Milan, Italy. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA. · Department of Surgery, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal. · Pubmed 26820652
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium2Medical Oncology Clinic, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Breast and Gynecological Surgery, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark6Danish Breast Cancer Cooperative Group, Copenhagen, Denmark. · Department of Pathology, European Institute of Oncology, University of Milan, Milan, Italy. · Avera Cancer Institute, Sioux Falls, South Dakota. · International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · International Breast Cancer Study Group Coordinating Center and Central Pathology Office, Bern, Switzerland. · Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark6Danish Breast Cancer Cooperative Group, Copenhagen, Denmark11Department of Oncology, Odense University Hospital, Odense, Denmark12AgeCare, Odense University Hospital, Odense. · Medical Oncology Clinic, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Villejuif, France14INSERM U1018, CESP, Université Paris-Sud, Villejuif France. · Pubmed 26633571
  • Division of Cancer Prevention and Genetics, European Institute of Oncology, Via Ripamonti 435, Milan, 20141, Italy. · International Breast Cancer Study Group (IBCSG) Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard T. H. Chan School of Public Health, 450 Brookline Avenue, Boston, MA, 02215, USA. · Institute of Oncology of Southern Switzerland (IOSI), Bellinzona, Switzerland. · International Breast Cancer Study Group, Bern, Switzerland. · Swiss Group for Clinical Cancer Research SAKK, Lugano Viganello, Switzerland. · IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA, 02215, USA. · Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Via Ripamonti 435, Milan, 20141, Italy. · Division of Cancer Prevention and Genetics, European Institute of Oncology, Via Ripamonti 435, Milan, 20141, Italy. · International Breast Cancer Study Group (IBCSG) Coordinating Center, Effingerstrasse 40, Bern, CH-3008, Switzerland. · Division of Medical Senology, European Institute of Oncology, Via Ripamonti 435, Milan, 20141, Italy. · IBCSG Statistical Center, Frontier Science and Technology Research Foundation, Boston, MA, USA. · Dana-Farber Cancer Institute, Department of Biostatistics and Computatonal Biology, 450 Brookline Ave, Boston, MA, 02215, USA. · International Breast Cancer Study Group and University of Sydney School of Public Health, Sydney, Australia. · IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Harvard Medical School, Frontier Science and Technology Research Foundation, 450 Brookline Avenue, Boston, MA, 02215, USA. · Program for Breast Health, European Institute of Oncology, Via Ripamonti 435, Milan, 20141, Italy. · Translational Research Coordination and Central Pathology Office, IBCSG Coordinating Center, Effingerstrasse 40, Bern, CH-3008, Switzerland. · Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · National Cancer Institute of Canada, Kingston, ON, Canada. · Pubmed 27825388
  • Medical Oncology Division & Breast Unit, 72100 Brindisi, Italy. Electronic address: · Pathology Division, European Institute of Oncology, University of Milan, 20141 Milan, Italy. · Medical Oncology & Breast Unit, University of Verona, Azienda Ospedaliera Universitaria Integrata, 37134 Verona, Italy. · Medical Oncology Division & Breast Unit, 72100 Brindisi, Italy. · Biostatistics, Regina Elena National Cancer Institute, 00144 Rome, Italy. · Pubmed 27750105
  • University of Milan, Istituto Europeo di Oncologia, Milan, Italy. · UCL Advanced Diagnostics, London, UK. · Clarient Pathology Services, Aliso Viejo, CA, USA. · Dako, An Agilent Technologies Company, Glostrup, Denmark. · Dx-Rx Institute, Baunevaenget 76, DK-3480 Fredensborg, Denmark. Electronic address: · Pubmed 27461826
  • Institute of Pathology, Charité Universitätsmedizin Berlin, Berlin, Germany. · German Cancer Consortium (DKTK), Partner site Berlin, Berlin, Germany. · VMscope GmbH, Berlin, Germany. · Service de Biostatistique et d'Epidémiologie; Institute Gustave Roussy, Villejuif, France. · German Breast Group (GBG), Neu-Isenburg, Germany. · Clinic of Gynecology and Obstetrics, Sana Klinikum Offenbach, Offenbach, Germany. · Indiana University School of Medicine, Indianapolis, IN, USA. · Clinical Institute of Pathology, Medizinische Universität Wien, Wien, Austria. · Department of Pathology & Molecular Medicine, McMaster University, Hamilton, ON, Canada. · Weill Cornell Medical College, Doha, Qatar. · Harvard Medical School, Boston, MA, USA. · Tumor Pathology Department, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice, Poland. · Institut für Pathologie, Medizinische Hochschule Hannover, Hannover, Germany. · Pathology, GZA Ziekenhuizen, Sint-Augustinus, Wilrijk, Belgium. · Radiation Oncology and Pathology, Weill Cornell Medical College, New York, NY, USA. · Department of Pathology and Cytology GZA Hospitals, Wilrijk, Belgium. · Department of Pathology University Hospitals Leuven, Leuven, Belgium. · Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · Anatomical Pathology, Vancouver Hospital, Vancouver, BC, Canada. · Division of Pathology, NSABP, Pittsburgh, PA, USA. · Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, ON, Canada. · UQ School of Medicine and Pathology Queensland, The University of Queensland Centre for Clinical Research, Brisbane, QLD, Australia. · ERTICa Research Team, Department of Pathology, Jean Perrin Comprehensive Cancer Center, University of Auvergne EA4677, Clermont-Ferrand, France. · Division of Pathology and Laboratory Medicine, University of Milan, Milan, Italy. · Department of Pathology, Yale University School of Medicine, New Haven, CT, USA. · Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA, USA. · Department for Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Sektion Gynäkopathologie, Pathologisches Institut, University of Heidelberg, Heidelberg, Germany. · Anatomie Pathologique, Institut Jules Bordet, Brussels, Belgium. · Molecular Diagnostic Oncology, Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Department of Pathology, European Institute of Oncology, University of Milan, Milan, Italy. · Department of Pathology, Netherlands Cancer Institute, Amsterdam, Netherlands. · Jules Bordet Institute, Brussels, Belgium. · Department of Gynecology, Helios-Klinikum Berlin-Buch, Berlin, Germany. · Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen EMN, Friedrich-Alexander University Erlangen, Erlangen, Germany. · Department of Gynecology, Klinikum Südstadt Rostock, Rostock, Germany. · Molecular Immunology Unit, Institut Jules Bordet, Brussels, Belgium. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Univ. Paris Sud, Univ. Paris-Saclay, Villejuif, France. · Division of Research and Clinical Medicine, Peter MacCallum Cancer Center, Melbourne, VIC, Australia. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Brussels, Belgium. · Pubmed 27363491
  • IFOM, the FIRC Institute of Molecular Oncology, Milan, Italy. · IFOM, the FIRC Institute of Molecular Oncology, Milan, Italy Department of Pediatrics, Graduate School of Medicine The University of Tokyo, Tokyo, Japan. · Molecular Medicine Program, European Institute of Oncology, Milan, Italy. · Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy Department of Pathology, European Institute of Oncology, Milan, Italy. · IFOM, the FIRC Institute of Molecular Oncology, Milan, Italy Molecular Medicine Program, European Institute of Oncology, Milan, Italy Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy. · IFOM, the FIRC Institute of Molecular Oncology, Milan, Italy Molecular Medicine Program, European Institute of Oncology, Milan, Italy. · Institut Curie, PSL Research University, Paris Cedex 05, France Centre National de la Recherche Scientifique, Unité Mixte de Recherche 144 CNRS UMR 144, Paris Cedex 05, France. · IFOM, the FIRC Institute of Molecular Oncology, Milan, Italy Molecular Medicine Program, European Institute of Oncology, Milan, Italy · Pubmed 27255086
  • Division of Research and Clinical Medicine, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Frontier Science Foundation- Hellas, Athens, Greece3University of Athens, Athens, Greece. · Frontier Science Foundation- Hellas, Athens, Greece4Athens University of Economics and Business, Athens, Greece. · Frontier Science Foundation- Hellas, Athens, Greece. · Avera Cancer Institute, Department of Molecular and Experimental Medicine, Sioux Falls, South Dakota. · Department of Pathology, University of Chicago, Chicago, Illinois. · BREAST Datacentre, Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. · University of Milan, European Institute of Oncology, Milan, Italy. · Targos Molecular Pathology GmbH, Kassel, Germany. · Department of Medicine, Institute Jules Bordet, Universite Libre de Bruxelles and Breast International Group (BIG), Brussels, Belgium12Breast International Group (BIG), Brussels, Belgium. · Royal Marsden Hospital, London, England. · INSERM U1018 CESP, Service de Biostatistique et d'Epidémiologie, Villejuif, France. · Pubmed 27100299
2015
  • Department of Histopathology and NIH Cambridge Biomedical Research Centre, Addenbrooke's Hospital, Cambridge, UK. · Department of Pathology, Yale University, New Haven, CT, USA. · Department of Pathology, European Institute of Oncology and University of Milan, Milan, Italy. · Edinburgh Cancer Research UK Centre,University of Edinburgh, Edinburgh, UK. · Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA. · Institute of Pathology, Charité Hospital, Berlin, Germany. · Department of Biopathology, Institut Bergonié, Bordeaux, France. · Department of Pathology, Centre Jean Perrin and Université d'Auvergne, Clermont-Ferrand, France. · Division of Subspecialty General Surgery, Mayo Clinic, Rochester, MN, USA. · Early Drug Development for Innovative Therapies Division, European Institute of Oncology, Milan, Italy. · Edinburgh Breast Unit, Western General Hospital, Edinburgh, UK. · Carol Franc Buck Breast Care Center, University of California, San Francisco, CA, USA. · Department of Radiotherapy and Radiation Oncology, Landeskrankenhaus, Paracelsus Medical University, Salzburg, Austria. · Department of Gynecology and Obstetrics, Interdisciplinary Breast Center, Klinikum Esslingen, Esslingen, Germany. · Institute of Pathology, Medical University of Graz, Graz, Austria. · Department of Gynecology, General Hospital Leoben, Leoben, Austria. · German Breast Group, Neu-Isenburg, and Department of Gynecology and Obstetrics, University Women's Hospital, Frankfurt, Germany. · Department of Radiation Oncology, Ohio State University, Columbus, OH, USA. · Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 26205180
  • Avera Cancer Institute, 1000 E 23rd Street, Sioux Falls, SD, 57105, USA. · Department of Biostatistics and Computational Biology, International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard T. H. Chan School of Public Health, 450 Brookline Ave, Boston, MA, 02215, USA. · VM Institute of Research, 6100 Av Royalmount, Montréal, QC, H4P 2R2, Canada. · AKESOgen, Inc., 3155 Northwoods Pl NW, Norcross, GA, 30071, USA. · Avera Cancer Institute, 1000 E 23rd Street, Sioux Falls, SD, 57105, USA. · Genomic and Molecular Pathology, University of Chicago, 900 E 57th St. Room 1260D, Chicago, IL, 60637, USA. · International Breast Cancer Study Group Coordinating Center and Central Pathology Office, Effingerstrasse 40, 3008, Bern, Switzerland. · Division of Pathology and Laboratory Medicine, International Breast Cancer Study Group Central Pathology Office, European Institute of Oncology, Via Ripamonti 435, 20146, Milan, Italy. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, Via Ripamonti 435, 20146, Milan, Italy. · Breast Center, Kantonsspital St. Gallen, Rorschacher Strasse 95, 9007, St. Gallen, Switzerland. · Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. · International Breast Cancer Study Group, Bern, Switzerland. · International Breast Cancer Study Group, Bern, Switzerland. · Auckland City Hospital, PO Box 26498, Epsom, Auckland, 1344, New Zealand. · Australia and New Zealand Breast Cancer Trials Group, Newcastle, Australia. · Department of Oncology, Multidisciplinary Breast Center, KULeuven (University of Leuven), University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium. · Institute Georges François Leclerc, 1 Rue Professeur Marion, BP 77 980, 21079, Dijon Cedex, France. · International Breast Cancer Study Group Coordinating Center, Effingerstrasse 40, 3008, Bern, Switzerland. · International Breast Cancer Study Group Statistical Center, Frontier Science and Technology Research Foundation, 450 Brookline Ave, Boston, MA, 02215, USA. · International Breast Cancer Study Group, Bern, Switzerland. · University of Sydney, Sydney, Australia. · International Breast Cancer Study Group, Bern, Switzerland. · Program for Breast Health (Senology), European Institute of Oncology, Via Ripamonti 435, 20146, Milan, Italy. · International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, Harvard T.H. Chan School of Public Health, Frontier Science and Technology Research Foundation, 450 Brookline Ave, Boston, MA, 02215, USA. · International Breast Cancer Study Group, Bern, Switzerland. · Institute of Oncology of Southern Switzerland (IOSI), Ospedale Italiano, Via Capelli, 6962, Viganello, Switzerland. · International Breast Cancer Study Group Central Pathology Office, Division of Pathology and Laboratory Medicine, European Institute of Oncology, University of Milan, Via Ripamonti 435, 20146, Milan, Italy. · Division of Hematology/Oncology, University of Michigan Comprehensive Cancer Center, 1500 E Medical Cntr Drive/SPC 5946, Ann Arbor, MI, 48109, USA. · Department of Biostatistics and Computational Biology, International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave, Boston, MA, 02215, USA. · Pubmed 26590813
  • Division of Medical Oncology, E.O. Ospedali Galliera, Genoa, Italy. Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom. · Office of the Scientific Director, E.O. Ospedali Galliera, Genoa, Italy. · Divisions of Cancer Prevention and Genetics, European Institute of Oncology, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy. · Division of Breast Surgery, European Institute of Oncology, Milan, Italy. · Division of Medical Oncology, E.O. Ospedali Galliera, Genoa, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy. University of Milan, School of Medicine, Milan, Italy. · Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom. · Pubmed 26276754
  • Division of Medical Senology, European Institute of Oncology, Milan, Italy. Electronic address: · Division of Epidemiology and Biostatistics, European Institute of Oncology, and Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Department of Pathology, European Institute of Oncology, Milan, Italy; University of Milan School of Medicine, Milan, Italy. · Department of Pathology, European Institute of Oncology, Milan, Italy. · University of Milan School of Medicine, Milan, Italy; Division of Senology, European Institute of Oncology, Milan, Italy. · Division of Senology, European Institute of Oncology, Milan, Italy. · Program of Senology (Breast Health), European Institute of Oncology, Milan, Italy. · Pubmed 25933934
  • Division of Experimental Therapeutics, Breast Health Program, Istituto Europeo di Oncologia, Italy. Electronic address: · Division of Epidemiology and Biostatistics, Istituto Europeo di Oncologia, Italy; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milano, Italy. · Laboratory Division of Hematology-Oncology, Italy. · Department of Experimental Oncology, Italy; University of Milano, School of Medicine, Milano, Italy. · Division of Experimental Therapeutics, Breast Health Program, Istituto Europeo di Oncologia, Italy. · Department of Pathology, Istituto Europeo di Oncologia, Italy; University of Milano, School of Medicine, Milano, Italy. · Pubmed 25772326
  • Department of Biostatistics and Computational Biology, International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Mailstop CLS-11007, Boston, MA, 02215, USA. · Institute of Oncology of Southern Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Lugano Viganello, Switzerland. · Peter MacCallum Cancer Center, St Vincent's Hospital, University of Melbourne, Melbourne, VIC, Australia. · Australia & New Zealand Breast Cancer Trials Group (ANZBCTG), University of Newcastle, Callaghan, NSW, Australia. · The University of Chicago Medical Center and Alliance for Clinical Trials in Oncology, Chicago, IL, USA. · Tom Baker Cancer Centre and NCIC Clinical Trials Group, Calgary, AB, Canada. · International Breast Cancer Study Group Coordinating Center and Central Pathology Office, Bern, Switzerland. · International Breast Cancer Study Group Central Pathology Office, Department of Pathology, European Institute of Oncology, Milan, Italy. · International Breast Cancer Study Group Central Pathology Office, Department of Pathology, European Institute of Oncology, Milan, Italy. · Pathological Department, National Institute of Oncology, Budapest, Hungary. · Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru. · Division of Pathology, Salvatore Maugeri Foundation, Pavia, Italy. · Struttura Operativa Complessa di Anatomia Patologica, Azienda Ospedaliero-Universitaria di Udine, Udine, Italy. · Kantonsspital St. Gallen, Swiss Group for Clinical Cancer Research (SAKK), St. Gallen, Switzerland. · University of Insubria-Ospedale di Circolo and Fondazione Macchi, Varese, Italy. · Department of Pathology, Vall d'Hebron University Hospital, SOLTI Group, Barcelona, Spain. · Pathology Department, Hospital Universitario «12 de Octubre», i+12, Universidad Complutense Madrid, SOLTI Group, Madrid, Spain. · Laboratoire Anatomopathologie, Institut Bergonié, Bordeaux, France. · EORTC, Brussels, Belgium. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Program for Breast Health, European Institute of Oncology, Milan, Italy. · International Breast Cancer Study Group Statistical Center, Frontier Science and Technology Research Foundation, Boston, MA, USA. · University of Sydney, Sydney, Australia. · International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Harvard T.H. Chan School of Public Health, Boston, MA, USA. · Frontier Science and Technology Research Foundation, Boston, MA, USA. · International Breast Cancer Study Group Central Pathology Office, European Institute of Oncology, University of Milan, Milan, Italy. · Pubmed 26493064
  • Targos Molecular Pathology GmbH, Kassel, Germany. · Institute of Pathology, University of Cologne, Cologne, Germany. · Institute of Pathology Nordhessen, Kassel, Germany. · Institute of Pathology, University of Göttingen, Göttingen, Germany. · Department of Pathology, University of Milan and European Institute of Oncology, Milan, Italy. · Nazarbayev University School of Medicine, Astana, Kazakhstan. · Clinic for Gynecology and Obstetrics, Helios Klinikum Berlin-Buch, Berlin, Germany. · Pubmed 26403781
  • Division of Medical Senology, European Institute of Oncology, Milan, Italy. Electronic address: · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy. · Division of Laboratory Medicine, European Institute of Oncology, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Department of Medicine, European Institute of Oncology, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy; School of Medicine, University of Milan, Milan, Italy. · Division of Senology, European Institute of Oncology, Milan, Italy. · Pubmed 26362840
  • Division of Medical Senology, European Institute of Oncology, Milan, Italy. Electronic address: · Department of Quantitative Methods and Statistics, University of Milan-Bicocca, Milan, Italy; Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Department of Pathology, European Institute of Oncology, Milan, Italy; School of Medicine, University of Milan, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Division of Senology, European Institute of Oncology, Milan, Italy. · Department of Pathology, European Institute of Oncology, Milan, Italy. · Program of Senology (Breast Health), European Institute of Oncology, Milan, Italy. · Pubmed 26255932
  • University of Milan, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy. Electronic address: · Pubmed 26255744
  • 1 Department of Biotechnology and Biosciences, University of Milano-Bicocca , Milan, Italy . · 2 SYSBIO Centre of Systems Biology , Milan, Italy . · 3 Department of Experimental Oncology, European Institute of Oncology , Milan, Italy . · 4 Department of Pathology, European Institute of Oncology , Milan, Italy . · 5 Department of Surgery, European Institute of Oncology , Milan, Italy . · 6 Oncology Research Unit, Pfizer Global Research and Development , La Jolla, California. · 7 Sanofi Oncology , Cambridge, Massachusetts. · 8 Institute for Applied Cancer, The University of Texas MD Anderson Cancer Center Science , Houston, Texas. · 9 Department of Biosciences, University of Milan , Milan, Italy . · Pubmed 25897982
  • Johns Hopkins Kimmel Comprehensive Cancer Center, Baltimore, MD. · University of Utah School of Medicine and Intermountain Healthcare, Salt Lake City, UT. · University of Rochester Medical Center, Rochester, NY. · Stanford University Medical Center, Stanford, CA. · Ontario Institute for Cancer Research, Toronto, Ontario, Canada. · University of Western Sydney and Healthscope Pathology, Sydney, New South Wales, Australia. · St Jude Medical Center, Fullerton, CA. · Sunnybrook Health Sciences Center, Toronto, Ontario, Canada. · Mayo Clinic, Rochester, MN. · American Society of Clinical Oncology, Alexandria, VA. · National Adjuvant Surgical Breast and Bowel Project, Pittsburgh, PA. · Mayo Clinic, Jacksonville, FL. · University of Southern California, Los Angeles, CA. · North Carolina State University, Raleigh, NC. · Indiana University Medical Center, Indianapolis, IN. · University of Milan, European Institute of Oncology, Milan, Italy. · Royal Marsden Hospital, London, United Kingdom. · National Cancer Institute, Bethesda, MD. · University of Michigan Comprehensive Cancer Care Center, Ann Arbor, MI. · Pubmed 25753441
  • BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Division of Pathology, European Institute of Oncology, Milan, Italy. · Fertility and Procreation Unit, Department of Gynecology Oncology, European Institute of Oncology, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy; University of Milan, School of Medicine, Milan, Italy. · Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Pubmed 25702955
  • Biometric Research Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland, USA. · Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy. · Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK. · Transformative Pathology, Ontario Institute for Cancer Research, Toronto, Ontario, Canada. · The Emmes Corporation, Rockville, Maryland, USA. · Indiana University Simon Cancer Center, Indianapolis, Indiana, USA. · Department of Pathology and Molecular Medicine, Juravinski Hospital and Cancer Centre, McMaster University, Hamilton, Ontario, Canada. · Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Lund, Sweden. · Montefiore Medical Center and the Albert Einstein College of Medicine, Bronx, New York, USA. · Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. · PhenoPath Laboratories, Seattle, Washington, USA. · Lester and Sue Smith Breast Center and Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas, USA. · Department of Laboratory Medicine and Pathology, University of Alberta, Alberta, Canada. · Department of Pathology, Kawasaki Medical School, Kurashiki City, Japan. · Department of Pathology, Hakuaikai Sagara Hospital, Matsubaracho, Kagoshima, Japan. · Department of Pathology, Centre Jean Perrin and Université d'Auvergne, Clermont-Ferrand, France. · Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK. · Department of Pathology, Jichi Medical University, Shimotsuke, Tochigi, Japan. · Institut Jules Bordet, Brussels, Belgium. · Birmingham Heart of England, National Health Service, Birmingham, UK. · Slagelse Hospital, Slagelse, Region Sjælland, Denmark. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, and University of Milan, Milan, Italy. · Academic Department of Biochemistry, Royal Marsden Hospital, London, UK. · Breast Oncology Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, USA. · Pubmed 25698062
  • Molecular Medicine Program, Department of Experimental Oncology, European Institute of Oncology, Milan, Italy. · Molecular Medicine Program, Department of Experimental Oncology, European Institute of Oncology, Milan, Italy; Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Molecular Medicine Program, Department of Experimental Oncology, European Institute of Oncology, Milan, Italy; IFOM, The FIRC Institute for Molecular Oncology Foundation, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy; School of Medicine, University of Milan, Milan, Italy. · Molecular Medicine Program, Department of Experimental Oncology, European Institute of Oncology, Milan, Italy; IFOM, The FIRC Institute for Molecular Oncology Foundation, Milan, Italy; Center for Genomic Science of IIT@SEMM, Istituto Italiano di Tecnologia (IIT), Milan, Italy. · Molecular Medicine Program, Department of Experimental Oncology, European Institute of Oncology, Milan, Italy; IFOM, The FIRC Institute for Molecular Oncology Foundation, Milan, Italy; Department of Scienze della Salute, University of Milan, Milan, Italy. Electronic address: · Molecular Medicine Program, Department of Experimental Oncology, European Institute of Oncology, Milan, Italy. Electronic address: · Pubmed 25459350
2014
  • Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada. · Institute of Pathology Nordhessen, Kassel, Germany. · Healthscope Pathology, Norwest Private Hospital, Bella Vista, NSW, Australia. · State of São Paulo Cancer Institute (ICESP), São Paulo, Brazil. · Royal Marsden Hospital, London, UK. · International University of Health and Welfare (IUHW), Center for Diagnostic Pathology, IUHW Mita Hospital, Tokyo, Japan. · Centre Jean Perrin and University of Auvergne, EA 4233, Clermont-Ferrand, France. · The Academic Medical Center (AMC), The University of Amsterdam, Amsterdam, The Netherlands. · University of Milan and European Institute of Oncology, Milan, Italy. · Pubmed 23807776
  • Division of Breast Surgery, European Institute of Oncology, Milan, Italy. Electronic address: · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy; Department of Occupational Health, University of Milan, Milan, Italy. · Division of Cancer Prevention and Genetics, European Institute of Oncology, Milan, Italy. · Division of Breast Surgery, European Institute of Oncology, Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy. · Scientific Directorate, European Institute of Oncology, Milan, Italy. · Pubmed 25261930
  • Fondazione Istituto FIRC di Oncologia Molecolare (IFOM), 20139 Milan, Italy. · Fondazione Istituto FIRC di Oncologia Molecolare (IFOM), 20139 Milan, Italy Dipartimento di Oncologia Sperimentale, Istituto Europeo di Oncologia, 20141 Milan, Italy. · Dipartimento di Oncologia Sperimentale, Istituto Europeo di Oncologia, 20141 Milan, Italy. · Fondazione Istituto FIRC di Oncologia Molecolare (IFOM), 20139 Milan, Italy Dipartimento di Oncologia Sperimentale, Istituto Europeo di Oncologia, 20141 Milan, Italy Dipartimento di Scienze della Salute, Università degli Studi di Milano, 20122 Milan, Italy · Fondazione Istituto FIRC di Oncologia Molecolare (IFOM), 20139 Milan, Italy Dipartimento di Scienze della Salute, Università degli Studi di Milano, 20122 Milan, Italy · Pubmed 25049275
  • Division of Medical Senology, European Institute of Oncology, Milan, Italy. Electronic address: · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Division of Prevention and Genetics, European Institute of Oncology, Milan, Italy. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy; University of Milan School of Medicine, Milan, Italy. · Division of Senology, European Institute of Oncology, Milan, Italy; University of Milan School of Medicine, Milan, Italy. · Division of Senology, European Institute of Oncology, Milan, Italy. · Scientific Direction, European Institute of Oncology, Milan, Italy. · Pubmed 24742826
  • Division of Pathology, European Institute of Oncology, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy; University of Milan School of Medicine; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy; University of Milan School of Medicine; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy. Electronic address: · Pubmed 24709436
  • Division of Medical Senology, European Institute of Oncology, Milan, Italy. Electronic address: · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy; Department of Statistics and Quantitative Methods, Unit of Biostatistics, Epidemiology and Public Health, University of Milan-Bicocca, Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy; School of Medicine, University of Milan, Italy. · School of Medicine, University of Milan, Italy; Molecular Senology Unit, European Institute of Oncology, Milan, Italy. · Division of Senology, European Institute of Oncology, Milan, Italy. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy. · Vice-Scientific Director, European Institute of Oncology, Milan, Italy. · Pubmed 24325948
  • Early Drug Development for Innovative Therapies Division, Department of Medicine, European Institute of Oncology, Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Department of Breast Oncology, National Cancer Institute "Fondazione Pascale", Naples, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy. · Department of Endocrinology and Molecular and Clinical Oncology, University of Naples Federico II, Napoli, Italy. · Department of Advanced Medical Sciences, Operative Unit of General Surgery and Transplants, University of Naples Federico II, Napoli, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy; University of Milan School of Medicine, Milan, Italy. · Early Drug Development for Innovative Therapies Division, Department of Medicine, European Institute of Oncology, Milan, Italy. Electronic address: · Pubmed 24314620
  • European Institute of Oncology, Medical Oncology, via Ripamonti 435, Milan, Italy. Electronic address: · European Institute of Oncology, Division of Epidemiology and Biostatistics, via Ripamonti 435, Milan, Italy. · European Institute of Oncology, Division of Pathology, via Ripamonti 435, Milan, Italy; University of Milan, School of Medicine, Milan, Italy. · European Institute of Oncology, Division of Epidemiology and Biostatistics, via Ripamonti 435, Milan, Italy; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, via Bicocca degli Arcimboldi 8, 20126 Milan, Italy. · European Institute of Oncology, Medical Oncology, via Ripamonti 435, Milan, Italy. · Second University of Naples, Medical Oncology, via Pansini 5, Naples, Italy. · Pubmed 24269135
  • Unit of Investigative Clinical Oncology (INCO), Fondazione del Piemonte per l'Oncologia, Institute for Cancer Research and Treatment (IRCCs), Candiolo, Italy. · Division of Medical Oncology, European Institute of Oncology, Milan, Italy. · Division of Medical Oncology, Fondazione del Piemonte per l'Oncologia, Institute for Cancer Research and Treatment (IRCCs), Candiolo, Italy. · University of Turin, Department of Biomedical Sciences and Human Oncology, Turin, Italy. · Department of Pathology and Laboratory Medicine, European Institute of Oncology, University of Milan, Milan, Italy. · Unit of Investigative Clinical Oncology (INCO), Fondazione del Piemonte per l'Oncologia, Institute for Cancer Research and Treatment (IRCCs), Candiolo, Italy; Division of Medical Oncology, Fondazione del Piemonte per l'Oncologia, Institute for Cancer Research and Treatment (IRCCs), Candiolo, Italy. Electronic address: · Pubmed 24210572
  • Division of Medical Senology, European Institute of Oncology, Milan, Italy. Electronic address: · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Division of Pathology and Laboratory Medicine, European Institute of Oncology and University of Milan, Italy. · Integrated Breast Surgery Unit, European Institute of Oncology and University of Milan, Italy. · Division of Senology, European Institute of Oncology, Milan, Italy. · Division of Radiation Oncology, European Institute of Oncology, Milan, Italy. · Department of Medicine, European Institute of Oncology, Milan, Italy. · Pubmed 24183613
  • Department of Medical Oncology, European Institute of Oncology, Milan, Italy. Electronic address: · Department of Medical Oncology, European Institute of Oncology, Milan, Italy. · Department of Pathology, European Institute of Oncology, Milan, Italy; University of Milan, School of Medicine, Italy. · Pubmed 24508454
2013
  • University of Milan School of Medicine, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy. Electronic address: · Pubmed 24074800
2011
  • Department of Pathology and Laboratory Medicine, European Institute of Oncology, University of Milan, Milan, Italy. · Pubmed 22015299
2009
  • Department of Pathology and Laboratory Medicine, European Institute of Oncology, University of Milan School of Medicine, Via Ripamonti 435, Milan, Italy. · Pubmed 19914539
  • Department of Pathology, European Institute of Oncology, University of Milan School of Medicine, Milan, Italy. · Pubmed 19775600
  • Division of Pathology, European Institute of Oncology, Università degli Studi di Milano, Milan, Italy. · Pubmed 19670216
2008
  • Division of Pathology and Laboratory Medicine, European Institute of Oncology, University of Milan, Milan, Italy. · Pubmed 18981464
2017
  • From the German Breast Group, Neu-Isenburg, Germany (G.M.); Frontier Science (Scotland), Kincraig, United Kingdom (M. Procter); the Breast European Adjuvant Study Team (BrEAST) Data Center (E.A., N.R.), the Breast International Group (D.Z., A.A.), and Institut Jules Bordet, Université Libre de Bruxelles (M. Piccart) - all in Brussels; Roche Pharma (M.B., E.C., A.K.) and the Department of Cardiology, Cardio-Oncology, Bern University Hospital (T.S.) - both in Bern, Switzerland; the Department of Pathology, European Institute of Oncology, University of Milan, Milan (G.V.); the National Institute of Oncology, Budapest, Hungary (I.L.); Centre François Baclesse, Caen, France (C.L.); the Sarah Cannon Research Institute and Tennessee Oncology, Nashville (D.A.Y.); Instituto Nacional de Câncer, Rio de Janeiro (J. Bines); Dana-Farber Cancer Institute, Harvard Medical School, Harvard T. H. Chan School of Public Health, and Frontier Science and Technology Research Foundation - all in Boston (R.D.G.); and the Department of Medicine, Memorial Sloan Kettering Cancer Center, New York (J. Baselga). · Pubmed 28581356
  • *School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, NY †Istituto Europeo di Oncologia, University of Milan, Milan, Italy ‡UCL Advanced Diagnostics, London, UK §Dako A/S, Glostrup, Denmark. · Pubmed 26657878
2016
  • From Champalimaud Clinical Center-Champalimaud Foundation, Lisbon, Portugal (F.C.); Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (L.J.V.); European Organization for Research and Treatment of Cancer Headquarters (J.B., L. Slaets, V.G., B.M., K.T.), Breast International Group Headquarters (T.G., C. Straehle), and Institut Jules Bordet, Université Libre de Bruxelles (C. Sotiriou, M.P.), Brussels, and Centre Hospitalier Universitaire Université Catholique de Louvain, Namur (P.V.) - both in Belgium; University of Milan and Istituto Europeo di Oncologia (G.V.) and Europa Donna-European Breast Cancer Coalition (S.K.), Milan, and Azienda Istituti Ospitalieri di Cremona, Cremona (R.P.) - both in Italy; Gustave Roussy, Villejuif (S.D., M.S.), Institut Curie Paris Sciences et Lettres, Université Paris Descartes, Sorbonne Paris Cité, Paris (J.-Y.P.). Institut Curie-Hôpital Rene Huguenin, Saint-Cloud (E.B.), and Centre Georges-Francois-Leclerc, Dijon (S.C.) - all in France; Swiss Institute of Bioinformatics and University of Lausanne, Lausanne, Switzerland (M.D.); Agendia (A.M.G., L. Stork) and the Netherlands Cancer Institute (R.B., E.R.), Amsterdam, Alrijne Ziekenhuis, Rijnland Leiderdorp (P.A.N.), Jeroen Bosch Hospital, 's-Hertogenbosch (T.J.S.), and Medisch Centrum Alkmaar, Alkmaar (J.M.H.) - all in the Netherlands; Institute of Oncology, Ljubljana, Slovenia (E.M.); Evangelisches Krankenhaus Bethesda, Duisburg, Germany (U.N.); University of Texas Health Sciences Center, San Antonio (P.R.); Hospital Universitario Vall d'Hebron, Barcelona (I.T.R.); Imperial College London, London (G.T.); and University of Texas M.D. Anderson Cancer Center, Houston (A.M.T.). · Pubmed 27557300
  • Marco Colleoni, Giuseppe Viale, and Aron Goldhirsch, European Institute of Oncology; Giuseppe Viale, University of Milan, Milan; Lorenzo Gianni, Ospedale degli Infermi, Rimini; Fabio Puglisi, University Hospital of Udine, University of Udine, Udine; Carlo Tondini, Osp. Papa Giovanni XXIII, Bergamo; Katia Cagossi, Ospedale di Carpi, Carpi, Italy; Kathryn P. Gray, Shari Gelber, Richard D. Gelber, Meredith M. Regan, and Karen N. Price, International Breast Cancer Study Group Statistical Center; Kathryn P. Gray, Shari Gelber, Richard D. Gelber, and Meredith M. Regan, Dana-Farber Cancer Institute; Kathryn P. Gray and Richard D. Gelber, Harvard T.H. Chan School of Public Health; Richard D. Gelber and Meredith M. Regan, Harvard Medical School; Richard D. Gelber and Karen N. Price, Frontier Science and Technology Foundation, Boston, MA; István Láng, National Institute of Oncology, Budapest, Hungary; Beat Thürlimann, Kantonsspital, St Gallen; Beat Thürlimann, Elena Kralidis, and Daniel Rauch, Swiss Group for Clinical Cancer Research, Bern; Elena Kralidis, Kantonsspital Aarau, Aarau; Daniel Rauch, Spital Thun, Thun, Switzerland; Ehtesham A. Abdi, The Tweed Head Hospital, Tweed Heads, New South Wales and Griffith University, Southport, Queensland; Ehtesham A. Abdi and Jacquie Chirgwin, Australia and New Zealand Breast Cancer Trials Group; Jacquie Chirgwin, Box Hill and Maroondah Hospitals and Monash University, Melbourne, Victoria; Alan S. Coates, International Breast Cancer Study Group and University of Sydney School of Public Health, Sydney, New South Wales, Australia; Henry L. Gomez, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru; Barbro K. Linderholm, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, and Sahlgrenska University Hospital, Gothenburg, Sweden; and Alexandru Eniu, Cancer Institute Ion Chiricuta, Cluj, Romania. · Marco Colleoni, Giuseppe Viale, and Aron Goldhirsch, European Institute of Oncology; Giuseppe Viale, University of Milan, Milan; Lorenzo Gianni, Ospedale degli Infermi, Rimini; Fabio Puglisi, University Hospital of Udine, University of Udine, Udine; Carlo Tondini, Osp. Papa Giovanni XXIII, Bergamo; Katia Cagossi, Ospedale di Carpi, Carpi, Italy; Kathryn P. Gray, Shari Gelber, Richard D. Gelber, Meredith M. Regan, and Karen N. Price, International Breast Cancer Study Group Statistical Center; Kathryn P. Gray, Shari Gelber, Richard D. Gelber, and Meredith M. Regan, Dana-Farber Cancer Institute; Kathryn P. Gray and Richard D. Gelber, Harvard T.H. Chan School of Public Health; Richard D. Gelber and Meredith M. Regan, Harvard Medical School; Richard D. Gelber and Karen N. Price, Frontier Science and Technology Foundation, Boston, MA; István Láng, National Institute of Oncology, Budapest, Hungary; Beat Thürlimann, Kantonsspital, St Gallen; Beat Thürlimann, Elena Kralidis, and Daniel Rauch, Swiss Group for Clinical Cancer Research, Bern; Elena Kralidis, Kantonsspital Aarau, Aarau; Daniel Rauch, Spital Thun, Thun, Switzerland; Ehtesham A. Abdi, The Tweed Head Hospital, Tweed Heads, New South Wales and Griffith University, Southport, Queensland; Ehtesham A. Abdi and Jacquie Chirgwin, Australia and New Zealand Breast Cancer Trials Group; Jacquie Chirgwin, Box Hill and Maroondah Hospitals and Monash University, Melbourne, Victoria; Alan S. Coates, International Breast Cancer Study Group and University of Sydney School of Public Health, Sydney, New South Wales, Australia; Henry L. Gomez, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru; Barbro K. Linderholm, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, and Sahlgrenska University Hospital, Gothenburg, Sweden; and Alexandru Eniu, Cancer Institute Ion Chiricuta, Cluj, Romania. · Pubmed 27325862
  • Martine Piccart-Gebhart, Université Libre de Bruxelles, Brussels, Belgium; Eileen Holmes, Eleanor McFadden, and Andrew P. Holmes, Frontier Science (Scotland), Kincraig, Kingussie, United Kingdom; José Baselga, Memorial Sloan Kettering Cancer Center, New York, NY; Evandro de Azambuja, Institut Jules Bordet, Brussels, Belgium; Evandro de Azambuja and Stella Dolci, Breast European Adjuvant Study Team, Brussels, Belgium; Amylou C. Dueck and Anne E. McCullough, Mayo Clinic, Scottsdale, AZ; Giuseppe Viale, University of Milan, Milan, Italy; Giuseppe Viale and Aron Goldhirsch, Istituto Europeo di Oncologia, Milan, Italy; Jo Anne Zujewski, National Cancer Institute, Bethesda, MD; Aron Goldhirsch, Ospedale Regionale di Lugano, Viganello-Lugano, Switzerland; Alison Armour, GlaxoSmithKline, Collegeville, PA; Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada; Kathleen I. Pritchard, University of Toronto, Toronto, Ontario, Canada; Liu Tonghua, Peking Union Medical College Hospital, Beijing, People's Republic of China; Liu Tonghua and Binghe Xu, China Academy of Chinese Medical Sciences, Beijing, People's Republic of China; Holger Eidtmann, University Hospital Kiel, Kiel, Germany; Phuong Dinh, Breast International Group, Brussels, Belgium; Serena Di Cosimo, Istituto Nazionale del Tumori, Milan, Italy; Serena Di Cosimo, SOLTI Breast Cancer Research Group, Barcelona, Spain; Nadia Harbeck, Frauenklinik der Universität München, Munich, Germany; Sergei Tjulandin, Blokhin Russian Cancer Research Center of RAMS, Moscow, Russia; Young-Hyuck Im, Korean Cancer Study Group, Seoul, South Korea; Young-Hyuck Im, Samsung Medical Center, Seoul, South Korea; Chiun-Shen Huang, National Taiwan University Hospital, Taipei, Republic of China; Véronique Diéras, Institut Curie, Paris, France; David W. Hillman, Mayo Clinic, Rochester, MN; Antonio C. Wolff, The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Christian Jackisch, Klinikum Offenba · Pubmed 26598744
  • Meredith M. Regan and Richard D. Gelber, Dana-Farber Cancer Institute, Harvard Medical School; Karen N. Price and Richard D. Gelber, Frontier Science and Technology Research Foundation; Richard D. Gelber, Harvard T.H. Chan School of Public Health, Boston, MA; Prudence A. Francis, MacCallum Cancer Center, St Vincent's Hospital, University of Melbourne, Melbourne; University of Newcastle, Newcastle; Alan S. Coates, University of Sydney, Sydney, Australia; Olivia Pagani, Institute of Oncology of Southern Switzerland, Lugano Viganello, Switzerland; Gini F. Fleming, University of Chicago Medical Center, Chicago, IL; Barbara A. Walley, National Cancer Institute of Canada Clinical Trials Group, Calgary, Alberta, Canada; Giuseppe Viale, University of Milan; Giuseppe Viale, Marco Colleoni, and Aron Goldhirsch, European Institute of Oncology, Milan; Carlo Tondini, Ospedale Papa Giovanni XXIII, Bergamo; Graziella Pinotti, Ospedale di Circolo and Fondazione Macchi, Varese, Italy; István Láng, National Institute of Oncology, Budapest, Hungary; Henry L. Gómez, Instituto Nacional de Enfermedades Neoplásticas, Lima, Peru. · Meredith M. Regan and Richard D. Gelber, Dana-Farber Cancer Institute, Harvard Medical School; Karen N. Price and Richard D. Gelber, Frontier Science and Technology Research Foundation; Richard D. Gelber, Harvard T.H. Chan School of Public Health, Boston, MA; Prudence A. Francis, MacCallum Cancer Center, St Vincent's Hospital, University of Melbourne, Melbourne; University of Newcastle, Newcastle; Alan S. Coates, University of Sydney, Sydney, Australia; Olivia Pagani, Institute of Oncology of Southern Switzerland, Lugano Viganello, Switzerland; Gini F. Fleming, University of Chicago Medical Center, Chicago, IL; Barbara A. Walley, National Cancer Institute of Canada Clinical Trials Group, Calgary, Alberta, Canada; Giuseppe Viale, University of Milan; Giuseppe Viale, Marco Colleoni, and Aron Goldhirsch, European Institute of Oncology, Milan; Carlo Tondini, Ospedale Papa Giovanni XXIII, Bergamo; Graziella Pinotti, Ospedale di Circolo and Fondazione Macchi, Varese, Italy; István Láng, National Institute of Oncology, Budapest, Hungary; Henry L. Gómez, Instituto Nacional de Enfermedades Neoplásticas, Lima, Peru. · Pubmed 27044936
  • Christine Desmedt, Gabriele Zoppoli, Denis Larsimont, Debora Fumagalli, David Brown, Françoise Rothé, Delphine Vincent, Naima Kheddoumi, Ghizlane Rouas, Samira Majjaj, Sylvain Brohée, Roberto Salgado, Martine Piccart-Gebhart, and Christos Sotiriou, Institut Jules Bordet; Christine Galant, Cliniques Universitaires Saint Luc, Brussels; Peter Van Loo, University of Leuven; Thomas Van Brussel and Diether Lambrechts, VIB Vesalius Research Center, Leuven, Belgium; Gabriele Zoppoli, University of Genoa and Istituto di Ricerca a Carattere Clinico-Scientifico San Martino-National Cancer Institute, Genoa; Giancarlo Pruneri, Patrick Maisonneuve, and Giuseppe Viale, European Institute of Oncology; Marco Fornili and Elia Biganzoli, University of Milan, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale Tumori, Milan, Italy; Gunes Gundem and Peter J. Campbell, Wellcome Trust Sanger Institute, Cambridgeshire; Peter Van Loo, The Francis Crick Institute, London, United Kingdom; Ron Bose, Washington University School of Medicine, St Louis, MO; Otto Metzger, Dana-Farber Cancer Institute, Boston, MA; and François Bertucci, Institut Paoli-Calmettes, Marseille, France. · Christine Desmedt, Gabriele Zoppoli, Denis Larsimont, Debora Fumagalli, David Brown, Françoise Rothé, Delphine Vincent, Naima Kheddoumi, Ghizlane Rouas, Samira Majjaj, Sylvain Brohée, Roberto Salgado, Martine Piccart-Gebhart, and Christos Sotiriou, Institut Jules Bordet; Christine Galant, Cliniques Universitaires Saint Luc, Brussels; Peter Van Loo, University of Leuven; Thomas Van Brussel and Diether Lambrechts, VIB Vesalius Research Center, Leuven, Belgium; Gabriele Zoppoli, University of Genoa and Istituto di Ricerca a Carattere Clinico-Scientifico San Martino-National Cancer Institute, Genoa; Giancarlo Pruneri, Patrick Maisonneuve, and Giuseppe Viale, European Institute of Oncology; Marco Fornili and Elia Biganzoli, University of Milan, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale Tumori, Milan, Italy; Gunes Gundem and Peter J. Campbell, Wellcome Trust Sanger Institute, Cambridgeshire; Peter Van Loo, The Francis Crick Institute, London, United Kingdom; Ron Bose, Washington University School of Medicine, St Louis, MO; Otto Metzger, Dana-Farber Cancer Institute, Boston, MA; and François Bertucci, Institut Paoli-Calmettes, Marseille, France. · Pubmed 26926684
2015
  • Otto Metzger Filho, Anita Giobbie-Hurder, and Eric P. Winer, Dana-Farber Cancer Institute; Richard D. Gelber and Meredith M. Regan, Harvard Medical School; Karen N. Price, Frontier Science and Technology Research, Boston, MA; Elizabeth Mallon, Southern General Hospital; Barry Gusterson, Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom; Giuseppe Viale, European Institute of Oncology and University of Milan; Marco Colleoni and Aron Goldhirsch, European Institute of Oncology, Milan, Italy; Beat Thürlimann, Kantonsspital, St. Gallen, and Swiss Group for Clinical Cancer Research, Bern, Switzerland; Bent Ejlertsen, Rigshospitalet, Copenhagen, Denmark; Marc Debled, Institut Bergoniié, Bordeaux, France; and Alan S. Coates, International Breast Cancer Study Group, Bern, Switzerland, and University of Sydney, Sydney, Australia. · Otto Metzger Filho, Anita Giobbie-Hurder, and Eric P. Winer, Dana-Farber Cancer Institute; Richard D. Gelber and Meredith M. Regan, Harvard Medical School; Karen N. Price, Frontier Science and Technology Research, Boston, MA; Elizabeth Mallon, Southern General Hospital; Barry Gusterson, Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom; Giuseppe Viale, European Institute of Oncology and University of Milan; Marco Colleoni and Aron Goldhirsch, European Institute of Oncology, Milan, Italy; Beat Thürlimann, Kantonsspital, St. Gallen, and Swiss Group for Clinical Cancer Research, Bern, Switzerland; Bent Ejlertsen, Rigshospitalet, Copenhagen, Denmark; Marc Debled, Institut Bergoniié, Bordeaux, France; and Alan S. Coates, International Breast Cancer Study Group, Bern, Switzerland, and University of Sydney, Sydney, Australia. · Pubmed 26215945
2014
  • Antonio C. Wolff, Johns Hopkins Kimmel Comprehensive Cancer Center, Baltimore; Lisa M. McShane, National Cancer Institute, Bethesda, MD; M. Elizabeth H. Hammond, University of Utah School of Medicine and Intermountain Healthcare, Salt Lake City, UT; David G. Hicks, University of Rochester Medical Center, Rochester, NY; Mitch Dowsett, Royal Marsden Hospital, London, United Kingdom; Kimberly H. Allison, Stanford University Medical Center, Stanford; Patrick Fitzgibbons, St Jude Medical Center, Fullerton; Michael F. Press, University of Southern California, Los Angeles, CA; Donald C. Allred, Washington University School of Medicine, St Louis, MO; John M.S. Bartlett, Ontario Institute for Cancer Research; Wedad Hanna, Sunnybrook Health Sciences Center, Toronto, Ontario, Canada; Michael Bilous, University of Western Sydney and Healthscope Pathology, Sydney, New South Wales, Australia; Robert B. Jenkins, Mayo Clinic, Rochester, MN; Pamela B. Mangu, American Society of Clinical Oncology, Alexandria, VA; Soonmyung Paik, National Surgical Adjuvant Breast and Bowel Project, Pitsburgh, PA; Edith A. Perez, Mayo Clinic, Jacksonville, FL; Patricia A. Spears, North Carolina State University, Raleigh, NC; Gail H. Vance, Indiana University Medical Center, Indianapolis, IN; Giuseppe Viale, University of Milan, European Institute of Oncology, Milan, Italy; and Daniel F. Hayes, University of Michigan Comprehensive Cancer Care Center, Ann Arbor, MI. · Pubmed 24099077
  • Felipe Ades, Lina Pugliano, Debora Fumagalli, Evandro de Azambuja, Christos Sotiriou, and Martine Piccart, Institut Jules Bordet, Université Libre de Bruxelles; Dimitrios Zardavas, Breast International Group, Brussels, Belgium; Ivana Bozovic-Spasojevic, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia; and Giuseppe Viale, European Institute of Oncology, University of Milan, Milan, Italy. · Felipe Ades, Lina Pugliano, Debora Fumagalli, Evandro de Azambuja, Christos Sotiriou, and Martine Piccart, Institut Jules Bordet, Université Libre de Bruxelles; Dimitrios Zardavas, Breast International Group, Brussels, Belgium; Ivana Bozovic-Spasojevic, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia; and Giuseppe Viale, European Institute of Oncology, University of Milan, Milan, Italy. · Pubmed 25049332
  • Department of Medical Sciences, University of Turin, Turin, Italy; Pathology Unit, Department of Laboratory Medicine, Azienda Ospedaliera Città della Salute e della Scienza di Torino, Turin, Italy; Pathology Division, Santa Croce Hospital, Moncalieri, Italy; Pathology Division, Azienda USL Valle d'Aosta, Aosta, Italy; Pathology Division, Valdese Hospital, Turin, Italy; Pathology Division, Martini Hospital, Turin, Italy; Pathology Division, ASL 9, Civile Hospital, Ivrea, Italy; Department of Pathology, Regina Elena National Cancer Institute, Rome, Italy; Division of Pathology, European Institute of Oncology, Milan, Italy; University of Milan School of Medicine, Milan, Italy · Department of Medical Sciences, University of Turin, Turin, Italy; Pathology Unit, Department of Laboratory Medicine, Azienda Ospedaliera Città della Salute e della Scienza di Torino, Turin, Italy; Pathology Division, Santa Croce Hospital, Moncalieri, Italy; Pathology Division, Azienda USL Valle d'Aosta, Aosta, Italy; Pathology Division, Valdese Hospital, Turin, Italy; Pathology Division, Martini Hospital, Turin, Italy; Pathology Division, ASL 9, Civile Hospital, Ivrea, Italy; Department of Pathology, Regina Elena National Cancer Institute, Rome, Italy; Division of Pathology, European Institute of Oncology, Milan, Italy; University of Milan School of Medicine, Milan, Italy. · Pubmed 25323485
  • Division of Medical Senology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy, · Pubmed 25007961
  • Department of MedicineInstitut Jules Bordet, BrEAST Data Centre, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 121, 1000 Brussels, BelgiumBreast Cancer Translational Research Laboratory (BCTL) J. C. HeusonInstitut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumFertility and Procreation UnitDepartment of Gynecologic Oncology, European Institute of Oncology, Milan, ItalyTranslational Breast Cancer Genomic LabCancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, AustraliaSir Peter MacCallum Department of OncologyUniversity of Melbourne, Parkville, Victoria, AustraliaVesalius Research CentreVIB, Leuven, BelgiumLaboratory of Translational GeneticsDepartment of Oncology, University of Leuven, Leuven, BelgiumDepartment of PathologyDivision of Epidemiology and BiostatisticsEuropean Institute of Oncology, Milan, ItalyDepartment of MedicineMedical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumDepartment of MedicineInstitut Jules Bordet, BrEAST Data Centre, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 121, 1000 Brussels, BelgiumBreast Cancer Translational Research Laboratory (BCTL) J. C. HeusonInstitut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumFertility and Procreation UnitDepartment of Gynecologic Oncology, European Institute of Oncology, Milan, ItalyTranslational Breast Cancer Genomic LabCancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, AustraliaSir Peter MacCallum Department of OncologyUniversity of Melbourne, Parkville, Victoria, AustraliaVesalius Research CentreVIB, Leuven, BelgiumLaboratory of Translational GeneticsDepartment of Oncology, University of Leuven, Leuven, BelgiumDepartment of PathologyDivision of Epidemiology and BiostatisticsEuropean Institute of Oncology, Milan, ItalyDepartment of MedicineMedical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxel · Department of MedicineInstitut Jules Bordet, BrEAST Data Centre, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 121, 1000 Brussels, BelgiumBreast Cancer Translational Research Laboratory (BCTL) J. C. HeusonInstitut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumFertility and Procreation UnitDepartment of Gynecologic Oncology, European Institute of Oncology, Milan, ItalyTranslational Breast Cancer Genomic LabCancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, AustraliaSir Peter MacCallum Department of OncologyUniversity of Melbourne, Parkville, Victoria, AustraliaVesalius Research CentreVIB, Leuven, BelgiumLaboratory of Translational GeneticsDepartment of Oncology, University of Leuven, Leuven, BelgiumDepartment of PathologyDivision of Epidemiology and BiostatisticsEuropean Institute of Oncology, Milan, ItalyDepartment of MedicineMedical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Pubmed 24825746
2013
  • Antonio C. Wolff, Johns Hopkins Kimmel Comprehensive Cancer Center, Baltimore; Lisa M. McShane, National Cancer Institute, Bethesda, MD; M. Elizabeth H. Hammond, University of Utah School of Medicine and Intermountain Healthcare, Salt Lake City, UT; David G. Hicks, University of Rochester Medical Center, Rochester, NY; Mitch Dowsett, Royal Marsden Hospital, London, United Kingdom; Kimberly H. Allison, Stanford University Medical Center, Stanford; Patrick Fitzgibbons, St Jude Medical Center, Fullerton; Michael F. Press, University of Southern California, Los Angeles, CA; Donald C. Allred, Washington University School of Medicine, St Louis, MO; John M.S. Bartlett, Ontario Institute for Cancer Research; Wedad Hanna, Sunnybrook Health Sciences Center, Toronto, Ontario, Canada; Michael Bilous, University of Western Sydney and Healthscope Pathology, Sydney, New South Wales, Australia; Robert B. Jenkins, Mayo Clinic, Rochester, MN; Pamela B. Mangu, American Society of Clinical Oncology, Alexandria, VA; Soonmyung Paik, National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA; Edith A. Perez, Mayo Clinic, Jacksonville, FL; Patricia A. Spears, North Carolina State University, Raleigh, NC; Gail H. Vance, Indiana University Medical Center, Indianapolis, IN; Giuseppe Viale, University of Milan, European Institute of Oncology, Milan, Italy; and Daniel F. Hayes, University of Michigan Comprehensive Cancer Care Center, Ann Arbor, MI. · Pubmed 24101045
  • Department of Medicine, European Institute of Oncology, Milan, Italy. Electronic address: · Pubmed 23871531
  • Molecular Senology Unit, Senology Division, European Institute of Oncology, Milan, Italy. · Pubmed 23491275
  • Scientific Directorate, European Institute of Oncology, Milan, Italy. Electronic address: · Pubmed 24225155
  • Affiliations of authors: Biometric Research Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD (MCP, LMM); Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada (SCYL, DG, EM, TON); Department of Laboratory Medicine and Pathology, University of Alberta, Alberta, Canada (JCH); Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy (MGM); Division of Pathology and Laboratory Medicine, European Institute of Oncology, and University of Milan, Milan, Italy (GV); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom (LAZ); Department of Pathology, Centre Jean Perrin, Clermont-Ferrand, and Université d'Auvergne, France (FP-L); Transformative Pathology, Ontario Institute for Cancer Research, Toronto, Ontario, Canada (JMSB); PhenoPath Laboratories, Seattle, WA (AMG); Department of Pathology, MD Anderson Cancer Center, Houston, TX (WFS); Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, United Kingdom (TP); The EMMES Corporation, Rockville, MD (RAE); Breast Oncology Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI (DFH); Academic Department of Biochemistry, Royal Marsden Hospital, London, United Kingdom (MD); on behalf of the International Ki67 in Breast Cancer Working Group of the Breast International Group and North American Breast Cancer Group. · Pubmed 24203987
  • Division of Medical Senology, Department of Medicine, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy. Electronic address: · Pubmed 24091127
  • Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Pubmed 23912960
  • Division of Pathology, European Institute of Oncology, Milan, Italy. · Pubmed 23763700
  • Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Pubmed 23412771
  • Research Unit in Medical Senology, Department of Medicine, European Institute of Oncology, Milan, Italy. · Pubmed 23245877
  • Research Unit in Medical Senology, Department of Medicine, European Institute of Oncology, Milan, Italy. · Pubmed 23098574
2012
  • Department of Medicine, European Institute of Oncology, Milan, Italy. · Pubmed 22520733
  • Division of Pathology and Laboratory Medicine Radiological Senology Unit, European Institute of Oncology, Milan, Italy. · Pubmed 22882656
  • Medical Senology Research Unit & Division of Medical Oncology, Department of Medicine, European Institute of Oncology, Milan, Italy. · Pubmed 22749924
  • Research Unit in Medical Senology, Department of Medicine, European Institute of Oncology, Milan, Italy. · Pubmed 22399188
  • Division of Pathology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · Pubmed 22228432
  • Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Pubmed 22212746
  • Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy. · Pubmed 22212008
  • Department of Medicine, European Institute of Oncology, Via Ripamonti 435, Milan, Italy. · Pubmed 22171586
  • Division of Senology, Unit of Molecular Senology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · Pubmed 21468637
2011
  • Division of Cancer Prevention and Genetics, European Institute of Oncology, Milan, Italy. · Pubmed 21685235
  • Division of Senology, European Institute of Oncology, Milano, Italy. · Pubmed 21479691
  • Division of Breast Surgery, European Institute of Oncology, Milan, Italy. · Pubmed 22015303
  • Division of Medical Oncology, Department of Medicine, Unit Research of Medical Senology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy. · Pubmed 21822638
  • Medical Senology Research Unit, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy. · Pubmed 21397505
  • Division of Senology, European Institute of Oncology, University of Milan, Milan, Italy. · Pubmed 21248632
  • Research Unit of Medical Senology at the Department of Medicine, European Institute of Oncology, Milano, Italy. · Pubmed 21221766
  • Research Unit of Medical Senology, European Institute of Oncology, via Ripamonti 435, Milan, Italy. · Pubmed 20638282
2010
  • Research Unit of Medical Senology, European Institute of Oncology, Milan, Italy. · Pubmed 21147693
  • IEO European Institute of Oncology, Milan, Italy. · Pubmed 21147866
  • Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Pubmed 20705566
  • Division of Medical Oncology, Department of Medicine, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · Pubmed 20625816
  • Department of Medicine, Research Unit in Medical Senology, European Institute of Oncology, Milan, Italy. · Pubmed 20471822
  • Research Unit in Medical Senology, Department of Medicine, European Institute of Oncology, Università degli Studi di Milano, Milan, Italy. · Pubmed 20458051
  • European Institute of Oncology, Milan, Italy. · Pubmed 20195151
  • Unit of Research in Medical Senology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · Pubmed 20117001
  • Division of Senology, European Institute of Oncology, Milan, Italy. · Pubmed 19662412
2009
  • Research Unit in Medical Senology, Department of Medicine, European Institute of Oncology, Via Ripamonti 435, Milan, Italy. · Pubmed 19914533
  • Department of Medicine, Research Unit in Medical Senology, European Institute of Oncology, Milan, Italy. · Pubmed 18941889
  • Research Unit in Medical Senology, Division of Medical Oncology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · Pubmed 20044624
  • Department of Medicine, Division of Medical Oncology, Istituto Europeo di Oncologia, Milano, Italy. · Pubmed 19884553
  • Scientific Director European Institute of Oncology, Milan, Italy. · Pubmed 19645785
  • Department of Radiology, Breast Imaging Unit, European Institute of Oncology, Milan, Italy. · Pubmed 19342236
  • Division of Cancer Prevention and Genetics, European Institute of Oncology, Milan, Italy. · Pubmed 19264824
  • Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy. · Pubmed 19222698
  • Research Unit of Medical Senology, European Institute of Oncology, Milan, Italy. · Pubmed 19182679
  • Scientific Director European Institute of Oncology, Via G. Ripamonti 435, I-20141 Milan, Italy. · Pubmed 19128957
University of Milan Statale
2017
  • European Institute of Oncology, Milano, Italy. Electronic address: · Champalimaud Clinical Center, Lisbon, Portugal. · European School of Oncology, Milano, Italy. · European Institute of Oncology, Milano, Italy; University of Milan, Milano, Italy. · European Institute of Oncology, Milano, Italy. · Pubmed 27876474
  • Molecular Biotechnology Center, Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin 10126, Italy. · Molecular Biotechnology Center, Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin 10126, Italy. Electronic address: · Department of Medical Sciences, University of Torino, Turin, Italy; Pathology Unit, Department of Laboratory Medicine, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Turin, Italy. · IFOM, The FIRC Institute for Molecular Oncology Foundation, Milan, Italy. · Program of Molecular Medicine, IEO, European Institute of Oncology, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy; Department of Oncology and Hemato-oncology (DIPO), University of Milan, Milan, Italy. · Department of Cell Physiology and Metabolism, University of Geneva, Geneva, Switzerland. · Molecular Biotechnology Center, Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin 10126, Italy; Department of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA. · Unit of Investigative Oncology, Candiolo Cancer Institute - FPO, IRCCS, Candiolo (TO), Italy. · Institute for Research in Biomedicine, Università della Svizzera Italiana, Bellinzona, Switzerland. · Department of Biological Science and Bioengineering, Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an, Shaanxi, P. R. China. · Program of Molecular Medicine, IEO, European Institute of Oncology, Milan, Italy; Department of Oncology and Hemato-oncology (DIPO), University of Milan, Milan, Italy. · Department of Medical Sciences, University of Torino, Turin, Italy; Unit of Pathology, Candiolo Cancer Institute - FPO, IRCCS, Candiolo (TO), Italy. · IFOM, The FIRC Institute for Molecular Oncology Foundation, Milan, Italy; Program of Molecular Medicine, IEO, European Institute of Oncology, Milan, Italy; Department of Oncology and Hemato-oncology (DIPO), University of Milan, Milan, Italy. · Molecular Biotechnology Center, Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin 10126, Italy. Electronic address: · Pubmed 29017056
  • Division of Radiation Oncology, European Institute of Oncology, Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy. · Unit of Medical Physics, European Institute of Oncology, Milan, Italy. · Division of Radiation Oncology, European Institute of Oncology, Milan, Italy; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy. · Division of Breast Surgery, European Institute of Oncology, Milan, Italy. · Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy; Division of Breast Surgery, European Institute of Oncology, Milan, Italy. · Division of Radiation Oncology, European Institute of Oncology, Milan, Italy; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy. Electronic address: · Division of Pathology, European Institute of Oncology, Milan, Italy; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy. · Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy; Department of Medical Imaging and Radiation Sciences, European Institute of Oncology, Milan, Italy. · Pubmed 28816144
  • Transformative Pathology, Ontario Institute for Cancer Research (OICR), MaRS Centre, 661 University Avenue, Suite 510, Toronto, ON M5G 0A3, Canada; University of Edinburgh Cancer Research Centre, Institute of Genetics and Molecular Medicine, The University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK. Electronic address: · Cancer Research UK Clinical Trials Unit, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK. Electronic address: · International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA. Electronic address: · Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University, Charterhouse Square, London EC1M 6BQ, UK. Electronic address: · Department of Pathology, Elizabeth University Hospital, 1345 Govan Road, Govan, Glasgow G51 4TF, UK. Electronic address: · Department of Pathology, European Institute of Oncology and University of Milan, Via Giuseppe Ripamonti, 435, 20141 Milan, Italy. Electronic address: · Breast Center, Kantonsspital, St. Gallen, and Swiss Group for Clinical Cancer Research SAKK, CH-9007 St. Gallen, Switzerland. Electronic address: · Department of Medical Oncology, Erasmus MC Cancer Institute, PO Box 5201, Rotterdam 3008 AE, The Netherlands. Electronic address: · Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands. Electronic address: · Division of Surgery, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands. Electronic address: · Leicester Clinical Trials Unit, University of Leicester, Leicester LE5 4PW, UK. Electronic address: · Surgical Oncology, University of Newcastle, Calvary Mater Newcastle Hospital, Locked Bag 7, HRMC, Newcastle, NSW 2310, Australia. Electronic address: · Department of Pathology, European Institute of Oncology and University of Milan, Via Giuseppe Ripamonti, 435, 20141 Milan, Italy. Electronic address: · Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University, Charterhouse Square, London EC1M 6BQ, UK. Electronic address: · Academic Department of Biochemistry, Royal Marsden Hospital, and Endocrinology, Breakthrough Breast Cancer Centre, Institute of Cancer Research, Fulham Road, London SW3 6JJ, UK. Electronic address: · Cancer Research UK Clinical Trials Unit, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK. Electronic address: · Pubmed 28494403
  • Institute of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland. · Private Group Practice for Pathology and PathoPlan GbR, Lübeck, Germany. · Department of Pathology and Laboratory of Pathology, West China Hospital, Sichuan University, Chengdu, China. · Institute of Pathology, University Erlangen-Nürnberg, Erlangen, Germany. · Centre Jean Perrin, Centre regional de Lutte contre le cancer d'Auvergne, Clermont-Ferrand, France. · European Institute of Oncology, University of Milan, Milan, Italy. · Institute of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Pathology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China. · Institute of Pathology, Klinikum Region Hannover, Hannover, Germany. · BioNTech Diagnostics GmbH, Mainz, Germany. · Department of Oncology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland. · ACOMED Statistik, Leipzig, Germany. · Department of Pathology, Heidelberg University Hospital, Heidelberg, Germany. · Transformative Pathology, Ontario Institute for Cancer Research (OICR), Toronto, ON, Canada. · Pubmed 28490348
  • Istituto Europeo di Oncologia, Milan, Italy. · IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy. · Dipartimento di Oncologia e Emato-oncologia, Università degli Studi di Milano, Milan, Italy. · Istituto Europeo di Oncologia, Milan, Italy · Pubmed 28298340
  • Department of Surgery and Cancer, Imperial College London, London, UK. · Department of Experimental Oncology, European Institute of Oncology Milan, Italy. · Hematology Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, IT. · Swammerdam Institute for Life Sciences, University of Amsterdam. · Genomics Division, Lawrence Berkeley National Laboratory, 1 Cyclotron Road, Berkeley, CA, USA. · Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Arcavacata di Rende (CS), Italy. · Division of Stem Cells and Cancer, Deutsches Krebsforschungszentrum (DKFZ), and Institute for Stem Cell Technology and Experimental Medicine GmbH, Heidelberg, Germany. · Division of Pathology, European Institute of Oncology and University of Milan, School of Medicine, Milan, Italy. · Department of Oncology and Hemato-oncology, University of Milano, Milan, IT. · Division of Medical Senology, European Institute of Oncology, IEO, Milan, Italy. · Department of Biosciences, University of Milano, Milan, IT. · Pubmed 28112739
  • Division of Breast Surgery, European Institute of Oncology, Milan, Italy. Electronic address: · Division of Breast Surgery, European Institute of Oncology, Milan, Italy. · Division of Plastic and Reconstructive Surgery, European Institute of Oncology, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Division of Cancer Prevention and Genetics, European Institute of Oncology, Milan, Italy. · Early Drug Development for Innovative Therapies Division, European Institute of Oncology, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy; University of Milan, School of Medicine, Milan, Italy. · Division of Breast Surgery, European Institute of Oncology, Milan, Italy; University of Milan, School of Medicine, Milan, Italy. · Pubmed 27810700
2016
  • IBCSG Central Pathology Laboratory, Department of Pathology and Laboratory Medicine, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · University of Milan, Milan, Italy. · International Breast Cancer Study Group (IBCSG) Statistical Center, Boston, MA, USA. · Harvard T. H. Chan School of Public Health, Boston, MA, USA. · IBCSG Central Pathology Laboratory, Department of Pathology and Laboratory Medicine, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · University of Milan, Milan, Italy. · Division of Experimental Therapeutics, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · National Institute of Oncology, Ráth György u. 7/9, Budapest, 1122, Hungary. · Breast Center St. Gallen, Kantonsspital, St. Gallen, Switzerland. · Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. · Divisione di Oncologia, Ospedale degli Infermi, Viale Settembrini 2, 47923, Rimini, Italy. · Program for Breast Health, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · International Breast Cancer Study Group, Translational Research Coordination and Central Pathology Office, IBCSG Coordinating Center, Effingerstrasse 40, 3008, Bern, Switzerland. · Frontier Science and Technology Research Foundation, Boston, MA, USA. · Division of Medical Senology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Harvard Medical School, Boston, MA, USA. · Pubmed 27372069
  • Department of Pathology, European Institute of Oncology and University of Milan, Via Ripamonti 435, 20141, Milan, Italy. · Department of Statistics, European Organization for Research and Treatment of Cancer, Brussels, Belgium. · Medical Affairs, Agendia, Amsterdam, The Netherlands. · Department of Pathology, European Institute of Oncology and University of Milan, Via Ripamonti 435, 20141, Milan, Italy. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA. · Department of Surgery, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal. · Pubmed 26820652
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium2Medical Oncology Clinic, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Breast and Gynecological Surgery, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark6Danish Breast Cancer Cooperative Group, Copenhagen, Denmark. · Department of Pathology, European Institute of Oncology, University of Milan, Milan, Italy. · Avera Cancer Institute, Sioux Falls, South Dakota. · International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · International Breast Cancer Study Group Coordinating Center and Central Pathology Office, Bern, Switzerland. · Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark6Danish Breast Cancer Cooperative Group, Copenhagen, Denmark11Department of Oncology, Odense University Hospital, Odense, Denmark12AgeCare, Odense University Hospital, Odense. · Medical Oncology Clinic, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Villejuif, France14INSERM U1018, CESP, Université Paris-Sud, Villejuif France. · Pubmed 26633571
  • Division of Cancer Prevention and Genetics, European Institute of Oncology, Via Ripamonti 435, Milan, 20141, Italy. · International Breast Cancer Study Group (IBCSG) Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard T. H. Chan School of Public Health, 450 Brookline Avenue, Boston, MA, 02215, USA. · Institute of Oncology of Southern Switzerland (IOSI), Bellinzona, Switzerland. · International Breast Cancer Study Group, Bern, Switzerland. · Swiss Group for Clinical Cancer Research SAKK, Lugano Viganello, Switzerland. · IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA, 02215, USA. · Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Via Ripamonti 435, Milan, 20141, Italy. · Division of Cancer Prevention and Genetics, European Institute of Oncology, Via Ripamonti 435, Milan, 20141, Italy. · International Breast Cancer Study Group (IBCSG) Coordinating Center, Effingerstrasse 40, Bern, CH-3008, Switzerland. · Division of Medical Senology, European Institute of Oncology, Via Ripamonti 435, Milan, 20141, Italy. · IBCSG Statistical Center, Frontier Science and Technology Research Foundation, Boston, MA, USA. · Dana-Farber Cancer Institute, Department of Biostatistics and Computatonal Biology, 450 Brookline Ave, Boston, MA, 02215, USA. · International Breast Cancer Study Group and University of Sydney School of Public Health, Sydney, Australia. · IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Harvard Medical School, Frontier Science and Technology Research Foundation, 450 Brookline Avenue, Boston, MA, 02215, USA. · Program for Breast Health, European Institute of Oncology, Via Ripamonti 435, Milan, 20141, Italy. · Translational Research Coordination and Central Pathology Office, IBCSG Coordinating Center, Effingerstrasse 40, Bern, CH-3008, Switzerland. · Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · National Cancer Institute of Canada, Kingston, ON, Canada. · Pubmed 27825388
  • Medical Oncology Division & Breast Unit, 72100 Brindisi, Italy. Electronic address: · Pathology Division, European Institute of Oncology, University of Milan, 20141 Milan, Italy. · Medical Oncology & Breast Unit, University of Verona, Azienda Ospedaliera Universitaria Integrata, 37134 Verona, Italy. · Medical Oncology Division & Breast Unit, 72100 Brindisi, Italy. · Biostatistics, Regina Elena National Cancer Institute, 00144 Rome, Italy. · Pubmed 27750105
  • University of Milan, Istituto Europeo di Oncologia, Milan, Italy. · UCL Advanced Diagnostics, London, UK. · Clarient Pathology Services, Aliso Viejo, CA, USA. · Dako, An Agilent Technologies Company, Glostrup, Denmark. · Dx-Rx Institute, Baunevaenget 76, DK-3480 Fredensborg, Denmark. Electronic address: · Pubmed 27461826
  • Institute of Pathology, Charité Universitätsmedizin Berlin, Berlin, Germany. · German Cancer Consortium (DKTK), Partner site Berlin, Berlin, Germany. · VMscope GmbH, Berlin, Germany. · Service de Biostatistique et d'Epidémiologie; Institute Gustave Roussy, Villejuif, France. · German Breast Group (GBG), Neu-Isenburg, Germany. · Clinic of Gynecology and Obstetrics, Sana Klinikum Offenbach, Offenbach, Germany. · Indiana University School of Medicine, Indianapolis, IN, USA. · Clinical Institute of Pathology, Medizinische Universität Wien, Wien, Austria. · Department of Pathology & Molecular Medicine, McMaster University, Hamilton, ON, Canada. · Weill Cornell Medical College, Doha, Qatar. · Harvard Medical School, Boston, MA, USA. · Tumor Pathology Department, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice, Poland. · Institut für Pathologie, Medizinische Hochschule Hannover, Hannover, Germany. · Pathology, GZA Ziekenhuizen, Sint-Augustinus, Wilrijk, Belgium. · Radiation Oncology and Pathology, Weill Cornell Medical College, New York, NY, USA. · Department of Pathology and Cytology GZA Hospitals, Wilrijk, Belgium. · Department of Pathology University Hospitals Leuven, Leuven, Belgium. · Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · Anatomical Pathology, Vancouver Hospital, Vancouver, BC, Canada. · Division of Pathology, NSABP, Pittsburgh, PA, USA. · Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, ON, Canada. · UQ School of Medicine and Pathology Queensland, The University of Queensland Centre for Clinical Research, Brisbane, QLD, Australia. · ERTICa Research Team, Department of Pathology, Jean Perrin Comprehensive Cancer Center, University of Auvergne EA4677, Clermont-Ferrand, France. · Division of Pathology and Laboratory Medicine, University of Milan, Milan, Italy. · Department of Pathology, Yale University School of Medicine, New Haven, CT, USA. · Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA, USA. · Department for Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Sektion Gynäkopathologie, Pathologisches Institut, University of Heidelberg, Heidelberg, Germany. · Anatomie Pathologique, Institut Jules Bordet, Brussels, Belgium. · Molecular Diagnostic Oncology, Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Department of Pathology, European Institute of Oncology, University of Milan, Milan, Italy. · Department of Pathology, Netherlands Cancer Institute, Amsterdam, Netherlands. · Jules Bordet Institute, Brussels, Belgium. · Department of Gynecology, Helios-Klinikum Berlin-Buch, Berlin, Germany. · Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen EMN, Friedrich-Alexander University Erlangen, Erlangen, Germany. · Department of Gynecology, Klinikum Südstadt Rostock, Rostock, Germany. · Molecular Immunology Unit, Institut Jules Bordet, Brussels, Belgium. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Univ. Paris Sud, Univ. Paris-Saclay, Villejuif, France. · Division of Research and Clinical Medicine, Peter MacCallum Cancer Center, Melbourne, VIC, Australia. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Brussels, Belgium. · Pubmed 27363491
  • Division of Experimental Therapeutics, University of Milan-Bicocca, Milan, Italy. · Division of Epidemiology and Biostatistics, University of Milan-Bicocca, Milan, Italy Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy. · Department of Pathology, School of Medicine, University of Milan, Milan, Italy. · Division of Epidemiology and Biostatistics, University of Milan-Bicocca, Milan, Italy. · Breast Health Program, European Institute of Oncology, Milan, Italy. · Division of Experimental Therapeutics, University of Milan-Bicocca, Milan, Italy · Pubmed 27354620
  • IFOM, the FIRC Institute of Molecular Oncology, Milan, Italy. · IFOM, the FIRC Institute of Molecular Oncology, Milan, Italy Department of Pediatrics, Graduate School of Medicine The University of Tokyo, Tokyo, Japan. · Molecular Medicine Program, European Institute of Oncology, Milan, Italy. · Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy Department of Pathology, European Institute of Oncology, Milan, Italy. · IFOM, the FIRC Institute of Molecular Oncology, Milan, Italy Molecular Medicine Program, European Institute of Oncology, Milan, Italy Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy. · IFOM, the FIRC Institute of Molecular Oncology, Milan, Italy Molecular Medicine Program, European Institute of Oncology, Milan, Italy. · Institut Curie, PSL Research University, Paris Cedex 05, France Centre National de la Recherche Scientifique, Unité Mixte de Recherche 144 CNRS UMR 144, Paris Cedex 05, France. · IFOM, the FIRC Institute of Molecular Oncology, Milan, Italy Molecular Medicine Program, European Institute of Oncology, Milan, Italy · Pubmed 27255086
  • Division of Research and Clinical Medicine, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Frontier Science Foundation- Hellas, Athens, Greece3University of Athens, Athens, Greece. · Frontier Science Foundation- Hellas, Athens, Greece4Athens University of Economics and Business, Athens, Greece. · Frontier Science Foundation- Hellas, Athens, Greece. · Avera Cancer Institute, Department of Molecular and Experimental Medicine, Sioux Falls, South Dakota. · Department of Pathology, University of Chicago, Chicago, Illinois. · BREAST Datacentre, Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. · University of Milan, European Institute of Oncology, Milan, Italy. · Targos Molecular Pathology GmbH, Kassel, Germany. · Department of Medicine, Institute Jules Bordet, Universite Libre de Bruxelles and Breast International Group (BIG), Brussels, Belgium12Breast International Group (BIG), Brussels, Belgium. · Royal Marsden Hospital, London, England. · INSERM U1018 CESP, Service de Biostatistique et d'Epidémiologie, Villejuif, France. · Pubmed 27100299
2015
  • Department of Histopathology and NIH Cambridge Biomedical Research Centre, Addenbrooke's Hospital, Cambridge, UK. · Department of Pathology, Yale University, New Haven, CT, USA. · Department of Pathology, European Institute of Oncology and University of Milan, Milan, Italy. · Edinburgh Cancer Research UK Centre,University of Edinburgh, Edinburgh, UK. · Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA. · Institute of Pathology, Charité Hospital, Berlin, Germany. · Department of Biopathology, Institut Bergonié, Bordeaux, France. · Department of Pathology, Centre Jean Perrin and Université d'Auvergne, Clermont-Ferrand, France. · Division of Subspecialty General Surgery, Mayo Clinic, Rochester, MN, USA. · Early Drug Development for Innovative Therapies Division, European Institute of Oncology, Milan, Italy. · Edinburgh Breast Unit, Western General Hospital, Edinburgh, UK. · Carol Franc Buck Breast Care Center, University of California, San Francisco, CA, USA. · Department of Radiotherapy and Radiation Oncology, Landeskrankenhaus, Paracelsus Medical University, Salzburg, Austria. · Department of Gynecology and Obstetrics, Interdisciplinary Breast Center, Klinikum Esslingen, Esslingen, Germany. · Institute of Pathology, Medical University of Graz, Graz, Austria. · Department of Gynecology, General Hospital Leoben, Leoben, Austria. · German Breast Group, Neu-Isenburg, and Department of Gynecology and Obstetrics, University Women's Hospital, Frankfurt, Germany. · Department of Radiation Oncology, Ohio State University, Columbus, OH, USA. · Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 26205180
  • Avera Cancer Institute, 1000 E 23rd Street, Sioux Falls, SD, 57105, USA. · Department of Biostatistics and Computational Biology, International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard T. H. Chan School of Public Health, 450 Brookline Ave, Boston, MA, 02215, USA. · VM Institute of Research, 6100 Av Royalmount, Montréal, QC, H4P 2R2, Canada. · AKESOgen, Inc., 3155 Northwoods Pl NW, Norcross, GA, 30071, USA. · Avera Cancer Institute, 1000 E 23rd Street, Sioux Falls, SD, 57105, USA. · Genomic and Molecular Pathology, University of Chicago, 900 E 57th St. Room 1260D, Chicago, IL, 60637, USA. · International Breast Cancer Study Group Coordinating Center and Central Pathology Office, Effingerstrasse 40, 3008, Bern, Switzerland. · Division of Pathology and Laboratory Medicine, International Breast Cancer Study Group Central Pathology Office, European Institute of Oncology, Via Ripamonti 435, 20146, Milan, Italy. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, Via Ripamonti 435, 20146, Milan, Italy. · Breast Center, Kantonsspital St. Gallen, Rorschacher Strasse 95, 9007, St. Gallen, Switzerland. · Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. · International Breast Cancer Study Group, Bern, Switzerland. · International Breast Cancer Study Group, Bern, Switzerland. · Auckland City Hospital, PO Box 26498, Epsom, Auckland, 1344, New Zealand. · Australia and New Zealand Breast Cancer Trials Group, Newcastle, Australia. · Department of Oncology, Multidisciplinary Breast Center, KULeuven (University of Leuven), University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium. · Institute Georges François Leclerc, 1 Rue Professeur Marion, BP 77 980, 21079, Dijon Cedex, France. · International Breast Cancer Study Group Coordinating Center, Effingerstrasse 40, 3008, Bern, Switzerland. · International Breast Cancer Study Group Statistical Center, Frontier Science and Technology Research Foundation, 450 Brookline Ave, Boston, MA, 02215, USA. · International Breast Cancer Study Group, Bern, Switzerland. · University of Sydney, Sydney, Australia. · International Breast Cancer Study Group, Bern, Switzerland. · Program for Breast Health (Senology), European Institute of Oncology, Via Ripamonti 435, 20146, Milan, Italy. · International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, Harvard T.H. Chan School of Public Health, Frontier Science and Technology Research Foundation, 450 Brookline Ave, Boston, MA, 02215, USA. · International Breast Cancer Study Group, Bern, Switzerland. · Institute of Oncology of Southern Switzerland (IOSI), Ospedale Italiano, Via Capelli, 6962, Viganello, Switzerland. · International Breast Cancer Study Group Central Pathology Office, Division of Pathology and Laboratory Medicine, European Institute of Oncology, University of Milan, Via Ripamonti 435, 20146, Milan, Italy. · Division of Hematology/Oncology, University of Michigan Comprehensive Cancer Center, 1500 E Medical Cntr Drive/SPC 5946, Ann Arbor, MI, 48109, USA. · Department of Biostatistics and Computational Biology, International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave, Boston, MA, 02215, USA. · Pubmed 26590813
  • Division of Medical Oncology, E.O. Ospedali Galliera, Genoa, Italy. Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom. · Office of the Scientific Director, E.O. Ospedali Galliera, Genoa, Italy. · Divisions of Cancer Prevention and Genetics, European Institute of Oncology, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy. · Division of Breast Surgery, European Institute of Oncology, Milan, Italy. · Division of Medical Oncology, E.O. Ospedali Galliera, Genoa, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy. University of Milan, School of Medicine, Milan, Italy. · Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom. · Pubmed 26276754
  • Division of Medical Senology, European Institute of Oncology, Milan, Italy. Electronic address: · Division of Epidemiology and Biostatistics, European Institute of Oncology, and Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Department of Pathology, European Institute of Oncology, Milan, Italy; University of Milan School of Medicine, Milan, Italy. · Department of Pathology, European Institute of Oncology, Milan, Italy. · University of Milan School of Medicine, Milan, Italy; Division of Senology, European Institute of Oncology, Milan, Italy. · Division of Senology, European Institute of Oncology, Milan, Italy. · Program of Senology (Breast Health), European Institute of Oncology, Milan, Italy. · Pubmed 25933934
  • Division of Experimental Therapeutics, Breast Health Program, Istituto Europeo di Oncologia, Italy. Electronic address: · Division of Epidemiology and Biostatistics, Istituto Europeo di Oncologia, Italy; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milano, Italy. · Laboratory Division of Hematology-Oncology, Italy. · Department of Experimental Oncology, Italy; University of Milano, School of Medicine, Milano, Italy. · Division of Experimental Therapeutics, Breast Health Program, Istituto Europeo di Oncologia, Italy. · Department of Pathology, Istituto Europeo di Oncologia, Italy; University of Milano, School of Medicine, Milano, Italy. · Pubmed 25772326
  • Department of Biostatistics and Computational Biology, International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Mailstop CLS-11007, Boston, MA, 02215, USA. · Institute of Oncology of Southern Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Lugano Viganello, Switzerland. · Peter MacCallum Cancer Center, St Vincent's Hospital, University of Melbourne, Melbourne, VIC, Australia. · Australia & New Zealand Breast Cancer Trials Group (ANZBCTG), University of Newcastle, Callaghan, NSW, Australia. · The University of Chicago Medical Center and Alliance for Clinical Trials in Oncology, Chicago, IL, USA. · Tom Baker Cancer Centre and NCIC Clinical Trials Group, Calgary, AB, Canada. · International Breast Cancer Study Group Coordinating Center and Central Pathology Office, Bern, Switzerland. · International Breast Cancer Study Group Central Pathology Office, Department of Pathology, European Institute of Oncology, Milan, Italy. · International Breast Cancer Study Group Central Pathology Office, Department of Pathology, European Institute of Oncology, Milan, Italy. · Pathological Department, National Institute of Oncology, Budapest, Hungary. · Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru. · Division of Pathology, Salvatore Maugeri Foundation, Pavia, Italy. · Struttura Operativa Complessa di Anatomia Patologica, Azienda Ospedaliero-Universitaria di Udine, Udine, Italy. · Kantonsspital St. Gallen, Swiss Group for Clinical Cancer Research (SAKK), St. Gallen, Switzerland. · University of Insubria-Ospedale di Circolo and Fondazione Macchi, Varese, Italy. · Department of Pathology, Vall d'Hebron University Hospital, SOLTI Group, Barcelona, Spain. · Pathology Department, Hospital Universitario «12 de Octubre», i+12, Universidad Complutense Madrid, SOLTI Group, Madrid, Spain. · Laboratoire Anatomopathologie, Institut Bergonié, Bordeaux, France. · EORTC, Brussels, Belgium. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Program for Breast Health, European Institute of Oncology, Milan, Italy. · International Breast Cancer Study Group Statistical Center, Frontier Science and Technology Research Foundation, Boston, MA, USA. · University of Sydney, Sydney, Australia. · International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Harvard T.H. Chan School of Public Health, Boston, MA, USA. · Frontier Science and Technology Research Foundation, Boston, MA, USA. · International Breast Cancer Study Group Central Pathology Office, European Institute of Oncology, University of Milan, Milan, Italy. · Pubmed 26493064
  • Targos Molecular Pathology GmbH, Kassel, Germany. · Institute of Pathology, University of Cologne, Cologne, Germany. · Institute of Pathology Nordhessen, Kassel, Germany. · Institute of Pathology, University of Göttingen, Göttingen, Germany. · Department of Pathology, University of Milan and European Institute of Oncology, Milan, Italy. · Nazarbayev University School of Medicine, Astana, Kazakhstan. · Clinic for Gynecology and Obstetrics, Helios Klinikum Berlin-Buch, Berlin, Germany. · Pubmed 26403781
  • Division of Medical Senology, European Institute of Oncology, Milan, Italy. Electronic address: · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy. · Division of Laboratory Medicine, European Institute of Oncology, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Department of Medicine, European Institute of Oncology, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy; School of Medicine, University of Milan, Milan, Italy. · Division of Senology, European Institute of Oncology, Milan, Italy. · Pubmed 26362840
  • Division of Medical Senology, European Institute of Oncology, Milan, Italy. Electronic address: · Department of Quantitative Methods and Statistics, University of Milan-Bicocca, Milan, Italy; Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Department of Pathology, European Institute of Oncology, Milan, Italy; School of Medicine, University of Milan, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Division of Senology, European Institute of Oncology, Milan, Italy. · Department of Pathology, European Institute of Oncology, Milan, Italy. · Program of Senology (Breast Health), European Institute of Oncology, Milan, Italy. · Pubmed 26255932
  • University of Milan, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy. Electronic address: · Pubmed 26255744
  • Johns Hopkins Kimmel Comprehensive Cancer Center, Baltimore, MD. · University of Utah School of Medicine and Intermountain Healthcare, Salt Lake City, UT. · University of Rochester Medical Center, Rochester, NY. · Stanford University Medical Center, Stanford, CA. · Ontario Institute for Cancer Research, Toronto, Ontario, Canada. · University of Western Sydney and Healthscope Pathology, Sydney, New South Wales, Australia. · St Jude Medical Center, Fullerton, CA. · Sunnybrook Health Sciences Center, Toronto, Ontario, Canada. · Mayo Clinic, Rochester, MN. · American Society of Clinical Oncology, Alexandria, VA. · National Adjuvant Surgical Breast and Bowel Project, Pittsburgh, PA. · Mayo Clinic, Jacksonville, FL. · University of Southern California, Los Angeles, CA. · North Carolina State University, Raleigh, NC. · Indiana University Medical Center, Indianapolis, IN. · University of Milan, European Institute of Oncology, Milan, Italy. · Royal Marsden Hospital, London, United Kingdom. · National Cancer Institute, Bethesda, MD. · University of Michigan Comprehensive Cancer Care Center, Ann Arbor, MI. · Pubmed 25753441
  • BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Division of Pathology, European Institute of Oncology, Milan, Italy. · Fertility and Procreation Unit, Department of Gynecology Oncology, European Institute of Oncology, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy; University of Milan, School of Medicine, Milan, Italy. · Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Pubmed 25702955
  • Biometric Research Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland, USA. · Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy. · Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK. · Transformative Pathology, Ontario Institute for Cancer Research, Toronto, Ontario, Canada. · The Emmes Corporation, Rockville, Maryland, USA. · Indiana University Simon Cancer Center, Indianapolis, Indiana, USA. · Department of Pathology and Molecular Medicine, Juravinski Hospital and Cancer Centre, McMaster University, Hamilton, Ontario, Canada. · Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Lund, Sweden. · Montefiore Medical Center and the Albert Einstein College of Medicine, Bronx, New York, USA. · Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. · PhenoPath Laboratories, Seattle, Washington, USA. · Lester and Sue Smith Breast Center and Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas, USA. · Department of Laboratory Medicine and Pathology, University of Alberta, Alberta, Canada. · Department of Pathology, Kawasaki Medical School, Kurashiki City, Japan. · Department of Pathology, Hakuaikai Sagara Hospital, Matsubaracho, Kagoshima, Japan. · Department of Pathology, Centre Jean Perrin and Université d'Auvergne, Clermont-Ferrand, France. · Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK. · Department of Pathology, Jichi Medical University, Shimotsuke, Tochigi, Japan. · Institut Jules Bordet, Brussels, Belgium. · Birmingham Heart of England, National Health Service, Birmingham, UK. · Slagelse Hospital, Slagelse, Region Sjælland, Denmark. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, and University of Milan, Milan, Italy. · Academic Department of Biochemistry, Royal Marsden Hospital, London, UK. · Breast Oncology Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, USA. · Pubmed 25698062
  • Molecular Medicine Program, Department of Experimental Oncology, European Institute of Oncology, Milan, Italy. · Molecular Medicine Program, Department of Experimental Oncology, European Institute of Oncology, Milan, Italy; Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Molecular Medicine Program, Department of Experimental Oncology, European Institute of Oncology, Milan, Italy; IFOM, The FIRC Institute for Molecular Oncology Foundation, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy; School of Medicine, University of Milan, Milan, Italy. · Molecular Medicine Program, Department of Experimental Oncology, European Institute of Oncology, Milan, Italy; IFOM, The FIRC Institute for Molecular Oncology Foundation, Milan, Italy; Center for Genomic Science of IIT@SEMM, Istituto Italiano di Tecnologia (IIT), Milan, Italy. · Molecular Medicine Program, Department of Experimental Oncology, European Institute of Oncology, Milan, Italy; IFOM, The FIRC Institute for Molecular Oncology Foundation, Milan, Italy; Department of Scienze della Salute, University of Milan, Milan, Italy. Electronic address: · Molecular Medicine Program, Department of Experimental Oncology, European Institute of Oncology, Milan, Italy. Electronic address: · Pubmed 25459350
2014
  • Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada. · Institute of Pathology Nordhessen, Kassel, Germany. · Healthscope Pathology, Norwest Private Hospital, Bella Vista, NSW, Australia. · State of São Paulo Cancer Institute (ICESP), São Paulo, Brazil. · Royal Marsden Hospital, London, UK. · International University of Health and Welfare (IUHW), Center for Diagnostic Pathology, IUHW Mita Hospital, Tokyo, Japan. · Centre Jean Perrin and University of Auvergne, EA 4233, Clermont-Ferrand, France. · The Academic Medical Center (AMC), The University of Amsterdam, Amsterdam, The Netherlands. · University of Milan and European Institute of Oncology, Milan, Italy. · Pubmed 23807776
  • Division of Medical Senology, European Institute of Oncology, Milan, Italy. Electronic address: · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Division of Prevention and Genetics, European Institute of Oncology, Milan, Italy. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy; University of Milan School of Medicine, Milan, Italy. · Division of Senology, European Institute of Oncology, Milan, Italy; University of Milan School of Medicine, Milan, Italy. · Division of Senology, European Institute of Oncology, Milan, Italy. · Scientific Direction, European Institute of Oncology, Milan, Italy. · Pubmed 24742826
  • Division of Medical Senology, European Institute of Oncology, Milan, Italy. Electronic address: · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy; Department of Statistics and Quantitative Methods, Unit of Biostatistics, Epidemiology and Public Health, University of Milan-Bicocca, Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy; School of Medicine, University of Milan, Italy. · School of Medicine, University of Milan, Italy; Molecular Senology Unit, European Institute of Oncology, Milan, Italy. · Division of Senology, European Institute of Oncology, Milan, Italy. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy. · Vice-Scientific Director, European Institute of Oncology, Milan, Italy. · Pubmed 24325948
  • Early Drug Development for Innovative Therapies Division, Department of Medicine, European Institute of Oncology, Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Department of Breast Oncology, National Cancer Institute "Fondazione Pascale", Naples, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy. · Department of Endocrinology and Molecular and Clinical Oncology, University of Naples Federico II, Napoli, Italy. · Department of Advanced Medical Sciences, Operative Unit of General Surgery and Transplants, University of Naples Federico II, Napoli, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy; University of Milan School of Medicine, Milan, Italy. · Early Drug Development for Innovative Therapies Division, Department of Medicine, European Institute of Oncology, Milan, Italy. Electronic address: · Pubmed 24314620
  • European Institute of Oncology, Medical Oncology, via Ripamonti 435, Milan, Italy. Electronic address: · European Institute of Oncology, Division of Epidemiology and Biostatistics, via Ripamonti 435, Milan, Italy. · European Institute of Oncology, Division of Pathology, via Ripamonti 435, Milan, Italy; University of Milan, School of Medicine, Milan, Italy. · European Institute of Oncology, Division of Epidemiology and Biostatistics, via Ripamonti 435, Milan, Italy; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, via Bicocca degli Arcimboldi 8, 20126 Milan, Italy. · European Institute of Oncology, Medical Oncology, via Ripamonti 435, Milan, Italy. · Second University of Naples, Medical Oncology, via Pansini 5, Naples, Italy. · Pubmed 24269135
  • Unit of Investigative Clinical Oncology (INCO), Fondazione del Piemonte per l'Oncologia, Institute for Cancer Research and Treatment (IRCCs), Candiolo, Italy. · Division of Medical Oncology, European Institute of Oncology, Milan, Italy. · Division of Medical Oncology, Fondazione del Piemonte per l'Oncologia, Institute for Cancer Research and Treatment (IRCCs), Candiolo, Italy. · University of Turin, Department of Biomedical Sciences and Human Oncology, Turin, Italy. · Department of Pathology and Laboratory Medicine, European Institute of Oncology, University of Milan, Milan, Italy. · Unit of Investigative Clinical Oncology (INCO), Fondazione del Piemonte per l'Oncologia, Institute for Cancer Research and Treatment (IRCCs), Candiolo, Italy; Division of Medical Oncology, Fondazione del Piemonte per l'Oncologia, Institute for Cancer Research and Treatment (IRCCs), Candiolo, Italy. Electronic address: · Pubmed 24210572
  • Division of Medical Senology, European Institute of Oncology, Milan, Italy. Electronic address: · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Division of Pathology and Laboratory Medicine, European Institute of Oncology and University of Milan, Italy. · Integrated Breast Surgery Unit, European Institute of Oncology and University of Milan, Italy. · Division of Senology, European Institute of Oncology, Milan, Italy. · Division of Radiation Oncology, European Institute of Oncology, Milan, Italy. · Department of Medicine, European Institute of Oncology, Milan, Italy. · Pubmed 24183613
  • Department of Medical Oncology, European Institute of Oncology, Milan, Italy. Electronic address: · Department of Medical Oncology, European Institute of Oncology, Milan, Italy. · Department of Pathology, European Institute of Oncology, Milan, Italy; University of Milan, School of Medicine, Italy. · Pubmed 24508454
2013
  • University of Milan School of Medicine, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy. Electronic address: · Pubmed 24074800
2011
  • Department of Pathology and Laboratory Medicine, European Institute of Oncology, University of Milan, Milan, Italy. · Pubmed 22015299
2009
  • Department of Pathology and Laboratory Medicine, European Institute of Oncology, University of Milan School of Medicine, Via Ripamonti 435, Milan, Italy. · Pubmed 19914539
  • Department of Pathology, European Institute of Oncology, University of Milan School of Medicine, Milan, Italy. · Pubmed 19775600
  • Division of Pathology, European Institute of Oncology, Università degli Studi di Milano, Milan, Italy. · Pubmed 19670216
2008
  • Division of Pathology and Laboratory Medicine, European Institute of Oncology, University of Milan, Milan, Italy. · Pubmed 18981464
2017
  • From the German Breast Group, Neu-Isenburg, Germany (G.M.); Frontier Science (Scotland), Kincraig, United Kingdom (M. Procter); the Breast European Adjuvant Study Team (BrEAST) Data Center (E.A., N.R.), the Breast International Group (D.Z., A.A.), and Institut Jules Bordet, Université Libre de Bruxelles (M. Piccart) - all in Brussels; Roche Pharma (M.B., E.C., A.K.) and the Department of Cardiology, Cardio-Oncology, Bern University Hospital (T.S.) - both in Bern, Switzerland; the Department of Pathology, European Institute of Oncology, University of Milan, Milan (G.V.); the National Institute of Oncology, Budapest, Hungary (I.L.); Centre François Baclesse, Caen, France (C.L.); the Sarah Cannon Research Institute and Tennessee Oncology, Nashville (D.A.Y.); Instituto Nacional de Câncer, Rio de Janeiro (J. Bines); Dana-Farber Cancer Institute, Harvard Medical School, Harvard T. H. Chan School of Public Health, and Frontier Science and Technology Research Foundation - all in Boston (R.D.G.); and the Department of Medicine, Memorial Sloan Kettering Cancer Center, New York (J. Baselga). · Pubmed 28581356
  • *School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, NY †Istituto Europeo di Oncologia, University of Milan, Milan, Italy ‡UCL Advanced Diagnostics, London, UK §Dako A/S, Glostrup, Denmark. · Pubmed 26657878
2016
  • From Champalimaud Clinical Center-Champalimaud Foundation, Lisbon, Portugal (F.C.); Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (L.J.V.); European Organization for Research and Treatment of Cancer Headquarters (J.B., L. Slaets, V.G., B.M., K.T.), Breast International Group Headquarters (T.G., C. Straehle), and Institut Jules Bordet, Université Libre de Bruxelles (C. Sotiriou, M.P.), Brussels, and Centre Hospitalier Universitaire Université Catholique de Louvain, Namur (P.V.) - both in Belgium; University of Milan and Istituto Europeo di Oncologia (G.V.) and Europa Donna-European Breast Cancer Coalition (S.K.), Milan, and Azienda Istituti Ospitalieri di Cremona, Cremona (R.P.) - both in Italy; Gustave Roussy, Villejuif (S.D., M.S.), Institut Curie Paris Sciences et Lettres, Université Paris Descartes, Sorbonne Paris Cité, Paris (J.-Y.P.). Institut Curie-Hôpital Rene Huguenin, Saint-Cloud (E.B.), and Centre Georges-Francois-Leclerc, Dijon (S.C.) - all in France; Swiss Institute of Bioinformatics and University of Lausanne, Lausanne, Switzerland (M.D.); Agendia (A.M.G., L. Stork) and the Netherlands Cancer Institute (R.B., E.R.), Amsterdam, Alrijne Ziekenhuis, Rijnland Leiderdorp (P.A.N.), Jeroen Bosch Hospital, 's-Hertogenbosch (T.J.S.), and Medisch Centrum Alkmaar, Alkmaar (J.M.H.) - all in the Netherlands; Institute of Oncology, Ljubljana, Slovenia (E.M.); Evangelisches Krankenhaus Bethesda, Duisburg, Germany (U.N.); University of Texas Health Sciences Center, San Antonio (P.R.); Hospital Universitario Vall d'Hebron, Barcelona (I.T.R.); Imperial College London, London (G.T.); and University of Texas M.D. Anderson Cancer Center, Houston (A.M.T.). · Pubmed 27557300
  • Marco Colleoni, Giuseppe Viale, and Aron Goldhirsch, European Institute of Oncology; Giuseppe Viale, University of Milan, Milan; Lorenzo Gianni, Ospedale degli Infermi, Rimini; Fabio Puglisi, University Hospital of Udine, University of Udine, Udine; Carlo Tondini, Osp. Papa Giovanni XXIII, Bergamo; Katia Cagossi, Ospedale di Carpi, Carpi, Italy; Kathryn P. Gray, Shari Gelber, Richard D. Gelber, Meredith M. Regan, and Karen N. Price, International Breast Cancer Study Group Statistical Center; Kathryn P. Gray, Shari Gelber, Richard D. Gelber, and Meredith M. Regan, Dana-Farber Cancer Institute; Kathryn P. Gray and Richard D. Gelber, Harvard T.H. Chan School of Public Health; Richard D. Gelber and Meredith M. Regan, Harvard Medical School; Richard D. Gelber and Karen N. Price, Frontier Science and Technology Foundation, Boston, MA; István Láng, National Institute of Oncology, Budapest, Hungary; Beat Thürlimann, Kantonsspital, St Gallen; Beat Thürlimann, Elena Kralidis, and Daniel Rauch, Swiss Group for Clinical Cancer Research, Bern; Elena Kralidis, Kantonsspital Aarau, Aarau; Daniel Rauch, Spital Thun, Thun, Switzerland; Ehtesham A. Abdi, The Tweed Head Hospital, Tweed Heads, New South Wales and Griffith University, Southport, Queensland; Ehtesham A. Abdi and Jacquie Chirgwin, Australia and New Zealand Breast Cancer Trials Group; Jacquie Chirgwin, Box Hill and Maroondah Hospitals and Monash University, Melbourne, Victoria; Alan S. Coates, International Breast Cancer Study Group and University of Sydney School of Public Health, Sydney, New South Wales, Australia; Henry L. Gomez, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru; Barbro K. Linderholm, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, and Sahlgrenska University Hospital, Gothenburg, Sweden; and Alexandru Eniu, Cancer Institute Ion Chiricuta, Cluj, Romania. · Marco Colleoni, Giuseppe Viale, and Aron Goldhirsch, European Institute of Oncology; Giuseppe Viale, University of Milan, Milan; Lorenzo Gianni, Ospedale degli Infermi, Rimini; Fabio Puglisi, University Hospital of Udine, University of Udine, Udine; Carlo Tondini, Osp. Papa Giovanni XXIII, Bergamo; Katia Cagossi, Ospedale di Carpi, Carpi, Italy; Kathryn P. Gray, Shari Gelber, Richard D. Gelber, Meredith M. Regan, and Karen N. Price, International Breast Cancer Study Group Statistical Center; Kathryn P. Gray, Shari Gelber, Richard D. Gelber, and Meredith M. Regan, Dana-Farber Cancer Institute; Kathryn P. Gray and Richard D. Gelber, Harvard T.H. Chan School of Public Health; Richard D. Gelber and Meredith M. Regan, Harvard Medical School; Richard D. Gelber and Karen N. Price, Frontier Science and Technology Foundation, Boston, MA; István Láng, National Institute of Oncology, Budapest, Hungary; Beat Thürlimann, Kantonsspital, St Gallen; Beat Thürlimann, Elena Kralidis, and Daniel Rauch, Swiss Group for Clinical Cancer Research, Bern; Elena Kralidis, Kantonsspital Aarau, Aarau; Daniel Rauch, Spital Thun, Thun, Switzerland; Ehtesham A. Abdi, The Tweed Head Hospital, Tweed Heads, New South Wales and Griffith University, Southport, Queensland; Ehtesham A. Abdi and Jacquie Chirgwin, Australia and New Zealand Breast Cancer Trials Group; Jacquie Chirgwin, Box Hill and Maroondah Hospitals and Monash University, Melbourne, Victoria; Alan S. Coates, International Breast Cancer Study Group and University of Sydney School of Public Health, Sydney, New South Wales, Australia; Henry L. Gomez, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru; Barbro K. Linderholm, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, and Sahlgrenska University Hospital, Gothenburg, Sweden; and Alexandru Eniu, Cancer Institute Ion Chiricuta, Cluj, Romania. · Pubmed 27325862
  • Martine Piccart-Gebhart, Université Libre de Bruxelles, Brussels, Belgium; Eileen Holmes, Eleanor McFadden, and Andrew P. Holmes, Frontier Science (Scotland), Kincraig, Kingussie, United Kingdom; José Baselga, Memorial Sloan Kettering Cancer Center, New York, NY; Evandro de Azambuja, Institut Jules Bordet, Brussels, Belgium; Evandro de Azambuja and Stella Dolci, Breast European Adjuvant Study Team, Brussels, Belgium; Amylou C. Dueck and Anne E. McCullough, Mayo Clinic, Scottsdale, AZ; Giuseppe Viale, University of Milan, Milan, Italy; Giuseppe Viale and Aron Goldhirsch, Istituto Europeo di Oncologia, Milan, Italy; Jo Anne Zujewski, National Cancer Institute, Bethesda, MD; Aron Goldhirsch, Ospedale Regionale di Lugano, Viganello-Lugano, Switzerland; Alison Armour, GlaxoSmithKline, Collegeville, PA; Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada; Kathleen I. Pritchard, University of Toronto, Toronto, Ontario, Canada; Liu Tonghua, Peking Union Medical College Hospital, Beijing, People's Republic of China; Liu Tonghua and Binghe Xu, China Academy of Chinese Medical Sciences, Beijing, People's Republic of China; Holger Eidtmann, University Hospital Kiel, Kiel, Germany; Phuong Dinh, Breast International Group, Brussels, Belgium; Serena Di Cosimo, Istituto Nazionale del Tumori, Milan, Italy; Serena Di Cosimo, SOLTI Breast Cancer Research Group, Barcelona, Spain; Nadia Harbeck, Frauenklinik der Universität München, Munich, Germany; Sergei Tjulandin, Blokhin Russian Cancer Research Center of RAMS, Moscow, Russia; Young-Hyuck Im, Korean Cancer Study Group, Seoul, South Korea; Young-Hyuck Im, Samsung Medical Center, Seoul, South Korea; Chiun-Shen Huang, National Taiwan University Hospital, Taipei, Republic of China; Véronique Diéras, Institut Curie, Paris, France; David W. Hillman, Mayo Clinic, Rochester, MN; Antonio C. Wolff, The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Christian Jackisch, Klinikum Offenba · Pubmed 26598744
  • Meredith M. Regan and Richard D. Gelber, Dana-Farber Cancer Institute, Harvard Medical School; Karen N. Price and Richard D. Gelber, Frontier Science and Technology Research Foundation; Richard D. Gelber, Harvard T.H. Chan School of Public Health, Boston, MA; Prudence A. Francis, MacCallum Cancer Center, St Vincent's Hospital, University of Melbourne, Melbourne; University of Newcastle, Newcastle; Alan S. Coates, University of Sydney, Sydney, Australia; Olivia Pagani, Institute of Oncology of Southern Switzerland, Lugano Viganello, Switzerland; Gini F. Fleming, University of Chicago Medical Center, Chicago, IL; Barbara A. Walley, National Cancer Institute of Canada Clinical Trials Group, Calgary, Alberta, Canada; Giuseppe Viale, University of Milan; Giuseppe Viale, Marco Colleoni, and Aron Goldhirsch, European Institute of Oncology, Milan; Carlo Tondini, Ospedale Papa Giovanni XXIII, Bergamo; Graziella Pinotti, Ospedale di Circolo and Fondazione Macchi, Varese, Italy; István Láng, National Institute of Oncology, Budapest, Hungary; Henry L. Gómez, Instituto Nacional de Enfermedades Neoplásticas, Lima, Peru. · Meredith M. Regan and Richard D. Gelber, Dana-Farber Cancer Institute, Harvard Medical School; Karen N. Price and Richard D. Gelber, Frontier Science and Technology Research Foundation; Richard D. Gelber, Harvard T.H. Chan School of Public Health, Boston, MA; Prudence A. Francis, MacCallum Cancer Center, St Vincent's Hospital, University of Melbourne, Melbourne; University of Newcastle, Newcastle; Alan S. Coates, University of Sydney, Sydney, Australia; Olivia Pagani, Institute of Oncology of Southern Switzerland, Lugano Viganello, Switzerland; Gini F. Fleming, University of Chicago Medical Center, Chicago, IL; Barbara A. Walley, National Cancer Institute of Canada Clinical Trials Group, Calgary, Alberta, Canada; Giuseppe Viale, University of Milan; Giuseppe Viale, Marco Colleoni, and Aron Goldhirsch, European Institute of Oncology, Milan; Carlo Tondini, Ospedale Papa Giovanni XXIII, Bergamo; Graziella Pinotti, Ospedale di Circolo and Fondazione Macchi, Varese, Italy; István Láng, National Institute of Oncology, Budapest, Hungary; Henry L. Gómez, Instituto Nacional de Enfermedades Neoplásticas, Lima, Peru. · Pubmed 27044936
  • Christine Desmedt, Gabriele Zoppoli, Denis Larsimont, Debora Fumagalli, David Brown, Françoise Rothé, Delphine Vincent, Naima Kheddoumi, Ghizlane Rouas, Samira Majjaj, Sylvain Brohée, Roberto Salgado, Martine Piccart-Gebhart, and Christos Sotiriou, Institut Jules Bordet; Christine Galant, Cliniques Universitaires Saint Luc, Brussels; Peter Van Loo, University of Leuven; Thomas Van Brussel and Diether Lambrechts, VIB Vesalius Research Center, Leuven, Belgium; Gabriele Zoppoli, University of Genoa and Istituto di Ricerca a Carattere Clinico-Scientifico San Martino-National Cancer Institute, Genoa; Giancarlo Pruneri, Patrick Maisonneuve, and Giuseppe Viale, European Institute of Oncology; Marco Fornili and Elia Biganzoli, University of Milan, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale Tumori, Milan, Italy; Gunes Gundem and Peter J. Campbell, Wellcome Trust Sanger Institute, Cambridgeshire; Peter Van Loo, The Francis Crick Institute, London, United Kingdom; Ron Bose, Washington University School of Medicine, St Louis, MO; Otto Metzger, Dana-Farber Cancer Institute, Boston, MA; and François Bertucci, Institut Paoli-Calmettes, Marseille, France. · Christine Desmedt, Gabriele Zoppoli, Denis Larsimont, Debora Fumagalli, David Brown, Françoise Rothé, Delphine Vincent, Naima Kheddoumi, Ghizlane Rouas, Samira Majjaj, Sylvain Brohée, Roberto Salgado, Martine Piccart-Gebhart, and Christos Sotiriou, Institut Jules Bordet; Christine Galant, Cliniques Universitaires Saint Luc, Brussels; Peter Van Loo, University of Leuven; Thomas Van Brussel and Diether Lambrechts, VIB Vesalius Research Center, Leuven, Belgium; Gabriele Zoppoli, University of Genoa and Istituto di Ricerca a Carattere Clinico-Scientifico San Martino-National Cancer Institute, Genoa; Giancarlo Pruneri, Patrick Maisonneuve, and Giuseppe Viale, European Institute of Oncology; Marco Fornili and Elia Biganzoli, University of Milan, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale Tumori, Milan, Italy; Gunes Gundem and Peter J. Campbell, Wellcome Trust Sanger Institute, Cambridgeshire; Peter Van Loo, The Francis Crick Institute, London, United Kingdom; Ron Bose, Washington University School of Medicine, St Louis, MO; Otto Metzger, Dana-Farber Cancer Institute, Boston, MA; and François Bertucci, Institut Paoli-Calmettes, Marseille, France. · Pubmed 26926684
2015
  • Otto Metzger Filho, Anita Giobbie-Hurder, and Eric P. Winer, Dana-Farber Cancer Institute; Richard D. Gelber and Meredith M. Regan, Harvard Medical School; Karen N. Price, Frontier Science and Technology Research, Boston, MA; Elizabeth Mallon, Southern General Hospital; Barry Gusterson, Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom; Giuseppe Viale, European Institute of Oncology and University of Milan; Marco Colleoni and Aron Goldhirsch, European Institute of Oncology, Milan, Italy; Beat Thürlimann, Kantonsspital, St. Gallen, and Swiss Group for Clinical Cancer Research, Bern, Switzerland; Bent Ejlertsen, Rigshospitalet, Copenhagen, Denmark; Marc Debled, Institut Bergoniié, Bordeaux, France; and Alan S. Coates, International Breast Cancer Study Group, Bern, Switzerland, and University of Sydney, Sydney, Australia. · Otto Metzger Filho, Anita Giobbie-Hurder, and Eric P. Winer, Dana-Farber Cancer Institute; Richard D. Gelber and Meredith M. Regan, Harvard Medical School; Karen N. Price, Frontier Science and Technology Research, Boston, MA; Elizabeth Mallon, Southern General Hospital; Barry Gusterson, Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom; Giuseppe Viale, European Institute of Oncology and University of Milan; Marco Colleoni and Aron Goldhirsch, European Institute of Oncology, Milan, Italy; Beat Thürlimann, Kantonsspital, St. Gallen, and Swiss Group for Clinical Cancer Research, Bern, Switzerland; Bent Ejlertsen, Rigshospitalet, Copenhagen, Denmark; Marc Debled, Institut Bergoniié, Bordeaux, France; and Alan S. Coates, International Breast Cancer Study Group, Bern, Switzerland, and University of Sydney, Sydney, Australia. · Pubmed 26215945
2014
  • Antonio C. Wolff, Johns Hopkins Kimmel Comprehensive Cancer Center, Baltimore; Lisa M. McShane, National Cancer Institute, Bethesda, MD; M. Elizabeth H. Hammond, University of Utah School of Medicine and Intermountain Healthcare, Salt Lake City, UT; David G. Hicks, University of Rochester Medical Center, Rochester, NY; Mitch Dowsett, Royal Marsden Hospital, London, United Kingdom; Kimberly H. Allison, Stanford University Medical Center, Stanford; Patrick Fitzgibbons, St Jude Medical Center, Fullerton; Michael F. Press, University of Southern California, Los Angeles, CA; Donald C. Allred, Washington University School of Medicine, St Louis, MO; John M.S. Bartlett, Ontario Institute for Cancer Research; Wedad Hanna, Sunnybrook Health Sciences Center, Toronto, Ontario, Canada; Michael Bilous, University of Western Sydney and Healthscope Pathology, Sydney, New South Wales, Australia; Robert B. Jenkins, Mayo Clinic, Rochester, MN; Pamela B. Mangu, American Society of Clinical Oncology, Alexandria, VA; Soonmyung Paik, National Surgical Adjuvant Breast and Bowel Project, Pitsburgh, PA; Edith A. Perez, Mayo Clinic, Jacksonville, FL; Patricia A. Spears, North Carolina State University, Raleigh, NC; Gail H. Vance, Indiana University Medical Center, Indianapolis, IN; Giuseppe Viale, University of Milan, European Institute of Oncology, Milan, Italy; and Daniel F. Hayes, University of Michigan Comprehensive Cancer Care Center, Ann Arbor, MI. · Pubmed 24099077
  • Felipe Ades, Lina Pugliano, Debora Fumagalli, Evandro de Azambuja, Christos Sotiriou, and Martine Piccart, Institut Jules Bordet, Université Libre de Bruxelles; Dimitrios Zardavas, Breast International Group, Brussels, Belgium; Ivana Bozovic-Spasojevic, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia; and Giuseppe Viale, European Institute of Oncology, University of Milan, Milan, Italy. · Felipe Ades, Lina Pugliano, Debora Fumagalli, Evandro de Azambuja, Christos Sotiriou, and Martine Piccart, Institut Jules Bordet, Université Libre de Bruxelles; Dimitrios Zardavas, Breast International Group, Brussels, Belgium; Ivana Bozovic-Spasojevic, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia; and Giuseppe Viale, European Institute of Oncology, University of Milan, Milan, Italy. · Pubmed 25049332
  • Department of Medical Sciences, University of Turin, Turin, Italy; Pathology Unit, Department of Laboratory Medicine, Azienda Ospedaliera Città della Salute e della Scienza di Torino, Turin, Italy; Pathology Division, Santa Croce Hospital, Moncalieri, Italy; Pathology Division, Azienda USL Valle d'Aosta, Aosta, Italy; Pathology Division, Valdese Hospital, Turin, Italy; Pathology Division, Martini Hospital, Turin, Italy; Pathology Division, ASL 9, Civile Hospital, Ivrea, Italy; Department of Pathology, Regina Elena National Cancer Institute, Rome, Italy; Division of Pathology, European Institute of Oncology, Milan, Italy; University of Milan School of Medicine, Milan, Italy · Department of Medical Sciences, University of Turin, Turin, Italy; Pathology Unit, Department of Laboratory Medicine, Azienda Ospedaliera Città della Salute e della Scienza di Torino, Turin, Italy; Pathology Division, Santa Croce Hospital, Moncalieri, Italy; Pathology Division, Azienda USL Valle d'Aosta, Aosta, Italy; Pathology Division, Valdese Hospital, Turin, Italy; Pathology Division, Martini Hospital, Turin, Italy; Pathology Division, ASL 9, Civile Hospital, Ivrea, Italy; Department of Pathology, Regina Elena National Cancer Institute, Rome, Italy; Division of Pathology, European Institute of Oncology, Milan, Italy; University of Milan School of Medicine, Milan, Italy. · Pubmed 25323485
2013
  • Antonio C. Wolff, Johns Hopkins Kimmel Comprehensive Cancer Center, Baltimore; Lisa M. McShane, National Cancer Institute, Bethesda, MD; M. Elizabeth H. Hammond, University of Utah School of Medicine and Intermountain Healthcare, Salt Lake City, UT; David G. Hicks, University of Rochester Medical Center, Rochester, NY; Mitch Dowsett, Royal Marsden Hospital, London, United Kingdom; Kimberly H. Allison, Stanford University Medical Center, Stanford; Patrick Fitzgibbons, St Jude Medical Center, Fullerton; Michael F. Press, University of Southern California, Los Angeles, CA; Donald C. Allred, Washington University School of Medicine, St Louis, MO; John M.S. Bartlett, Ontario Institute for Cancer Research; Wedad Hanna, Sunnybrook Health Sciences Center, Toronto, Ontario, Canada; Michael Bilous, University of Western Sydney and Healthscope Pathology, Sydney, New South Wales, Australia; Robert B. Jenkins, Mayo Clinic, Rochester, MN; Pamela B. Mangu, American Society of Clinical Oncology, Alexandria, VA; Soonmyung Paik, National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA; Edith A. Perez, Mayo Clinic, Jacksonville, FL; Patricia A. Spears, North Carolina State University, Raleigh, NC; Gail H. Vance, Indiana University Medical Center, Indianapolis, IN; Giuseppe Viale, University of Milan, European Institute of Oncology, Milan, Italy; and Daniel F. Hayes, University of Michigan Comprehensive Cancer Care Center, Ann Arbor, MI. · Pubmed 24101045
  • Affiliations of authors: Biometric Research Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD (MCP, LMM); Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada (SCYL, DG, EM, TON); Department of Laboratory Medicine and Pathology, University of Alberta, Alberta, Canada (JCH); Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy (MGM); Division of Pathology and Laboratory Medicine, European Institute of Oncology, and University of Milan, Milan, Italy (GV); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom (LAZ); Department of Pathology, Centre Jean Perrin, Clermont-Ferrand, and Université d'Auvergne, France (FP-L); Transformative Pathology, Ontario Institute for Cancer Research, Toronto, Ontario, Canada (JMSB); PhenoPath Laboratories, Seattle, WA (AMG); Department of Pathology, MD Anderson Cancer Center, Houston, TX (WFS); Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, United Kingdom (TP); The EMMES Corporation, Rockville, MD (RAE); Breast Oncology Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI (DFH); Academic Department of Biochemistry, Royal Marsden Hospital, London, United Kingdom (MD); on behalf of the International Ki67 in Breast Cancer Working Group of the Breast International Group and North American Breast Cancer Group. · Pubmed 24203987
  • Division of Pathology, European Institute of Oncology, Milan, Italy. · Pubmed 23763700
2011
  • Division of Senology, European Institute of Oncology, University of Milan, Milan, Italy. · Pubmed 21248632
2010
  • Research Unit in Medical Senology, Department of Medicine, European Institute of Oncology, Università degli Studi di Milano, Milan, Italy. · Pubmed 20458051
University of Milan Bicocca
2014
  • Division of Pathology, European Institute of Oncology, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy; University of Milan School of Medicine; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy; University of Milan School of Medicine; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy. Electronic address: · Pubmed 24709436
99 Other Locations Show
Yearly article counts 010152021201614211620